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The gilthead seabream (Sparus aurata) and European seabass (Dicentrarchus labrax) 
require n-3 long-chain polyunsaturated fatty acids (LC-PUFA), eicosapentaenoic acid 
(EPA) and docosahexaenoic acid DHA, for optimal growth and health. Due to the rapid 
growth of global aquaculture the quantity of marine oils used in aquafeeds has been 
limited, yet the overall quantity of oil in an aquafeed has increased by the addition of 
vegetable oil (VO) to supply dietary energy. For aquaculture to continue to grow more 
fish must be produced with less marine ingredients, yet EPA and DHA must be 
maintained at levels above fish requirements. This project set out to re-evaluate the 
requirement for EPA and DHA in gilthead seabream and European seabass. Two 
dose-response studies were designed and executed where juvenile seabream and seabass 
were fed one of six levels of EPA+DHA (0.2 – 3.2 % as fed). Biometric data were 
collected and analysed to determine new requirement estimates for EPA+DHA for fish 
of two weight ranges (24 – 80 g and 80 – 200 g). The effects of the dietary LC-PUFA 
gradient on lipid composition and metabolism were also considered. This project found 
that the requirement for EPA+DHA declines with fish weight and that the current 
published EFA requirements are too low for both species when fed modern diet 
formulations. At a size range of 24 – 80 g, the period when a 3 mm pellet is consumed, 
the optimum requirement for growth is 1.3 – 1.5 % EPA+DHA, for both species. Beyond 
~80 g (4.5 mm pellet) seabream require 1.20 – 1.25 % EPA+DHA, whereas seabass 
require 1.10 – 1.20 % EPA+DHA. Previous studies in both species, indicated that 
juveniles require approximately 1% LC-PUFA in their diets. In both species the addition 
of VO to the diet increased the level of lipid in the liver. Fatty acid and gene expression 




mid-intestine, as FO was replaced by VO. The expression of lipogenic genes was also 
upregulated in the mid-intestine of both species but in liver only in seabream. The 
implications of this project are that EPA and DHA need to be supplied at a higher level 
when fish are < 80 g (3 mm pellet) and then in larger pellet sizes dietary FO can be 
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AGR – Absolute growth rate (g day-1) 
AIC – Akaike information criterion 
ALA – Alpha linolenic acid 
ANOVA – Analysis of variance 
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FER – Feed efficiency ratio 
FM – Fishmeal 
FO – Fish oil 
FOB – Free on board 
FPL – Four parameter logistic function 




GC – Gas chromatography 
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Gilthead seabream (Sparus aurata) and European seabass (Dicentrarchus labrax) 
represent the principal farmed finfish species in the Mediterranean region. Both are 
essentially marine species, although the European seabass is known to enter estuarine 
waters. In 2015, global aquaculture production of gilthead seabream and European 
seabass was 166,794 and 162,399 tonnes, respectively (Faostat 2015). Gilthead seabream 
and European seabass are typically produced in intensive inshore submerged net cages, 
where fish are fed extruded aquafeeds (Rosa, Marques et al. 2014). They are mainly 
carnivorous species that obtain energy from the protein and lipid components of their 
diets, and make poor use of dietary carbohydrates (Oliva-Teles 2000). Modern diets for 
finfish species have reduced fishmeal (FM) and fish oil (FO) contents, which is driven by 
two key incentives: 1) these raw materials are expensive, and 2) their supply is limited by 
the productivity of marine fisheries (Fisheries 2016). Aquaculture is a growing sector 
with a vital role to play in increasing world food supply. However, if it is to be a net 
producer of fish it must seek to minimise its use of capture fisheries production by seeking 
alternative sources of protein and lipid to support its expansion (Tacon, Hasan et al. 2006, 
Merino, Barange et al. 2012, Shepherd, Jackson 2013).  
Living organisms have requirements for specific nutrients. In its simplest terms, a 
requirement can be defined as the quantity of a given nutrient required for growth and 
reproduction (Molina-Poveda 2016). Traditionally, in nutritional studies growth is used 
as the response from which to define a requirement as this is the primary concern of 
aquaculturists (National Research Council 2011). The definition of requirement becomes 




even colour) of the product are considered. Furthermore, a diet is supplied to the organism 
as a mixture of nutrients that may have interactions with one another and may contain 
antinutrients that affect ingredient digestibility (Krogdahl, Penn et al. 2010). Organisms 
must acquire essential nutrients from their diets; a nutrient is essential to an organism if 
it cannot be synthesised de novo, or in sufficient quantities to meet physiological demand 
(Molina-Poveda 2016). Essential nutrients, therefore, have quantitative requirements, 
which are usually expressed as a proportion of the diet (National Research Council 2011). 
Therefore, essential fatty acids (EFA) must be supplied in feeds for farmed fish 
(aquafeeds) to ensure growth and normal physiological functions. There are two fatty 
acids that cannot be synthesised by vertebrates, namely the C18 polyunsaturated fatty 
acids (PUFA) α-linolenic acid (18:3n-3, ALA) and linoleic acid (18:2n-6, LOA), due to 
the absence of enzymes that produce them from oleic acid (18:1n-9) (Castro, Tocher et 
al. 2016). However, particularly in marine species, long-chain (C ≥ 20) polyunsaturated 
fatty acids (LC-PUFA) are also required preformed in the diet as the activities of 
elongation and desaturation enzymes are insufficient to supply LC-PUFA from C18 PUFA 
precursors (Glencross 2009, Sargent, Tocher et al. 2002). Consequently, three LC-PUFA 
are regarded as EFA for marine species with low LC-PUFA biosynthetic capability, 
namely the n-3 fatty acids eicosapentaenoic acid (EPA, 20:5n-3) and docosahexaenoic 
acid (DHA, 22:6n-3), and the n-6 arachidonic acid (ARA, 20:4n-6) (see Section I.2.1.2) 
(Sargent et al. 2002). 
EPA and DHA are abundant in marine ingredients, particularly FO, and aquafeeds 
formulated with these raw materials can satisfy the physiological demands of fish. 
However, oils derived from terrestrial crops, herein referred to as “vegetable oils” (VO) 




instead, are rich in oleic acid, ALA and LOA. As a dietary ingredient, VO is an effective 
means of supplying dietary energy but the requirements for LC-PUFA must be met with 
FO or an alternative source. This is important to ensure good growth, health, welfare and 
fillet EFA content of farmed fish (Sargent et al. 2002, Tocher 2003, National Research 
Council 2011). 
There has been a move towards higher energy diet formulations, by the addition of 
oil such as VO to promote fast growth and to “spare” dietary protein (Sargent et al. 2002), 
and this may affect the nutrient demands of the fish (Glencross 2009). The requirements 
for n-3 LC-PUFA in gilthead seabream and European seabass are based on very few 
studies and so further data would contribute towards diet formulations while the pressure 
on limited marine materials is growing. Due to the increased lipid levels of today’s diet 
formulations there is a need to revisit requirement levels for LC-PUFA, particularly in 
the diets of marine fish where oil content (typically as VO) has increased while FM 
content has been reduced (National Research Council 2011,  Glencross 2009).  
I.2 Lipids, structure, function and metabolism 
Lipids and fatty acids are a diverse group of organic molecules unified by their 
solubility in organic solvents. Most lipids are found in biological samples as lipid classes, 
such as triacylglycerols (TAG), phospholipids or sphingolipids, many lipid classes 
include fatty acids conjugated with ester bonds (Christie 2003). This section will give a 
brief introduction to aspects of lipid metabolism that are relevant to EFA requirement 
research. The reader should appreciate that most of the data presented in this section are 




qualitatively, in a similar way to fish. The contents of this section are generally applicable 
to all vertebrates.  
I.2.1 Lipid structure and nomenclature 
I.2.1.1 Lipid classes  
Analytically, lipid classes are separated by their polarity and can thus be classified 
as non-polar (or neutral) lipids and polar lipids. The molecule TAG, is composed of three 
fatty acids esterified to glycerol hydroxyl groups. The three positions of the fatty acids 
are denoted: sn-1, sn-2 and sn-3. All animal tissues contain TAG but there are tissues 
used as lipid depots (e.g. adipose tissue) where TAG will dominate the lipid class 
composition. The primary function of TAG is to store energy. TAG fatty acid 
compositions are highly susceptible to dietary fatty acid compositions (Christie 2003). 
 The sterols are planar tetracyclic carbon compounds. The main sterol in animal 
tissues is cholesterol, which has a single hydroxyl group at one end and a flexible octyl 
side chain at the other end. The structure of cholesterol allows the rigid aliphatic rings to 
embed into the acyl chains of animal membranes and its polar hydroxyl group interacts 
with the polar head groups of fatty acids. Cholesterol is also the precursor molecule for 
the steroid hormones. The hydroxyl group of cholesterol may also be esterified to a fatty 
acid creating a sterol ester (Christie 2003).  
Polar lipids include phospholipids and sphingolipids. The term phospholipid (or 
glycerophospholipid) refers to the major lipid constituent of membranes and typically 
they consist of two fatty acids esterified to glycerol and a hydrophilic phosphate group. 




ethanolamine or serine) and two aliphatic acyl chains esterified to glycerol in the sn-1 and 
sn-2 positions. The diversity of fatty acids gives rise to a great diversity of chemical 
species, but generally a PUFA is esterified to the sn-2 position and a saturated fatty acid 
(SFA) to the sn-1 position (Sargent et al. 2002). The principal phospholipids are 
phosphatidylinositol (PI), phosphatidylserine (PS), phosphatidylethanolamine (PE) and 
phosphatidylcholine (PC). The amphipathic properties of the phospholipids are central in 
their main role in the formation of bilayer cellular membranes (Christie 2003). 
Sphingolipids are another important lipid class associated with the polar fraction. They 
are formed from a long chain fatty acid linked to a sphingosine base (an 18-carbon amino 
alcohol) by an amine bond to form a ceramide. A vast range of molecules can be attached 
to one of the hydroxyl groups (carbohydrates and polar head groups) making 
sphingolipids important in cell recognition and signalling. Sphingomyelin is a ceramide 
with a polar head group (choline, ethanolamine) and interacts with cholesterol in the outer 
leaflet of cellular membranes to form microdomains (lipid rafts) (Christie 2003).  
I.2.1.2 Fatty acids 
Fatty acids consist of a chain of carbon and hydrogen atoms, called the acyl chain, with 
one end having a methyl group (CH3) and the other a carboxylic acid group (COOH). The 
acyl chain can be any number of carbons but in animal lipids mostly even numbers of 
carbons are found. The acyl chain is also classified by varying degrees of saturation. A 
SFA has all the carbon atoms occupied by two hydrogen atoms and three for the methyl 
end. Unsaturations (or double bonds) occur in fatty acyl chains when two hydrogens are 
removed from two adjacent carbons forming an ethylene group (RHC=CHR), natural 




chain. Unsaturation increases the fluidity (i.e. reduces the melting point) of the fatty acid. 
If there is one ethylene group the fatty acid is a monounsaturated fatty acid (MUFA) or 
“monoene”, when two or more are present it is a polyunsaturated fatty acid (PUFA) or 
“polyene”. The nomenclature for classifying PUFA used in the nutrition literature is the 
n (or ω) series, which denotes the position of the first ethylene group relative to the methyl 
terminal of the acyl chain. This nomenclature is adopted here. Series of PUFA occurring 
in animal samples include n-3, n-6, n-9 and n-11 series. The Δ nomenclature denotes the 
position of the first ethylene group relative to the carboxyl group but is not widely used 
by nutritionists. As an example, 18:1n-9 (cis Δ9 octadecanoic acid, 18:1 Δ9) has 18 
carbons, with one single ethylene bond (i.e. MUFA) on the 9th carbon from the methyl 
group and termed with the trivial name of oleic acid. Representative fatty acids from the 
SFA, MUFA, and n-3 and n-6 PUFA are given in Figure I.1. (Christie 2003, Tocher 2003, 
Sargent et al. 2002).  
 
Figure I.1. A representative from each fatty acid group 
Figure I.1. A representative from each fatty acid group: a saturated fatty acid, palmitic 
acid (a); a monounsaturated fatty acid, oleic acid (b); an n-3 polyunsaturated fatty acid, 




I.2.2 Fatty acid and LC-PUFA biosynthesis 
Vertebrate animals have varying capacities for the de novo synthesis and 
modification of fatty acids (Monroig, Navarro et al. 2011). There are several key enzymes 
involved in the synthesis and modification of fatty acids, these including the fatty acid 
synthase complex, fatty acid elongases and desaturases (Guillou, Zadravec et al. 2010). 
I.2.2.1 Synthesis of saturated and monounsaturated fatty acids 
In animals, the SFA palmitic acid (16:0) and stearic acid (18:0) can be produced by 
a cytosolic enzyme complex termed the type I fatty acid synthase (FAS I). This complex 
is formed of two identical monomers arranged in an anti-parallel manner, a feature which 
is crucial to its function (Chirala, Wakil 2004). The first substrate is acetyl-CoA 
(COCH3-CoA). Two carbons are sequentially added in a cyclic series of reactions 
sourcing carbons from the substrate malonyl-CoA (a 3-carbon unit, one lost as CO2), 
which involves condensation, keto-reduction, dehydration and enoyl-reduction. The 
overall reaction is summarised as: 
𝐴𝑐𝑒𝑡𝑦𝑙 − 𝐶𝑜𝐴 + 7 𝑀𝑎𝑙𝑜𝑛𝑦𝑙 − 𝐶𝑜𝐴 + 14 𝑁𝐴𝐷𝑃𝐻 + 14 𝐻+  
→ 𝑃𝑎𝑙𝑚𝑖𝑡𝑖𝑐 𝑎𝑐𝑖𝑑 + 7 𝐶𝑂2 + 8 𝐶𝑜𝐴 + 14 𝑁𝐴𝐷𝑃 + 6 𝐻2𝑂  
Although the primary products of FAS I are palmitic acid (16:0) and stearic acid 
(18:0), the FAS I complex is not completely substrate specific and other products include 
shorter chain length SFA such as lauric acid (12:0) and myristic acid (14:0), and even 
branched chain fatty acids (Smith 1994, Chirala, Wakil 2004). FAS I activity in marine 
carnivorous fish is not likely to be of high importance since these fish have high lipid 




The biosynthesis of MUFA is achieved by the action of the stearoyl CoA desaturase-1 
(SCD), an enzyme with Δ9 desaturation activity (Guillou et al. 2010). Consequently, SCD 
can desaturate palmitic (16:0) and stearic (18:0) acids to palmitoleic (16:1n-7) and oleic 
(18:1n-9) acids, respectively. 
I.2.2.2 LC-PUFA biosynthesis in vertebrates 
LC-PUFA biosynthesis (Figure I.2) is the alternate elongation and desaturation 
reaction sequence of PUFA by elongase and desaturase enzymes, respectively. The 
protein/gene names for elongases and desaturases are Elovl/Elovl and Fads/Fads, 
respectively (Castro et al. 2016). It is an organism’s repertoire of functional elongases 
and desaturases that determines whether the LC-PUFA (EPA, ARA and DHA) are 
essential in the diet (Castro et al. 2016). Vertebrates do not possess enzymes capable of 
the Δ12 or Δ15 desaturations that are required to desaturate oleic acid (18:1n-9) to n-6 
LOA or n-3 ALA, respectively, and therefore LOA and ALA have a dietary requirement 
(Wallis, Watts et al. 2002). Many marine fish cannot elongate and or desaturate LOA and 
ALA so therefore LC-PUFA are essential (Castro et al. 2016). 
The elongases, or elongation of very long-chain fatty acid (ELOVL) proteins, are a 
family of enzymes that elongate fatty acids in the endoplasmic reticulum. In mammalian 
models, Guillou et al. (2010) describes seven elongases (ELOVL1-7), these being divided 
into two groups according to their substrate specificities: 1) ELOVL1, 3, 6 and 7, which 
elongate SFA and MUFA; and 2) ELOVL2, 4 and 5, which primarily elongate PUFA. 
However, this is a simplistic generalisation as ELOVL4 has also been shown to be 
involved in the elongation of SFA to produce very long-chain SFA (VLC-SFA) of C28-30 




condense them with malonyl-CoA moieties, therefore extending the acyl chain by two 
carbons per interaction with the elongase. ELOVL1, 5 and 6 are ubiquitously expressed 
in tissues, whereas, ELOVL2, 3, 4 and 7 show tissue specific expression (Guillou et al. 
2010). Studies in murine models indicate that tissue specific expression of these enzymes 
is related to the respective tissues demand for very long chain (VLC, >C24) fatty acids 
(Guillou et al. 2010, Jakobsson, Westerberg et al. 2006).  
 
Figure I.2. Long-chain polyunsaturated fatty acid biosynthesis 
Figure I.2. Pathways of n-3 LC-PUFA biosynthesis (Castro, Monroig et al. 2012). 
Desaturations performed by Fads enzymes proceed from left to right and elongations 
performed by elongases proceed from top to bottom. Note: 1. The same enzymes modify 
the n-6 PUFA. 2. The critical position of Δ5 Fads. 
The Fads insert double bonds into acyl chains at specific positions, denoted from the 
Δx carbon. As with the Elovl enzymes, the Fads are localised in the endoplasmic 
reticulum. The same enzymes operate on n-3 and n-6 equivalent substrates. ARA and 
EPA can be produced by the action of a Δ6/8 Fads and elongation by ELOVL5. 
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ELOVL2/4/5 can further elongate ARA or EPA to docosapentaenoic acid (DPA, 22:5n-
3) and a Δ4 Fads is required to produce DHA, however most vertebrates (except some 
fish) do not possess a Δ4 Fads. Therefore, DHA is produced via the Sprecher pathway, 
DPA is elongated to 24:5n-3, which can be desaturated by a Δ6 Fads to 24:6n-3, this fatty 
acid being subsequently shortened by a single round peroxisomal β-oxidation to produce 
DHA (Voss, Reinhart et al. 1991). As a result, all LC-PUFA can be produced with Δ5 
and Δ6 Fads enzymes (i.e. no Δ4 activity required). However, some Δ8 activity has also 
been demonstrated towards 20:2n-6 and 20:3n-3 using a baboon (Papio anubis) FADS2 
sequence (Park, Kothapalli et al. 2009). In mammals there are three Fads genes, FADS1, 
FADS2 and FADS3. FADS1 and FADS2 encode proteins with Δ5 and Δ6 activity, 
respectively (Guillou et al. 2010, Zhang, Qin et al. 2014). FADS3 has recently been shown 
to be important in regulating hepatic DHA synthesis in new-born mice (Zhang, Qin et al. 
2017). Due to the presence of this pathway only LOA and ALA are EFA in many 
mammals as they can be used to synthesise LC-PUFA. 
I.2.2.3 LC-PUFA biosynthesis in fish 
As mentioned, the ability to produce LC-PUFA is determined by the complement of 
Elovl and Fads enzymes expressed by an organism and their regulatory mechanisms 
(Sargent, Bell et al. 1999, Monroig et al. 2011). The inability of marine fish such as 
gilthead seabream and European seabass, to operate LC-PUFA biosynthesis pathways is 
largely related to the absence or inefficient activity of Δ5 Fads and absence of an Elovl2 
(Castro et al. 2016).  
The presence of functional teleost elongases has been demonstrated in yeast 




have been found in any marine farmed fish species (Morais, Monroig et al. 2009,  Castro 
et al. 2016), but Elovl2 has been found in Atlantic salmon (Morais et al. 2009) and 
zebrafish (Danio rerio) (Monroig, Rotllant et al. 2009). As in mammals, the teleost Elovl5 
has activity on C18 and C20 substrates, but also with some activity towards C22 substrates 
in gilthead seabream, Atlantic salmon (Salmo salar) and turbot (Psetta maxima) (Agaba, 
Tocher et al. 2005). Furthermore, the meagre (Argyrosomus regius) has been shown to 
possess an Elovl5 with activity towards C16 - C20 substrates (Monroig, Tocher et al. 2013). 
Thus, it can be concluded that Elovl5 is more functionally diverse in marine teleosts than 
mammals (Castro et al. 2016). There are two Elovl4 isoforms in fish (Elovl4a and 
Elovl4b) in zebrafish, both were shown to have capacity to elongate SFA up to C36 but 
the Elovl4b also showed activity against PUFA (Monroig et al. 2009). Elovl4b 
orthologues have been found to be active in Cobia (Rachycentrum canadum) (Monroig, 
Webb et al. 2011) Atlantic salmon (Carmona-Antoñanzas, Monroig et al. 2011), 
rabbitfish (Siganus canaliculatus) (Monroig et al. 2011) and Nibe croaker (Kabeya, 
Yamamoto et al. 2015). The evidence suggests that this elongase can perform the 
elongation of 22:5n-3 to 24:5n-3, which can reach DHA via Δ6 desaturation and β-
oxidation. Whence, in some marine species, Elovl4b may perform some elongations 
previously thought to be limited to Elovl2 (Castro et al. 2016). 
Teleost Fads are all orthologues of mammalian FADS2 with mostly Δ6 activities 
(Monroig et al. 2011). However, in zebrafish (Danio rerio), a bifunctional Fads was 
discovered with Δ5 and Δ6 activities (Hastings, Agaba et al. 2001) and in rabbitfish (Li, 
Monroig et al. 2010) a bifunctional Fads enzyme has been described that possesses Δ5 
and Δ6 activities. Subsequently, the Atlantic salmon was found to have a monofunctional 




Carmona-Antoñanzas et al. 2016). Interestingly, the rabbitfish (Li et al. 2010), Senagalese 
sole (Solea senegalensis) (Morais, Castanheira et al. 2012), medaka (Oryzias latipes) and 
Nile tilapia (Oreochromis niloticus) also possesses a Fads with Δ4 activity required to 
desaturate DPA (22:5n-3) to DHA (22:6n-3) (Oboh, Kabeya et al. 2017). Therefore, there 
are two pathways in fish that could potentially produce DHA, the Sprecher pathway and 
the Δ4 pathway (Oboh et al. 2017, Castro et al. 2016). 
It has been demonstrated in Atlantic salmon that the pathways for LC-PUFA 
synthesis are influenced by levels of EPA and DHA in the diet; activities of the relevant 
enzymes can be increased in the absence of dietary EPA and DHA (Zheng, Tocher et al. 
2005). Due to this ability, Atlantic salmon have a lower requirement for EPA and DHA. 
However, the expression of the pathway is tissue specific with highest activities reported 
in the intestine, liver and neural tissues (Zheng et al. 2005). Therefore, despite an ability 
to synthesise LC-PUFA, it is still desirable to supply Atlantic salmon with LC-PUFA as 
muscle EPA and DHA will be low (Bell, Tocher et al. 2003, Tocher 2015). The point to 
emphasise with this example is that an organism with the capacity to synthesise LC-PUFA 
will do so in the tissues where LC-PUFA is required and not necessarily in the edible 
muscle. 
In agreement with the marine species described above, the herein studied species 
gilthead seabream and European seabass have inefficient LC-PUFA biosynthetic 
pathways. In gilthead seabream, a Δ6 Fads2 with minimal Δ5 desaturase activity has been 
demonstrated in the brain, eye and liver by injection of C14-labelled linolenate and 
recovery of radioactive DHA, albeit low quantities (Mourente, Tocher 1998). Further 




viscera but not a Δ5. Furthermore, Δ6 desaturation products such as 18:3n-6 and Iso 
18:2n, are known to accumulate in tissues when gilthead seabream is fed a diet deficient 
in LC-PUFA (Torrecillas, Robaina et al. 2017). According to a recent study, the gilthead 
seabream Fads2 is active towards C24 substrates, which could be shortened to DHA via 
peroxisomal β-oxidation, providing adequate dietary precursors (i.e. EPA or DPA) are 
present (Oboh et al. 2017). Like other marine species, incomplete LC-PUFA synthesis in 
gilthead seabream is due to absence of Δ5 desaturase and elongase activity towards C20 
PUFA (Elovl2). European seabass has been shown to possess Fads with Δ6 activity, but 
no Δ5 activity and Δ6 activity was unaffected by VO inclusion (Mourente, Dick et al. 
2005, Mourente, Dick 2002). Genetic characterisation has demonstrated that this is a 
fads2 homologue with higher expression patterns in the brain and intestine (Santigosa, 
Geay et al. 2011, González-Rovira, Mourente et al. 2009, Geay, Santigosa et al. 2010). 
However, when expressed in yeast one study found Fads2 to show n-3 substrate 
preferences (González-Rovira et al. 2009) and a later study found no preference for n-3 
or n-6 substrates (Santigosa et al. 2011). Importantly, biochemical and polymerase chain 
reaction (PCR) based approaches have generated coherent data. Like other marine 
species, LC-PUFA synthesis in European seabass is primarily due to absence of Δ5 
desaturase and elongase activity towards C20 PUFA (Elovl2). 
In summary, gilthead seabream and European seabass do not have the ability to 
produce LC-PUFA from C18 precursor fatty acids, and so, these must be supplied in the 
diet, as is the case with most marine carnivorous fish (Sargent et al. 2002). The presence 
or absence of an active pathway for LC-PUFA biosynthesis is most likely a result of the 
animal’s diet, but this interpretation may also be complicated by the phylogenetic history 




I.2.3 Fatty acid oxidation 
Chemical energy from the carbon bonds of a fatty acid can be accessed by the 
β-oxidation pathway. β-oxidation occurs primarily in mitochondria although some 
branched chain fatty acids or LC-PUFA must be catabolised by peroxisomal β-oxidation. 
The role of mitochondrial β-oxidation is to produce acetyl-CoA for the tricarboxylic acid 
cycle and the reducing agents nicotidinamide adenine dinucleotide (NADH) and flavin 
adenine dinucleotide (FADH2) that participate in oxidative phosphorylation. β-oxidation 
is a cyclical process and two carbon acetyl are removed from the carboxyl end of the acyl-
CoA each cycle (Halver, Hardy 2002). β-oxidation involves five reactions:  
1. Formation of the acyl-CoA, consuming 2ATP (cytosol), the acyl-CoA is 
transferred into mitochondria via the carnitine shuttle 
2. Dehydration to form β-dehyroacyl-CoA 
3. Hydration to form β-hyroxyacyl-CoA 
4. Oxidation to β-ketoacyl-CoA 
5. Lysis (after the β carbon) to form an acyl-CoA and an acetyl-CoA 
Using palmitate as an example: 
𝑃𝑎𝑙𝑚𝑖𝑡𝑜𝑦𝑙 𝐶𝑜𝐴 + 2𝐴𝑇𝑃 + 7𝑁𝐴𝐷 + 7𝐹𝐴𝐷 
→ 8 𝐴𝑐𝑒𝑡𝑦𝑙 𝐶𝑜𝐴 (96𝐴𝑇𝑃) + 7𝑁𝐴𝐷𝐻 (21𝐴𝑇𝑃) + 7𝐹𝐴𝐷𝐻2 (14𝐴𝑇𝑃)  
The acetyl-CoA molecules are available for the tricarboxylic acid cycle and NADH 
and FADH2 are electron transporters in oxidative phosphorylation. In the mitochondria, 
β-oxidation is coupled to oxidative phosphorylation and provides energy to the organism 




The oxidation of fatty acids can have an impact on the fatty acid composition, particularly 
in the TAG fraction. The fatty acids, 22:1n-11, 20:1n-9, 18:1n-9, 16:1n-7, 16:0 and 18:0 
are good substrates for β-oxidation in fish (Tocher 2003, Henderson, Sargent 1985). 
In mammals, long chain fatty acids (> C20) and branched chain fatty acids cannot be 
handled by mitochondrial β-oxidation and are oxidised within peroxisomes, which 
employ a different subset of enzymes (Wanders, Poll-The 2017). This appears to be 
different in fish, at least in Notothenia gibberifrons, where C20 PUFA were demonstrated 
to be adequate substrates for mitochondrial β-oxidation (Crockett, Sidell 1993).  
The chemical energy stored in the carbon bonds of fatty acids is accessed via 
mitochondrial or peroxisomal oxidation (Houten, Wanders 2010). The purpose of 
peroxisomal oxidation appear to be to process fatty acids (branched or LC-PUFA) that 
cannot be handled by mitochondrial oxidation. The energy yield of peroxisomal β-
oxidation is approximately half of the yield of mitochondrial β-oxidation (Mannaerts, van 
Veldhoven 1996). It should be noted that vertebrates must catabolise or store carbon 
compounds.  
I.2.4 Membranes and DHA 
Membrane lipid bilayers are formed of a complex mixture of lipid classes, mainly 
the glycerophospholipids, cholesterol and sphingolipids. Membranes are not homogenous 
and their lipid compositions vary between the leaflets, laterally, between different cellular 
organelles or even between basolateral and apical membranes in epithelial cells. DHA 
has specialised functions within membranes, particularly in retina and neural tissues 




rely on complex control mechanisms to regulate the synthesis of lipids and ship them to 
different cellular locations. To this effect ~5% of the transcribed mammal genome is 
involved in lipid biosynthesis and regulation (Van Meer, Voelker et al. 2008). The role 
of the fatty acids within the membrane is to provide the hydrophobic barrier and the 
properties of the membrane are a function of its fatty acid composition (Van Meer et al. 
2008). 
Phospholipids have two fatty acid chains and, as previously noted, a PUFA often 
occupies the sn-2 position of glycerol and a SFA, usually stearic or palmitic acids, 
occupies the sn-1 position. The functional significance of this is to keep the membrane in 
a fluid phase at physiological temperatures. DHA forms 30 – 50% of total fatty acids in 
vertebrate nervous tissues (Salem Jr, Litman et al. 2001). Although the precise functions 
of the molecule within these membranes are not entirely clear, studies of molecular state 
of DHA phospholipids reveal that this molecule is highly flexible due to the C-C bonds 
in between each of its C=C (Gawrisch, Eldho et al. 2003). It has been postulated that 
DHA containing phospholipids accommodates the conformational changes that proteins 
undergo that are critical to their functions (Gawrisch et al. 2003). Furthermore, DHA 
plasmaethanolamine is thought to accelerate membrane fusion events that are critical to 
release neurotransmitters into synaptic junctions (Bari et al. 2017, Géraldine, Stéphanie 
et al. 2010). The effect of DHA rich glycerophospholipids has also been studied in the 
context of lipid-lipid interactions and the presence of this fatty acid is suggested to 
facilitate lateral heterogeneity across the membrane by excluding cholesterol and 
sphingomyelin rich domains (lipid rafts) (Stillwell, Shaikh et al. 2005, Van Meer et al. 
2008). The neurological tissues exhibit pathologies when DHA is absent and therefore 




above, DHA has unique properties that appear to enhance the properties of membranes 
that are essential to their function and performance.  
I.2.5 Fatty acid derivatives 
LC-PUFA are precursor molecules for secondary metabolites (lipid mediators) that 
play roles as retrograde mediators of inflammation. Eicosanoids and docosanoids are 
produced by the cleavage of LC-PUFA of the n-3 or n-6 series from membrane 
phospholipids. Lipid mediator classes include the eicosanoids (derived from C20 fatty 
acids), prostanoids (prostaglandins and prostacyclins), thromboxanes, leukotrienes, 
lipoxins, hydroxyl and epoxy fatty acids and the docosanoids (derived from DHA): 
resolvins, protectins and maresins. It is important to emphasise that the fatty acid 
composition of membrane phospholipids influences the production of lipid mediators and 
thus the resolution or stimulation of inflammation (Tocher, Glencross 2015). 
Lipid mediators are potent molecules with short half-lives (10s to 10mins depending 
on metabolite and species) exerting their effects locally in inflamed tissues. Inflammation 
is a natural response to infection or injury, and its primary purpose is to make the local 
tissue more accessible to the host immune system. In vertebrates, symptoms of 
inflammation include swelling, pain and redness due to vasodilation. Leukocytes of the 
host are attracted to inflammatory sites by a range of cytokines (e.g. Tumor-necrosis-
factor 1α, Interleukin 1, 6) and the production of some of these cytokines can be amplified 
or dampened by pro- or anti-inflammatory eicosanoids (e.g. Prostaglandin E2, F2). Acute 
inflammation helps resolve infection and recover from injury, but chronic inflammation 
can be the cause of inflammatory diseases, therefore it is imperative that the host can 




After LC-PUFA are cleaved from phospholipids by phospholipiase A2, lipid 
mediators are produced by the action of lipoxygenase (LOX) and cyclooxygenase (COX) 
enzymes (except the epoxyeicosatetranoic acids which involve cytochrome P450 
epoxygenase). The COX and LOX enzymes oxygenate and restructure acyl chains 
inserting ring structures, hydroxyl and epoxy groups (Calder 2006). Lipid mediators have 
an extensive range of physiological functions, such as vasodilation or constriction, 
platelet aggregation, sensitise neurones (leading to pain), regulation of hormones, tissue 
regeneration and apoptosis. Functional diversity is derived not only from molecular 
diversity but also receptor diversity (Calder 2006, O'Connor, Manigrasso et al. 2014). As 
C20 lipid mediators are derived from C20 fatty acids of the n-3 or n-6 series, the ratio 
between the n-3 and n-6 fatty acids determine the moieties of prostaglandins, thromboxins 
or leukotrienes that will be produced by substrate competition for the COX or LOX 
pathways. Generally, autocoids (hormone-like molecules that exert their action locally) 
from n-3 fatty acid such as EPA and eicosatetraenoic acid (20:4n-3) have anti-
inflammatory effects, whereas the n-6 autocoids have pro-inflammatory effects. 
Therefore, the fatty acid composition of polar lipid classes has consequences on the 
organism’s response to disease or trauma, particularly those involving chronic 
inflammation (Schmitz, Ecker 2008). However, prostaglandin-E2 exerts both pro- and 
anti-inflammatory actions complicating the generalisation between n-3 and n-6 derived 
lipid mediators (Calder 2009). Compared to mammals, lipid mediators are not well 
understood in fish, but the available data suggest that their metabolism is broadly similar 
(Ghioni, Porter et al. 2002). Lipid mediators are essential to vertebrates and these cannot 




I.2.6  Conclusions  
Animals need lipids for energy and to build cell membranes. Animals also need 
specific n-3 or n-6 fatty acids for their properties within membranes but also as 
autocrine/paracrine messenger molecules. Organisms have the machinery required to 
apply complex organisation to their lipids. Marine carnivores have limited capacity to 
biosynthesise LC-PUFA due to the absence of enzymatic abilities, which is driven by 
evolutionary forces, particularly diets rich in preformed LC-PUFA.  
I.3 Methods for defining EFA requirements 
Two possible methods for defining nutrient requirements are the factorial method 
and empirical method. In the factorial method, nutrient demand is modelled using data on 
nutrient intake, endogenous losses and requirements for tissue synthesis (Shearer 1995, 
Hauschild, Pomar et al. 2010). In the empirical method, the response of an animal is 
measured after delivery of a gradient of the nutrient in question, the response is typically 
some metric of growth, for example weight gain (WG) or daily growth index (DGI) but 
other responses maybe considered, for instance feed conversion ratio (FCR) (National 
Research Council 2011). The empirical method is the most frequently applied in fish 
studies and is the method presented here. 
The empirical method to assess nutrient requirements involves dose-response studies 
and analysis of the data is performed using regression techniques (Mambrini, Guillaume 
1999). Statistically, it is necessary to have five or more treatments to allow sufficiently 
robust regression analysis (Shearer 2000). Deducing requirements from studies that do 




manipulated. A measurable response (or endpoint) is used to define the requirement, and 
this is usually growth. The requirement can then be determined using regression analysis 
to establish the response as a function of the supply of the nutrient in question. Low levels 
of the nutrient will suppress growth, increasing levels will cause gains in growth until a 
threshold level is reached and gains in growth diminish, this nutrient level is the 
requirement. This is the traditional approach to define a requirement and is still very 
practical and commonly used (National Research Council 2011). However, other 
responses could be considered such as health or welfare, but they must be measurable by 
suitable and established biomarkers. This is not widely employed because growth is a 
robust parameter to gauge health and welfare, and further parameters considerably 
complicate the task of defining a requirement. 
Several points are important to consider when assessing EFA requirements. The 
dietary lipid level should be established as the EFA requirements can be increased with 
the lipid content of the diet (National Research Council 2011). As mentioned, current 
diets are richer in oil for supplying dietary energy to rapidly growing farmed fish and 
sparing protein for growth (Sargent et al. 2002, Corraze 2001). Growth in fish is not linear 
and small fish have relatively higher growth rates. Furthermore, the partitioning of dietary 
components between growth and maintenance changes as the fish grow, with the 
maintenance components increasing as a function of fish size as the relative growth rate 
decreases (Lupatsch, Kissil et al. 2003a, Lupatsch 2005). Lipids are added to fish diets 
primarily as a source of energy but protein, and carbohydrates to a lesser extent, can also 
supply energy, so there is not an absolute requirement for lipid, rather a range of lipid 
levels that can be tolerated by a species (National Research Council 2011). The range 




obtain energy via protein and lipid, whereas herbivores make a more efficient use of 
carbohydrates (Halver, Hardy 2002). The requirements for any nutrient should be 
determined under conditions (environmental and nutritional), that allows the species to 
grow at its maximum rate, and only the nutrients to which the research pertains should be 
restricted with all the others being at levels that satisfy the known physiological demands 
for that species. Failure in this regard is likely to result in underestimations of the 
requirements.  
The researcher may still have to make trade-offs. For instance, does the researcher 
use realistic sources of dietary nutrients that are commercially available or, instead, 
purified components such as purified amino acids or fatty acid methyl ester derivatives 
that may have higher digestibility and performance characteristics, but will never be used 
in the practical diets of farmed fish? Trade-offs in EFA nutrition research are paramount 
as fatty acids are supplied as a complex mixture and there is strong evidence that there 
are interactions between these components that must be understood prior to designing a 
diet (Izquierdo 2005, Sargent et al. 2002, Watanabe 1982). It is nearly impossible to 
design an experiment that perfectly defines the requirement for each of the EFA, and 
perhaps meaningless, as this level is affected by its ratio with other fatty acids. Most 
studies group the EFA together and express them as EPA+DHA or n-3 LC-PUFA 
(previously as “n-3 HUFA”, standing for “n-3 highly unsaturated fatty acids”). 
Furthermore, what is the best way to express the requirement value? The studies cited 
above seem to indicate that expressing fatty acids as a fraction of total fatty acids is most 
meaningful as it is dependent on the lipid level of the diet (Watanabe 1982). However, in 
terms of practicality expressing EFA requirements as a fraction of diet makes more sense 




Chapters III and IV and the EFA are expressed as the sum of EPA and DHA 
(EPA+DHA% of diet). Practically, the key question is: How much EFA are required by 
a species and what is the most practical (and economical) way to supply it?  
I.4 Current n-3 LC-PUFA requirements of gilthead seabream and 
European seabass 
This section will review the current understanding of the LC-PUFA requirements of 
gilthead seabream and European seabass existing prior to this study. Initial requirement 
levels will be given as referenced by the NRC (2011). Then the studies from which these 
data are derived will be evaluated. 
I.4.1 Gilthead seabream 
According to the NRC (2011), juvenile gilthead seabream have a dietary requirement 
for LC-PUFA of 0.9-1.9 % with DHA:EPA ratios of 0.5-1. Kalogeropoulos et al. (1992) 
used six diets with 13% crude lipid formulated with soya oil and cod liver oil to yield 
EPA + DHA values of 0.3-1.9% of diet, the DHA:EPA ratio was approximately 1. The 
initial weight of the fish was 1.2 g and the experimental groups reached 10-12 g in weight 
over five months feeding. The SGR values were not reported, but assuming 150 d growth, 
they can be estimated to be 1.39 – 1.54 ln(g).d-1. The authors concluded that the 
requirements for n-3 LC-PUFA were 0.9% of dry diet. Subsequently, Ibeas et al. (1994) 
reported a requirement value of 1.9% for n-3 LC-PUFA, with diets with DHA:EPA of 
0.5%, albeit in larger fish (43 g) than the former study. This result was somewhat 
surprising as many studies have shown that LC-PUFA requirements (relative to fish mass) 




demands of neural tissues forming during early life-cycle stages (Sargent, McEvoy et al. 
1997). Two later studies, by the same authors, found that the best growth rates with 11.5 
g gilthead seabream were achieved at n-3 LC-PUFA levels of 1.1% when the DHA:EPA 
ratio was 0.5 (Ibeas, Cejas et al. 1996, Ibeas, Cejas et al. 1997). The discrepancy in EFA 
requirement estimations between the earlier publication (Ibeas et al. 1994) and the later 
publications (Ibeas et al. 1996, Ibeas et al. 1997) is most likely related to the four 
treatment levels of n-3 LC-PUFA used in the former publication (0.76%; 1.87%; 2.87%; 
2.94%), which meant that the lower treatment was just below requirements but leading 
the authors to conclude that the requirement was 1.9%. Furthermore, larval gilthead 
seabream require a higher DHA:EPA ratio than juveniles, suggesting that larval gilthead 
seabream have a higher requirement for DHA than juveniles (Rodriguez, Pérez et al. 
1998).  
Therefore, the two values provided in the NRC Report are valid guides, but they 
should be qualified. In the first study the fish were relatively small (1.2 grams) and the 
higher DHA:EPA value of 1 may have been more appropriate as the gilthead seabream 
grow from larvae to juvenile (Kalogeropoulos et al. 1992). However, the value 1.9% n-3 
LC-PUFA (Ibeas et al. 1994) study is likely to be an overestimation as later good growth 
was reported by the same authors with n-3 LC-PUFA levels of ~1% of dry diet with 
smaller fish (Ibeas et al. 1996). Therefore, some conflicting results have been attained 
and these can be related to the size of the fish, the levels of EFA supply and the DHA:EPA 




I.4.2 European seabass 
The NRC (2011) recommends that European seabass diets should contain 1% dry 
weight EPA and DHA, with at least 0.5% DHA. This value was derived from a study with 
only two LC-PUFA levels, 1 and 2.5 % dry diet, which are not a sufficient number of  
treatment levels to define a requirement, and the data were not compared to fish fed on 
deficient diets (Coutteau, Van Stappen et al. 1996). The study that could have been 
considered by the NRC was published by Skali and Robin (2004). The latter study was 
designed to specifically determine the n-3 LC-PUFA requirement of European seabass 
juveniles (14-35 g). There were six levels of dietary LC-PUFA, 0.23-1.89% of dry diet, 
achieved using blends of rapeseed oil (RO) and FO. The crude protein and lipid levels 
were 54% and 18%, respectively, using 12% FM and 3% fish hydrolysate as the marine 
sources of protein. Using regression analysis of daily growth index (DGI) as a function 
of dietary LC-PUFA, it was concluded that the minimum n-3 LC-PUFA requirements 
were 0.7% on a dry diet basis. The DGI values attained in this study were not optimal 
(0.97 – 1.09), subsequent authors have reported much higher growth rates in juvenile 
European seabass (Yildiz, Şener 2004, Torrecillas et al. 2017). Therefore, the NRC value 
of 1% n-3 LC-PUFA remains as a valid conservative value for which to design diets for 
juvenile European seabass with ~20% crude lipids. Two reviews have reported that this 
value is too low and that growth performance of European seabass can be further 
enhanced by increasing LC-PUFA to 3.5 % of diet (Izquierdo 2005, Kousoulaki, Sæther 
et al. 2015). The origins of this value can be traced to two studies. The first, was an 
investigation into the use of fatty acid salts as experimental diets (Lanari, Ballestrazzi et 
al. 1993) and the second, examining the effects of increased lipid and starch in the diet 




source of increased growth is clearly the level of lipid in the diet. Work into FO 
replacement has shown that up to 60% of dietary FO can be replaced in European seabass 
diets with no impact to growth (Montero, Robaina et al. 2005, Mourente et al. 2005). 
Therefore, further study of the n-3 LC-PUFA requirements of European seabass and 
gilthead seabream would increase the knowledge of the requirements of these species  
I.5 Effects of dietary fatty acid composition on body composition of 
gilthead seabream and European seabass 
In order to support the continued growth of aquaculture the content of FM and FO 
needs to be reduced due to the limited production of these marine ingredients mostly 
derived from capture fisheries (Tacon, Metian 2015,  Glencross 2009, Merino et al. 2012). 
This will rely heavily on clear knowledge of EFA requirements. The fatty acid 
composition of fish is mainly dependent up on the fatty acid composition of the diet 
(Tocher 2015), which in turn is dependent on the lipid sources used to formulate the feed. 
When gilthead seabream or European seabass are fed diets including VO, whole body or 
fillet fatty acid compositions are altered. There is an increase the proportion of C18 PUFA 
and MUFA, particularly ALA, LOA and oleic acid, but LC-PUFA (both n-3 and n-6) 
decrease as these fatty acids are not found in VO (Izquierdo, Montero et al. 2005, 
Mourente et al. 2005, Turchini, Ng et al. 2010, Yildiz, Şener 2004). DHA is more 
efficiently accumulated than EPA in tissues demonstrating positive retention of this fatty 
acid (Glencross 2009). The composition of neutral lipids is more sensitive to dietary 
modification than the polar lipid fraction (Mourente, Bell 2006). Gilthead seabream and 
European seabass have lean fillets with lipid levels of 2-6% and both species deposit 




are therefore better consumed as sources of LC-PUFA for humans (Mourente, Bell 2006). 
The detrimental effects of dietary VO on muscle fatty acid composition can be partially 
restored by several weeks feeding with FO “finishing” diets in gilthead seabream and 
European seabass (Mourente, Bell 2006, Izquierdo et al. 2005). However, this technique 
was not as efficient as in Atlantic salmon, which stores fat reserves in the edible muscle 
(Bell et al. 2003). To the author’s knowledge this technique is not used in commercial 
rearing of gilthead seabream and European seabass as the production cycle is much 
shorter than Atlantic salmon. The response to FO substitution is very similar in gilthead 
seabream and European seabass as other fish species because the diet is the main factor 
that influences fatty acid composition (Turchini et al. 2010,  Glencross 2009). 
I.6 Project aims 
The major objective of the present project was to re-define the requirements of 
gilthead seabream and European seabass for EPA and DHA using modern diet 
formulations (20% crude fat, 12.5% FM), as recommended by the NRC (2011). The 
strategy to achieve this aim involved two feeding trials to deliver a gradient of EPA and 
DHA to juvenile gilthead seabream and European seabass. Furthermore, the effects of 
this gradient on the composition, fatty acid content and gene expression of key metabolic 
tissues were explored. As the two trial designs were nearly identical, the species’ 
responses to EFA gradient were discussed comparatively. This thesis contains four result 
chapters (Chapters III - VI) that have been prepared as stand-alone manuscripts. Finally, 






The results chapters: 
III) A comparison of regression models for defining EPA+DHA requirements 
using the gilthead seabream (Sparus aurata) as a model species 
A range of modelling strategies for defining the requirements for EPA and DHA are 
described and illustrated in this chapter. The regression strategies are presented in more 
detail in this chapter than in Chapter IV (EFA requirements of European seabass) and the 
advantages and drawbacks addressed in the discussion. Requirements for EPA+ DHA are 
presented for seabream of two different weight ranges. Evidence for a dynamic 
requirement for LC-PUFA is presented and discussed. The economic considerations of 
the diets are also considered in a hypothetical cost-benefit analysis. 
The main hypothesis addressed in this chapter is a re-evaluation of EPA+DHA 
requirements for juvenile gilthead seabream. However, the chapter also explores the 
range of analyses that can be applied to biometric data and, furthermore, analyses the data 
over two pellet sizes.  
IV) Application of robust nonlinear regression to determine the requirements 
of juvenile European seabass (Dicentrarchus labrax) for eicosapentaenoic (EPA) and 
docosahexaenoic (DHA) acids 
Like Chapter III, this chapter will advance the EPA and DHA requirement estimates 
for European seabass. However, as the foundations have been laid, this chapter also serves 
to confirm that conclusions drawn from Chapter III apply to other marine carnivorous 




The main hypothesis in this chapter is the reassessment of EPA+DHA requirements 
in juvenile European seabass. 
V) The compositional and metabolic responses of gilthead seabream (Sparus 
aurata) to a gradient of dietary fish oil and associated n-3 long-chain 
polyunsaturated fatty acid content 
This chapter addresses the dietary effect on composition, tissue fatty acids and lipid 
metabolic gene expression in the gilthead seabream. The chapter makes some 
relationships between compositional and gene expression data using regression and 
correlation analyses. The results show that dietary effects are subtle and detected as trends 
against dietary VO. This manuscript was published: Houston et al.  (2017) British Journal 
of Nutrition 118, 1010-1022. 
VI) Dietary n-3 LC-PUFA gradients in the European seabass (Dicentrarchus 
labrax); effects on composition and metabolism  
This chapter addresses the dietary effect on composition, tissue fatty acids and lipid 
metabolic gene expression in the European seabass. The chapter makes some 
relationships between compositional and gene expression data using of regression and 
correlation analyses. The response to the dietary gradient of LC-PUFA is compared to 
seabream in the discussion, drawing attention to the apparent differences between the 
species. Compositional data regarding the fish is presented and the effects of the diets on 
lipid metabolic gene expression is also considered. 
The hypotheses addressed in chapters V and VI are: What are the effect of a dietary 




impact does this gradient have on the fatty acid composition and lipid metabolic gene 









The four result chapters (III – VI) present analysis from two feeding trials conducted 
in parallel in Hirtshals, Denmark, during April – August 2014. The two species were 
gilthead seabream (S. aurata) and European seabass (D. labrax). The design of these trials 
draws on theory outlined in the Introduction (Section I.3: Methods for defining EFA 
requirements). The two hypotheses driving the experimental design were: 
What are the EPA+DHA requirements of gilthead seabream? 
What are the EPA+DHA requirements of European seabass? 
The wording of these hypotheses, with regards to “EPA+DHA”, reveals an important 
caveat that, although previously introduced (Section I.3), is worthy of mention here. EPA 
and DHA are treated as though they represent a single nutrient, i.e. the sum of EPA+DHA. 
This is a consequence of using commercially relevant FO and FM as the sources of 
LC-PUFA to formulate the experimental feeds. The present chapter gives detailed 
description of the fish feeding trials and associated biochemical, molecular and statistical 
analyses. More chapter-specific materials and methods are further provided in the 
corresponding result chapter where appropriate. 
II.2 The feeding trials 
The feeding experiments were designed and conducted by BioMar, who were 
responsible for formulating the diets and executing the experiments. This placed some 




Six experimental diets (D1-D6) were formulated, for each species, to contain precise 
levels of EPA+DHA. They were formulated to be representative of modern aquafeeds 
currently fed to the two species, gilthead seabream and European seabass. To achieve 
these EPA+DHA levels, three commercially available oils were used: A South American 
FO, rich in EPA+DHA; rapeseed oil (RO), rich in oleic acid (18:1n-9) and linoleic acid 
(18:2n-6) and palm oil (PO), rich in palmitic acid (16:0) and oleic acid (18:1n-9). Six 
mixtures of these oils were used as the added oil component of the seabream and seabass 
diets, with D1 containing only a blend of RO and PO whereas D6 contained only FO as 
the sole added oil (Table II.1). 
Table II.1. Blends of oil used to formulate the experimental diets 
Table II.1. The oil mixtures used to formulate the experimental diets expressed as 
percentage of the mixture and the targeted level of EPA+DHA as a percentage of total 
fatty acids. 
Diet: D1 D2 D3 D4 D5 D6 
Fish oil 0.0 11.9 17.9 30.3 55.4 100.0 
Rapeseed oil  66.8 59.0 55.1 46.5 29.8 0.0 
Palm oil 33.2 29.1 27.0 23.2 14.8 0.0 
EPA+DHA1  1.4 3.5 4.6 6.8 12.3 23.4 
1% total fatty acids 
Other ingredients were selected to meet the known nutrient requirements of gilthead 
seabream (Oliva-Teles, Lupatsch et al. 2011, National Research Council 2011) and 
European seabass (National Research Council 2011). Small differences in formulation, 
between the gilthead seabream and European seabass basal diets reflect the current 
understanding of the nutrient requirements of these species. Due to imbalances in certain 
nutrients present in FO but not VO, some nutrients, namely cholesterol and phospholipids 
(Emulthin G35), required to be balanced so that they did not compromise the growth of 
the fish and therefore the experiments. As a large part of the dietary protein was supplied 




crystalline lysine and methionine (a common commercial practice). The gilthead 
seabream and European seabass dietary formulations and proximate analysis are provided 
in Table II.2 and Table II.3, respectively. An inert marker, yttrium was added to the 
formulation, however due to time constraints during the experiment faecal samples were 
not collected and consequentially no digestibility work was carried out. 
The diets were produced by extrusion at the BioMar TechCentre, Brande, Denmark. 
They were produced as two pellet sizes, 3 mm and 4.5 mm to cover the anticipated growth 
of the fish during the experimental periods. The feeds were delivered to the BioMar Feed 
Trial Unit, Hirtshals, Denmark, where they were stored at room temperature. Samples of 
diets were also shipped to the Institute of Aquaculture (IoA), University of Stirling (UoS), 
where they were stored at -20°C until further analysis of proximate and fatty acid 
composition. 
All experimental fish were maintained under the current European legislation on 
handling experimental animals (2010/63/EU). Furthermore, this project was submitted to 
the UoS Animal Welfare and Ethical Review Board (AWERB) for detailed ethical review 
and was authorised by the board. The gilthead seabream and European seabass used in 
this study were purchased from a commercial hatchery (Les Poissons du Soleil, Balaruc-
les-Bains, France) and transported to Hirtshals. Before commencing the trial, they were 
fed a commercial diet rich in FM and FO and grown to a weight of approximately 25 g. 





Table II.2. Gilthead seabream diet formulations and proximate analysis. 
Table II.2. Diet formulations and proximate analyses of the six experimental diets for 
gilthead seabream (Chapter III). 
DIET  
Ingredients (%) 
D1 D2 D3 D4 D5 D6 
Fishmeal 12.5 12.5 12.5 12.5 12.5 12.5 
Soya Protein Concentrate 21.9 21.9 21.9 21.9 21.9 21.9 
Rape seed meal 10.0 10.0 10.0 10.0 10.0 10.0 
Wheat Gluten 4.0 4.0 4.0 4.0 4.0 4.0 
Corn Gluten 25.0 25.0 25.0 25.0 25.0 25.0 
Wheat 7.1 7.1 7.1 7.1 7.1 7.1 
Aminoacids1 0.8 0.8 0.8 0.8 0.8 0.8 
Micro-ingredients2 3.1 3.2 3.2 3.3 3.5 3.9 
Yttrium 0.03 0.03 0.03 0.03 0.03 0.03 
OILS (%)       
Fish Oil (SA) 0.0 1.8 2.6 4.4 8.0 14.9 
Rapeseed Oil 10.4 9.2 8.6 7.3 4.8 0.0 
Palm Oil 5.2 4. 6 4.2 3.6 2.4 0.0 
       
PROXIMATE 
COMPOSITION       
(% of diet as fed) 
Protein   41.8 43.0 42.9 41.7 42.4 42.5 
Lipid  22.2 21.7 21.7 21.5 21.8 20.8 
Ash  6.1 6.1 5.9 5.9 6.1 6.2 
Moisture  10.3 9.7 9.4 10.7 8.9 8.9 
Energy crude (MJ/kg)3 22.0 22.1 22.2 21.8 22.2 22.0 
1 Lysine and methionine 
2 Vitamin and mineral premix, monocalcium-phosphate (MCP), cholesterol, Emulthin G35, 
antioxidants  
3 Calculated by using the mean values of gross energy for proteins, lipids and carbohydrates 






Table II.3. European seabass diet formulations and proximate analysis. 
Table II.3. Diet formulations and proximate analyses of the six experimental diets for 
European seabass (Chapter IV). 
DIET  
Ingredients (%) 
D1 D2 D3 D4 D5 D6 
Fishmeal 12.5 12.5 12.5 12.5 12.5 12.5 
Soya Protein Concentrate 18.3 18.3 18.3 18.3 18.3 18.3 
Rape seed meal 10.0 10.0 10.0 10.0 10.0 10.0 
Wheat Gluten 5.0 5.0 5.0 5.0 5.0 5.0 
Corn Gluten 25.0 25.0 25.0 25.0 25.0 25.0 
Wheat 9.6 9.6 9.6 9.6 9.6 9.6 
Aminoacids1 0.9 0.9 0.9 0.9 0.9 0.9 
Micro-ingredients2 3.8 3.9 4.0 4.1 4.2 4.5 
Yttrium 0.03 0.03 0.03 0.03 0.03 0.03 
OILS (%)       
Fish Oil (SA) 0.0 1.8 2.6 4.4 8.0 14.1 
Rapeseed Oil 9.9 8.7 8.1 6.8 4.3 0.0 
Palm Oil 4.9 4.3 4.0 3.4 2.1 0.0 
       
PROXIMATE 
COMPOSITION 
(% of diet as fed)       
Protein 39.8 42.5 41.0 41.4 41.8 41.6 
Lipid 21.4 20.7 21.8 21.0 20.6 20.9 
Ash 5.8 5.8 5.9 6.0 6.0 5.9 
Moisture 10.8 9.3 10.5 10.5 9.8 11.0 
Energy crude (MJ/kg)3 21.7 21.9 21.9 21.7 21.8 21.6 
1 Lysine and methionine 
2 Vitamin and mineral premix, monocalcium-phosphate (MCP), cholesterol, Emulthin G35, 
antioxidants  
3 Calculated using the mean values of gross energy for proteins, lipids and carbohydrates 23.6, 





At the start of the trials 150 fish of each species were randomly distributed to 
triplicate 1 m3 tanks (n = 3) in a recirculation saltwater system and initial bulk weights 
recorded in each tank. The mean initial fish weights (± SD) were 24.3 g (± 0.0) and 23.2 
(± 0.9) for seabream and seabass, respectively. Feeding of the experimental diets 
commenced on the 7th April 2014 and lasted until the 13th August for the seabass (127 
days) and 14th August for the seabream (128 days). The 3 mm pellet was fed till the 2nd 
June 2014 (56 days, P1) and the 4.5 mm was fed till termination (72 and 71 days, P2). 
The fish were fed to apparent satiation twice per day. Excess feed was delivered using 
belt feeders and uneaten pellets collected. Delivered and uneaten feed were recorded to 
accurately determine biological feed conversion ratio (FCR). The densities reached at the 
end of each trial were 32.5 Kg m-3 and 21.3 Kg m-3 for seabream and seabass, respectively. 
During the trials, mortalities were 1.6 % and 0.3 % for the seabream and seabass, 
respectively. Mortalities were weighed and deducted from biomass calculations. 
Mortalities were unrelated to dietary treatment. The fish were reared at 24°C and 32 g L-1 
salinity and under 12:12 L:D photoperiod. 
The fish in each tank were bulk weighed at the change of pellet size and on 
termination of the trial. Prior to bulk weighing feed was withdrawn for 24 h. The fish 
were anaesthetised with benzocaine (Centrovet, Kalagin, Santiago, Brazil), removed to a 
table to allow excess water to drain and weighed in manageable batches. After weighing 
the fish were placed in clean seawater to recover and returned to their tanks. Feeding 
recommenced the following day. 
The following fish and samples were taken from fish that were euthanised with a 




were taken for proximate composition analysis. Three further fish from each tank were 
taken and separated to eviscerated carcasses, livers and viscera (minus liver). The fish 
and body compartments were pooled by tank. These samples were stored at -20°C. Tissue 
samples (liver and mid-intestine) were collected from three fish from each replicate tank. 
A small piece of liver and a short piece of mid-intestine (~1 cm) was dissected about 1 
cm behind the pyloric caeca. The mid-intestine sample was cleaned of any contents and 
perivisceral fat removed. A 1 - 2 mm3 piece of each tissue was cut and placed in 
RNAlater® (Sigma-Aldrich, UK) and a ~0.5 cm3 piece was taken for fatty acid analysis. 
Tissue samples for RNA extraction were perfused with RNAlater® for 24 h at 4°C and 
subsequently stored at -20°C.  Samples for fatty acid analysis were stored at -20°C. 
All the samples mentioned above were stored for 1-2 months in freezers at Hirtshals 
at -20°C. Then they were shipped to the IoA using a 24 h courier service. All samples 
were packed into polystyrene boxes containing dry ice. On arrival samples were stored at 
-20°C, whereas samples for RNA extraction were stored at -70°C. 
II.3 Laboratory analyses 
Most reagents were purchased from Fisher Scientific UK (Loughborough, UK) or 
Sigma-Aldrich (recently acquired by Merck, Darmstadt, Germany). Solvents 
(chloroform, methanol, isohexane, diethyl ether, toluene, isopropanol, ethanol) were 
invariably HPLC grade from Fisher Scientific. Gases were obtained from the British 
Oxygen Company (Glasgow, UK). Reagents or materials purchased elsewhere will be 




II.3.1 Proximate composition 
The proximate chemical composition of whole fish, carcasses, viscera and livers were 
determined by standard methods described the Association of Analytical Chemists 
(2000). Samples, pooled by tank, were homogenised and sub-sampled, all further 
analyses were carried out with untreated homogenate. Analyses were carried out in 
duplicate and repeated if technical replicates were not in agreement, coefficient of 
variation (CV) > 5 %.  
Moisture content of samples was determined by drying at 90°C for 24 h. 1.0 - 5.0 g 
of homogenate (0.5 g for liver) was placed in a pre-weighed dish and then placed in a 
drying oven until a constant mass was achieved (usually 24 h). The dish was then re-
weighed after cooling in a desiccator and the moisture content determined using the 
equation: 
𝑀𝑜𝑖𝑠𝑡𝑢𝑟𝑒 (%) =
𝑆𝑎𝑚𝑝𝑙𝑒 𝑤𝑒𝑖𝑔ℎ𝑡 (𝑔) − 𝐷𝑟𝑦 𝑠𝑎𝑚𝑝𝑙𝑒 𝑤𝑒𝑖𝑔ℎ𝑡 (𝑔)
𝑆𝑎𝑚𝑝𝑙𝑒 𝑤𝑒𝑖𝑔ℎ𝑡 (𝑔)
 × 100 
Ash content was determined by combustion of samples at 600°C in a muffler furnace. 
A total of 1.0-2.0 g of sample homogenate (0.5 g for liver) was placed in a pre-weighed 
porcelain dish. Samples were combusted overnight and then re-weighed after cooling in 




 × 100 
Crude protein content of samples was determined using the Kjeldahl method 




(Persson, Wennerholm et al. 2008). Nitrogen content was analysed by titration using a 
Kjeltec analyser (Foss 2300, Gemini, Apeldoorn, Netherlands) after sample hydrolysis. 
Briefly, 250 mg of homogenate was weighed into a test tube with two copper kjeltabs 
(Fisher Scientific) and 5 ml of concentrated sulphuric acid (Fisher Scientific). Two blanks 
and two standards (pure lysine, Sigma-Aldrich) were routinely run with each batch of 
samples. Acid hydrolysis was carried out on a hot block at 420°C for 1 h. Samples were 
cooled to room temperature before adding 20 ml of distilled water and vortexing. All 
tubes were then titrated on the Kjeltec analyser and protein content determined using the 
equation: 




where 1750.875 is a conversion factor to convert sample titre volume to percent protein 
based on the standardised protein factor.  
The total lipid content of samples was determined using the Folch (1957) method and 
is described in Section II.3.2.1 on fatty acid analysis. Whole body lipid samples were 
stored at 10 mg ml-1 in chloroform/methanol (2:1, v/v) under oxygen free nitrogen (OFN) 
at -20°C for whole body fatty acid analysis. 
II.3.2 Fatty acid analysis 
II.3.2.1 Lipid extraction 
The total lipids from feeds, whole fish, carcass, viscera and tissue samples were 
extracted according to Folch et al. (1957) and quantitated to calculate the tissue 




Sigma-Aldrich) in 20 ml chloroform/methanol (2:1) and allowed to stand on ice for 1 h 
in 50 mL glass test tubes. Feeds or feed materials were extracted using 36 ml of solvent 
and left in a freezer overnight. The samples were washed with 5 ml 0.88 % (w/v) KCl 
(Sigma-Aldrich) and centrifuged at 400 g (Jouan, C312, Fisher Scientific). The aqueous 
fraction was removed by aspiration and the solids by filtration of the organic phase. The 
solvent was evaporated under OFN and then by desiccation in vacuo overnight. The total 
lipids were weighed and then dissolved in chloroform/methanol (2:1) + 0.01 % (w/v) 
butylated hydroxytoluene (BHT, Sigma-Aldrich) at 10 mg mL-1 and stored under OFN at 
-20°C for fatty acid analysis. 
II.3.2.2 Separation and purification of fatty acid methyl esters 
Fatty acid methyl esters (FAME) were prepared from total lipids samples by acid 
catalysed transesterification and purification by thin layer chromatography (TLC) 
(Christie 2003). An internal standard, 0.1 mg of heptadecanoic acid (17:0, Sigma-
Aldrich) was added to 1 mg of total lipid in glass test tubes and the solvent evaporated 
under OFN. Transesterification was started by adding 1 ml of toluene and 2 ml of 1% 
(v/v) sulphuric acid (Fisher Scientific) in methanol and heating to 50°C for 16 h. The 
reaction was stopped by addition of 2 ml of 2% (w/v) KHCO3 (Sigma-Aldrich). FAME 
were recovered by the addition of 5 ml isohexane/diethyl ether (1:1) with 0.01% (w/v) 
BHT. Tubes were mixed and centrifuged for 2 min at 400 g (Jouan, C312) and the organic 
fraction removed by pipette. A further 5 ml isohexane/diethyl ether (1:1) was added to 
the original tubes and the process repeated to recover any remaining methyl esters. 
Solvent from the collected fractions was evaporated under OFN and FAME were purified 




acid (90:10:1, v/v/v). FAME bands were visualised by spraying with 1% (w/v) iodine in 
chloroform, the silica was scrapped off the plate to a fresh tube and purified FAME were 
eluted by addition of 10 ml isohexane/diethyl ether (1:1) with 0.01% (w/v) BHT followed 
by centrifugation. The supernatant was pipetted into a new tube and the solvent 
evaporated under OFN. FAME were dissolved in 0.8 ml of isohexane and stored under 
OFN at -20°C until analysis by gas chromatography. 
II.3.2.3 Gas chromatography 
The gas chromatograph used for FAME analysis was a Fisons GC-8160 (Thermo 
Scientific, Milan, Italy) equipped with a 30 m x 0.32 mm i.d. x 0.25 µm ZB-wax column 
(Phenomenex, Cheshire, UK). Samples were injected on-column by an auto sampler and 
detection was by flame ionisation. The carrier gas was hydrogen with an initial oven 
thermal gradient from 50 °C to 150 °C at 40 °C min-1 to a final temperature of 225 °C at 
2 °C min-1. Chromcard for Windows (Version 1.19; Thermoquest Italia S.p.A., Milan, 
Italy) was the software used to export the data. FAME were identified by comparison to 
known commercial standards (Supelco 37-FAME mix, Sigma-Aldrich) and a marine oil 
prepared in the laboratory. Fatty acid contents were expressed as percentage (%) of total 
fatty acids and absolute values (mg g-1). 
Corrected percentage calculation: 
Percentage of total fatty acids = (Raw peak area * 100 / ∑ Raw peak area) * (100 / (100 
– 17.0 Peak area))  




Fatty acid sample concentration (mg g-1) = (Raw peak area * 100 / ∑ Raw peak area) * 
(100 / 17.0 Peak area) * (Sample lipid (%) / 100) 
where the Raw peak area is the fraction of total area of the chromatogram of an identified 
fatty acid and 17.0 is the corrected peak area of the internal standard. 
II.3.3 Relative gene expression 
II.3.3.1 Extraction of RNA 
The method to extract total RNA from fish tissues was based on Tri Reagent 
(Ambion, Sigma-Aldrich) and use of 1-bromo-3-chloropropane (BCP, Sigma-Aldrich). 
Approximately 100 mg of tissue was homogenised in 1.0 mL of Tri Reagent using a Mini-
Beadbeater 24 (Biospec, Bartlesville, USA). Homogenised samples were stored at -40 °C 
overnight before continuing with the protocol. The samples were thawed and then 
centrifuged for 10 min, 4 °C at 12,000 g (SciQuip 4K15, Sigma-Aldrich) and the Tri 
Reagent transferred to a fresh tube. One hundred µl of BCP was added to separate the 
aqueous and organic phases. After shaking vigorously, the tubes were incubated for 15 
min at room temperature before centrifugation for 15 min at 20,000 g and 4 °C. Then 400 
µl of the aqueous phase was pipetted and transferred to a fresh tube. Precipitation of the 
RNA was achieved by adding 200 µl isopropanol and 200 µl RNA precipitation solution 
(see below), mixing the tubes gently and incubating at -20 °C for at least 10 min and 
followed by centrifugation for 10 min at 20,000 g and 4 °C. The supernatant was removed, 
and the RNA pellet washed twice with ice-cold 75% ethanol in milliQ H2O (v/v). Ethanol 
was pipetted from the pellet and the excess allowed to dry at room temperature. The RNA 
was resuspended in milliQ H2O and the concentration measured spectrophotometrically 




absorbance ratio (260:280 nm) and by agarose gel electrophoresis (Section II.3.3.4). 
Bands of 18S and 28S ribosomal subunits were visualised under ultra violet light to check 
for RNA degradation. Total RNA extracts were stored at -80 °C until further analysis.  
RNA precipitation solution (1 L) 
1.2 M sodium chloride (Sigma-Aldrich), NaCl – 70 g  
0.8 M Sodium Citrate Sesquihydrate (Sigma-Aldrich), C6H6Na2O7 · 1.5 H2O – 210.5 g 
Made up to 1 L with milliQ water 
II.3.3.2 Preparation of cDNA by reverse transcription 
Reverse transcription (RT) of the RNA was performed using a High-Capacity cDNA 
Reverse Transcription kit without RNAase inhibitor (Applied Biosystems, Warrington, 
UK). A 2.0 µg aliquot of RNA in 10 µl of milliQ H2O was used as reaction substrate. The 
total volume was 20 µl and the master mix made up according to manufacturer’s protocol, 
except the addition of oligo(dT) primers (Eurofins Genomics, Ebersberg, Germany) as 
follows: reverse transcription buffer, 2.0 µl; deoxynucleotide (dNTP) mix (100 mM), 0.8 
µl; random primers, 2.0 µl; oligo T primers, 0.5 µl; nuclease-free H2O, 4.2 µl and reverse 
transcriptase (RTase), 1.0 µl. Initially, samples were denatured at 75 °C and then the 
master mix was added. The reaction was performed on a Biometra Thermocycler 
(Analytik Jena, Goettingen, Germany) using the following program: 25 °C for 10 min; 37 
°C for 120 min; 85 °C for 5 min and terminated at 4 °C. Five samples from each tissue 
were prepared as negative controls (RT-) in the same way but without addition of reverse 
transcriptase (RTase) and a non-template control (NTC) was prepared without RNA. 
These were run on the first plate for RT-qPCR, as described in Section II.3.3.3. RT was 




tank (N = 54). The reaction products were used to prepare cDNA samples at 1:20 dilution 
with milliQ H2O. A pooled cDNA sample was also prepared using 4.0 µl from each 
reaction. cDNA samples were stored at -20 °C for further analysis. 
II.3.3.3 Real-time quantitative polymerase chain reaction 
Real-time quantitative polymerase chain reaction (RT-qPCR) was performed with 
Luminaris Color HiGreen qPCR Master Mix (SYBRgreen, Thermo Scientific, Hemel 
Hempstead, UK). Each seabream cDNA samples were analysed in duplicate on a 
Biometra TOptical Thermocycler instrument (Analytik Jena, Goettingen, Germany) in 96 
well plates (StarLab, Milton Keynes, UK). As there were 54 samples per tissue, each 
analysed in duplicate, two plates were used for each gene and a calibration sample (1:20 
of the pool) run to check and control for inter assay variation. Plate corrections were rarely 
required as the two plates were run sequentially using the same master mix. Total reaction 
volume was 20 µl and each well contained: SYBRgreen, 10.0 µl; milliQ H2O, 3.0 µl; 
forward primer 10.0 pM, 1.0 µl; reverse primer 10.0 pM, 1.0 µl and 5.0 µl of cDNA (for 
reference genes this was reduced to 2.0 µl and 3.0 µl additional milliQ H2O added). The 
seabass samples were performed in triplicate on a Lightcycler-480 instrument (Roche 
Diagnostics Corp, Indianapolis, USA) using 384-well plates (Roch Diagnostic Corp). 
Total reaction volume was 10.0 µl and each well contained: SYBRgreen, 5.0 µl; milliQ 
H2O, 1.5 µl; forward primer 10.0 pM, 0.5 µl; reverse primer 10.0 pM, 0.5 µl and 2.5 µl 
of cDNA (for reference genes this was reduced to 1.0 µl and 1.5 µl additional milliQ H2O 
added). Plates were prepared with a standard curve of pooled cDNA diluted with milliQ 
H2O (dilutions: 1/5; 1/10; 1/20; 1/50; 1/100; 1/200 and 1/500), a calibrator (1/20 pool, 




vortexed and centrifuged. Both seabream and seabass samples were analysed using 
identical thermocycling protocols as follows: 50 °C for 2 min, 95 °C for 10 min, then 35 
cycles of 95 °C for 15 s, 60 °C for 30 s and 72 °C for 30 s, and a final melting curve to 
check for non-specific products.  
II.3.3.4 Agarose gel electrophoresis 
Agarose gel electrophoresis was used to: 1) determine the specificity of primer pairs 
to their target genes, 2) visualise the integrity of RNA extractions and 3) purify PCR 
products. The 1% (w/v) agarose (Sigma-Aldrich) gels were prepared in Tris-Acetate 
buffer (1x, TAE, see below) with 0.5 µg ml-1 ethidium bromide. Electrophoresis tanks 
were filled with the same 1x TAE buffer. Gels were placed in the tanks and PCR products 
loaded with an appropriate “ready-to-use” GeneRuler (Fisher Scientific) (100 bp for PCR 
products and 1 Kb for RNA extractions). Gels were run at 50 – 100 V for the necessary 
time to visualise the products of interest.  
Tris-Acetate buffer (TAE, *50) 
242 g Tris base (Sigma-Aldrich) 
57.1 mL glacial acetic acid (Fisher Scientific) 
100 mL 0.5M Ethylenediaminetetraacetic acid (EDTA pH8, Sigma-Aldrich) 
Made up to 1 L with milliQ water. 
 
II.3.3.5 Sequencing  
Partial coding DNA sequences (CDS) were sequenced for some of the European 
seabass candidate genes reported in Chapter VI. Primers were designed on conserved 




(Ibis Therapeutics, Carlsbad, California, USA). PCR were carried out on pooled cDNA 
as template using MyTaq HS DNA polymerase master mix (Bioline, London, UK) in 20.0 
µl reactions containing: 10.0 µl of mastermix; 2.0 µl of 1:20 pooled cDNA and 1.0 µl of 
forward and reverse primers (10 pM). The reactions were run on a Biometra thermocycler 
with the following cycling conditions: 95°C for 1 min then 35 cycles of 95°C for 15 s, 
60°C for 30 s and 72°C for 30 s. Products were visualised by gel electrophoresis (Section 
II.3.3.4) and when necessary, products were purified on gel to obtain the fragment of the 
correct length. Purification of the products was carried out using an Illustra GFX PCR 
DNA and gel band purification kit (GE Healthcare Lifesciences, Little Chalfont, UK), 
according to the manufacturer’s protocol. 
Purified PCR products were sent for DNA sequencing at GATC Biotech ltd. 
(Cologne, Germany). Sequence reads were checked and assembled in Bioedit and 
translated to peptide sequences using ExPASy (Swiss Institute for Bioinformatics, 
Lausanne, Switzerland) (Artimo, Jonnalagedda et al. 2012). Once a clean fragment was 
obtained it was submitted to GenBank via National Centre for Biotechnology Information 
(NCBI) online submission tool BankIt (NCBI, Bethesda, USA). Partial sequences for the 
seabass srebp2, fas and pparα1 were submitted to NCBI (Chapter VI). 
II.3.3.6 Primer design and verification 
For sequencing purposes, primers were designed manually in alignments performed 
in Bioedit and verified by gel electrophoresis (Section II.3.3.4) and then by use of the 
NCBI’s basic local alignment search tool (BLAST) on the returned sequence. For RT-
qPCR primers designed using Primer3 (Untergasser, Cutcutache et al. 2012, Koressaar, 




were designed to have 60°C annealing temperatures. Primer specificity and annealing 
temperature was verified with MyTaq HS DNA polymerase master mix in 20.0 µl 
reactions containing: 10.0 µl of master mix, 2.0 µl of 1:20 pooled cDNA and 1.0 µl of 
forward and reverse primers (10 pM). The reactions were run on a Biometra thermocycler 
with the following cycling conditions: 95°C for 1 min then 35 cycles of 95°C for 15 s, 
temperature gradient 58 - 62°C for 15 s and 72°C for 10 s. A single reaction was carried 
out at each annealing temperature (58, 60, 62°C). The amplification of a single band of 
the appropriate length was visualised after gel electrophoresis. The efficiency of the 
primer was determined using RT-qPCR with a dilution curve of pooled cDNA (1/20 
dilution), as described in Section II.3.3.3. Primers with efficiencies < 1.8 were rejected. 
The melting curves for each well were inspected to check for secondary products. 
II.3.3.7 Data handling 
Threshold cycle (Ct) values were exported for all wells from the relevant instrument’s 
software and further calculations carried out in Excel. Coefficients of variation (CV, %) 
were calculated at the level of Ct. The sample was deleted if the CV was over 1.5%. 
Coefficients for the standard curve were calculated so that reaction efficiency could be 
calculated using the following equation: 
Efficiency (E) = 10(-1 / Slope of standard curve) 











where E is the determined efficiency, ref is the geometric mean of four reference genes 
(ef1α, β-actin, tuba1α and rplp0), goi is the gene of interest (candidate gene), Ct is the 
threshold cycle and Calibrator is a 1/20 dilution of the pool. These ratios were log2 
transformed (Hellemans, Vandesompelle 2011). The above calculation was selected 
because the data are normalised to their centre (the calibrator sample), this means that 
variance is shared evenly across the data set rather than being loaded unequally to the 
treatments due to the choice of a control treatment. Taking the log2 of the expression ratio 
controls the error distribution for the down-stream statistical analysis (Hellemans, 
Vandesompelle 2011). 
II.4 Statistics 
All statistics and figures were carried out in the statistical programming language R 
(Venables, Smith 2015). There are two major sections under this heading: section II.4.1 
deals with the nonlinear regression analysis of biometric data derived from the two 
experiments that form Chapters III and IV; section II.4.2 deals with statistical treatment 
of the data presented in Chapters V and VI. The first part of each section will outline the 
methods of statistical treatment and the second part will give details about implementation 





II.4.1 Nonlinear regression models for requirement determination 
II.4.1.1 Statistical methods 
This section refers to the statistical techniques applied to the biometric data presented 
in Chapters III and IV. The biometrics were weight gain (WG), daily growth index (DGI) 
and feed conversion ratio (FCR). These biometrics are defined as follows: 
WG = Final mean weight (g) – Initial mean weight (g) 
DGI = Final mean weight (g)0.333 – Initial mean weight (g)0.333 / Days 
FCR = Ingested feed (Kg) / (Final biomass (Kg) – Initial biomass (Kg)) 
These metrics were calculated at the level of tank and for each pellet size (P1 = 3 mm 
pellet, P2 = 4.5 mm pellet) and over both pellet sizes (OV) to produce the raw data for 
analysis (N = 18). All the relevant regression models applied to these data are presented 
in Chapters III and IV. Invariably, the predictor variable (x-axis) was dietary EPA+DHA 
(percentage of diet as fed) and the response (y-axis) was one of the metrics described 
above. All model assumptions were checked according to techniques described by Ritz 
and Streibig (2008) and where violations occurred, these were declared in the text. In 
Chapter IV, robust fitting algorithms were used, thus relaxing the normality of error 
assumption. The diagnostic tests of the models included: 1) Levene’s test for 
homogeneity of variances, 2) Shapiro-Wilkinson test for normality of error, 3) the Run’s 
test to check for non-independent errors, 4) the lack-of-fit test, which tests the nonlinear 
model against an analysis of variance (ANOVA) model, 5) the null test, which tests the 
significance of the model against the mean of the data (tests for the existence of a 




assessment work flow. To assess the fit of a function two metrics are given. Firstly, the 
residual error after fitting was presented as the residual sum of the squares (RSS, in the 
case of Chapter III) and iteratively reweighted least squares (IRLS, in the case of chapter 
IV). Secondly, the Akaike information criterion (AIC) is presented, this value compares 
nonlinear models and penalises models for over parameterisation. Calculation of the 
uncertainty of a nonlinear function is not trivial, and usually omitted by authors. The 
model output gives standard errors of the parameter estimates, but these are not useful 
because it is the error around the model’s ability to predict that is of interest. The methods 
used to calculate the uncertainty (95% prediction interval) were second order propagation 
and Monte-Carlo simulation (Spiess 2013). Propagation was suitable for asymptotic 
curved functions (Gompertz and four parameter logistic functions) and Monte-Carlo 
simulation for the split linear or quadratic functions (see Chapter III). These allowed the 
calculation of a 95% prediction interval around a model’s fitted values, these being 
shaded in the relevant figures. Plots of the models are given in Chapters III and IV. The 
components were: the response (y-axis) as a function of the predictor (x-axis), the raw 
biometric data (coloured points), the fitted values (plotted as a black line), the 95% 
prediction intervals of the fitted values (shaded) and, in the case of asymptotic functions, 
the derived requirement estimates. With the asymptotic models an explicit requirement 
estimate is not given by the function, and this value is derived by using the model 
backwards (i.e. a value for the predictor is derived from a chosen level of the response). 
This is somewhat statistically flawed as one of the assumptions of regression is that the 
predictor has been measured with certainty, yet this value is derived from the response 
that is not known with certainty. Therefore, it is critical to present the level of uncertainty 




OV, P1 and P2 a technique for objective comparison was required. Therefore, in the 
model tables presented in Chapters III and IV, the model RSS/IRLS and the AIC values 
are included. The lower the RSS/IRLS the more variation explained by the model. The 
lower the AIC value the more parsimonious the model (Sakamoto, Ishiguro et al. 1986). 
The use of R2 values for nonlinear functions is debated, but R2 is calculated from RSS, 
therefore this indicator of the error was chosen for presentation.  
II.4.1.2 Implementation in R 
This section introduces the function calls and their “package” of origin that were used 
to call statistical tests or calculations to the data. It is not a repeat of all the necessary code 
to reproduce the analyses. The R environment is extremely diverse and powerful 
containing thousands of “base” functions for statistics and data manipulation, additional 
functions are available in the form of “packages” downloaded from the Comprehensive 
R Archive Network (CRAN, https://cran.r-project.org). Furthermore, R is open source 
and free to anyone. 
The environment in R holds data “objects” in the computer’s random-access memory 
(RAM). These are created by functions and manipulated by other functions to produce 
new objects. Nonlinear regression models are stored in the environment as objects of 
class: “nls”. All nonlinear models were called with R’s base function nls(), in the case of 
Chapter III or nlrob(), in the case of Chapter IV, from the package Robustbase 
(Rousseeuw, Croux et al. 2015).  
The model diagnostics, listed in Section II.4.1.1, were carried out to verify the 




(Baty, Ritz et al. 2015). For 2), 3) and 6) the input is the nonlinear error (residuals), which 
are extracted from the “nls” object with nlsResiduals() (nlstools) and this object passed 
to the relevant functions listed below.  
1) Levene’s test: leveneTest() – Car package 
2) Shapiro-Wilkinson: test.nlsResiduals() – nlstools package 
3) Run’s test: test.nlsResiduals() – nlstools package 
4) Lack-of-fit test: lm() to create ANOVA model followed by anova() to compare 
the nonlinear model with its nested ANOVA model –  base R 
5) Null test: lm() to create null model (a single intercept model, the mean of the data) 
followed by anova() to compare the nonlinear model with its null model –  base 
R  
6) Diagnostic plots: plot() – base R 
As mentioned above, calculation of the uncertainty surrounding nonlinear functions 
is not trivial. The package propagate (Spiess 2013) contained the function necessary to 
achieve this task, predictNLS(). This function simultaneously calculates Monte-Carlo 
simulations and carries out second-order Taylor expansion of a series of model derived 
fitted values obtained using predict() (base R). The propagation method could not be 
applied to split models (models that ascend to a static plateau) and so the Monte-Carlo 
values were used in these cases. 
AIC values for a model were called with AIC() (base R). To plot the various models 
and uncertainty the graphics package ggplot2 was used to bring the relevant information 
together (Wickham 2016), as described in Section II.4.1.1. The model parameters, 




II.4.2 Statistical techniques applied to compositional and gene expression data 
The techniques applied to data in Chapters V and VI were: principal components 
analysis (PCA), linear and quadratic regression and ANOVA. This section is divided 
under those headings with the appropriate functions summarised in the last sub-section. 
II.4.2.1 Principal components analysis 
PCA is a dimension reduction technique and is particularly useful to explore 
multivariate data, such as fatty acid compositions. PCA was applied to fatty acid data as 
means of identifying the main correlations between fatty acids and, fatty acids that may 
be physiologically interesting. The data were cleaned of fatty acids (variables) that 
contained many zeros and a few remaining zeros were imputed with a constant (0.005, 
chosen because it is approximately one order of magnitude below the detection limit of 
the gas chromatograph). The C20 and C22 MUFA were summed to single variables as the 
peaks do not always separate on the GC instrument. The variables were scaled so that 
each fatty acid had equal weight in the analysis. The results of PCA are presented 
graphically in the relevant chapters, this includes a biplot of the first two principal 
component scores and a loadings plot indicating the contribution of the variables (fatty 
acids) to the construction of the principal components. Dietary fatty acid profiles were 
included as “supplementary individuals” in the biplots, allowing the diet fatty acid 
profiles to be compared to the tissue profiles. The loadings plot contains arrows for each 





II.4.2.2 Regression  
Regression (linear or quadratic) was applied to composition, fatty acid and gene 
expression data. The predictor variable was either dietary VO (% diet) or in the case of 
fatty acids, the dietary level of that fatty acid. The assumptions of linear or quadratic 
regression were tested, mostly in the same way as the nonlinear regression models 
described in Section II.4.1.1. In some cases, transformations were required and usually 
applied as logarithms or power transforms. 
II.4.2.3 Analysis of variance 
ANOVA was also applied to fatty acid data. To test for the effect of tank it was 
included as a variable nested in diet and tested against a model without tank. The Levene’s 
test and Shapiro-Wilkinson test checked for heteroscedasticity and normality, 
respectively. When required, transformations were applied to the data, usually a power 
transformation to control heteroscedasticity. When differences were identified, Tukey’s, 
honest significant differences (HSD) tests were applied to establish which means differed.  
II.4.2.4 Implementation in R 
PCA was performed using the function PCA(). From the FactoMineR package 
(Husson, Josse et al. 2016). This package allows supplementary individuals (rows in a 
data table) and supplementary variables (columns in a data table) to be added to the 
analysis. These are not used to generate the analyses or scores but given scores after 
analysis. The dietary fatty acid profiles were used as supplementary individuals in 
Chapter VI. To present this data, data from the PCA object was extracted and passed to 




Regression analyses were performed using the function lm() and models were 
verified using the tools described previously (Section II.4.1.2) but with R base functions 
or tools from the Car package. Where necessary power transforms were applied (usually 
to control heteroscedasticity). 
ANOVA models were called using R’s base function aov() and models assessed as 
above. Where necessary power transforms were applied (usually to control 
heteroscedasticity). The lambda value was obtained using the function powerTransform() 
from the Car package. When differences were identified (P(>F) > 0.05) Tukey’s HSD 





III. A comparison of regression models for defining EPA+DHA 
requirements using the gilthead seabream (Sparus aurata) as 






Carnivorous marine fish species, such as gilthead seabream (Sparus aurata) require 
dietary EPA and DHA for optimal growth and wellbeing. Due to the rapid growth of 
global aquaculture the quantity of marine oils used in aquafeeds has been limited, yet the 
overall quantity of oil in an aquafeed has increased to supply energy to rapidly growing 
farmed finfish. This has been satisfied by vegetable oils (VO) and, therefore, essential 
fatty acid (EFA) requirements in juvenile marine fish requires reassessment. A dietary 
trial was carried out with six experimental groups of gilthead seabream (~25 g) fed diets 
with specific EPA+DHA levels (0.2-3.2 % diet, as fed). For each pellet size, the biometric 
data (weight gain, daily growth index and feed conversion ratio) were analysed by four 
different regression strategies, namely split linear, split quadratric, the Gompertz 
function, and the four-parameter logistic function. Over the whole experimental period 
(two pellet sizes) the current published requirement (1% of diet) appeared too low and 
should be increased to at least 1.2%. However, when the first pellet size, for fish of 25 – 
80 g was considered the requirement was at least 1.4% of diet. Thus, we demonstrate for 
the first time in a single trial that EFA requirement is a function of fish mass, decreasing 
as the fish grows. If FCR is considered, the requirement may be as high as 2 %. A range 
of regression models were required, for instance the first pellet growth data was best fit 
by curves but, over both pellet sizes, the split linear fit the data best. For asymptotic 
models, (Gompertz and four-parameter logistic functions) a novel way of defining the 
requirement is presented, the “elbow” calculation to identify an optimal point of 
diminishing returns on the nutrient response curve. Furthermore, it was illustrated how a 
range of regression approaches should be explored when determining nutrient 




III.1  Introduction 
EPA and DHA are primarily found in marine oils. For marine carnivorous fish 
species, EPA and DHA are regarded as EFA due to the limited ability that these species 
possess for their biosynthesis from the C18 precursor, ALA (18:3n-3) ( Castro et al. 2016). 
Consequently, marine carnivorous finfish have a dietary requirement for EPA+DHA to 
guarantee survival, health and normal growth (Oliva‐Teles 2012, Tocher, Glencross 
2015) and, currently FO is the primary source of these fatty acids in aquafeeds. ARA is 
also an important EFA and, although usually found at lower levels compared to EPA and 
DHA, is a key component of diets for larvae and broodstock (Bell, Sargent 2003).  
An essential nutrient must be present in the animal’s diet because it cannot be 
synthesised endogenously to fulfil physiological demands (Sargent et al. 2002). The 
response of an animal to the supply of an essential nutrient can be described by four levels 
of supply (Figure III.1). At lower levels, there is deficiency and the response (e.g. body 
weight) may take on negative values (e.g. weight loss). At some level, supply is balanced, 
and deficiency symptoms are not apparent (Lassiter, Edwards 1982). This can be referred 
to as the “maintenance requirement”. Further increase in the dietary level of the nutrient 
takes the animal to optimum supply, at this point the response is close to maximum and 
characteristics such as growth and feed conversion are optimal (Bailleul, Bernier et al. 
2000, Hauschild et al. 2010). This is the level that is usually considered a minimum 
requirement in terms of animal production, particularly for nutrients, such as EPA+DHA, 
derived from high value materials such as FO (Bacon 2017). Further increases in the 
nutrient supply only elicit very small gains in the response variable until maximum 




determination of a nutrient requirement defines a minimum level of nutrient supply to 
attain an optimum/maximum response, and differs from nutrient specification, a term 
commonly used in animal feed formulation that refers to the quantity delivered in the feed 
(Glencross 2009). The exact characteristics of the nutrient response curve depend on the 
precise nutrient, the species, its life stage, and the selected response (Rodehutscord, Pack 
1999). The most commonly used response is growth but not all nutrients will arrest 
growth and consequently the deficient, and maintenance part of the response may not be 
realised. This situation applies to EFA for juvenile marine fish (Kalogeropoulos et al. 
1992, Skalli, Robin 2004), where low supply leads to slower growth but does not stop 
growth completely. However other symptoms of deficiency may become apparent (Bou, 
Berge et al. 2017). The NRC, Nutrient Requirements of Fish and Shrimp (2011) reports 
that the EPA+DHA requirements for gilthead seabream (Sparus aurata) for EPA+DHA 
is 0.9% of diet (dry weight) based on studies by Kalogeropoulos et al. (1992) and Ibeas 
et al. (1994, 1996, 1997). Moreover, Ibeas et al. (1997) suggested that, in addition to the 
EPA+DHA dietary level, the DHA:EPA ratio is also an important factor, with a value of 
0.5 to be regarded as appropriate at a 0.9% EPA+DHA dietary supply (Ibeas et al. 1997). 
In fact, many species of fish such as Atlantic salmon (Salmo salar), Asian seabass (Lates 
calcarifer), turbot (Psetta maxima), sea bass (Dicentrarchus labrax), starry flounder 
(Platichthys stellatus), Korean rockfish (Sebastes schlegeli) and red drum (Sciaenops 
ocellatus) have been reported to have EPA+DHA (often referred to as  n-3 (≥C20), LC-
PUFA) requirements of ~1 % of diet (Coutteau et al. 1996, Lee, Lee et al. 2003, 
Lochmann, Gatlin 1993, Gatesoupe, Leger et al. 1977,  Glencross, Rutherford 2011,  
Glencross, Tocher et al. 2014). However, other species such as yellowtail flounder 




(Rhabdosargus sarba) and striped jack (Pseudocaranx dentex) have been shown to 
require EPA+DHA at a higher level (1.3-2.5 %) (T. Takeuchi 1997, T. Takeuchi, Shiina 
et al. 1992, Whalen, Brown et al. 1998, Leu, Yang et al. 1994). Thus, EFA requirements 
vary among fish species, but also among developmental stages, with larvae known to 
require relatively higher levels of LC-PUFA, particularly DHA, to satisfy the high 
demands required in rapidly growing neural tissues where DHA is required (T. Takeuchi 
1997, Tocher 2010).  
It is appropriate to revisit the question of EPA+DHA requirements for two key 
reasons. First, in the last two decades there has been a substantial reduction in the use of 
FM and FO (sources of EPA and DHA) in aquafeeds. Second, the oil content of modern 
aquafeeds has increased to supply high energy for growth while sparing protein 
(Glencross 2009, Sargent et al. 2002), and it has been suggested that the EFA requirement 
may be dependent on the lipid content of the diet (Watanabe 1982, Glencross, Smith 
2001). Therefore, the feed ingredients that contain EPA and DHA are being reduced while 
dietary energy is increased by the addition of vegetable oils (VO) that lack LC-PUFA, 
which may affect the requirement. The present study investigated the EFA requirements 
of a commercially important marine species, the gilthead seabream, fed a dietary gradient 
of EPA+DHA achieved by blending FO and VO. We herein discuss the benefits and 
drawbacks of a range of regression models used for nutrient requirement studies in fish 
(NRC, 2011) and provide estimations of EFA requirements in gilthead seabream juveniles 
calculated under the different regression strategies involving different responses 
including WG, DGI and FCR. A cost-benefit analysis associated with the dietary 
EPA+DHA inclusion levels used in this study was also carried out to explore the 




III.2  Methods 
III.2.1 Diets, fish husbandry and sampling 
As described in Section II.2 and briefly described here, six experimental diets (D1 – 
D6) were formulated to deliver graded levels of EPA+DHA to juvenile gilthead 
seabream. The diet formulations and measured proximate compositions are detailed in 
Table II.2 and diet fatty acid compositions in Table III.1. Commercially available oils 
including FO, RO and PO were blended to achieve specific levels of EPA+DHA. Other 
ingredients were selected to meet the known nutrient requirements of this species 
(National Research Council 2011, Oliva-Teles et al. 2011).  
The nutritional trial was carried out at the BioMar Feed Trial Unit (Hirtshals, 
Denmark) between April and August 2014 as described previously in Section II.2. 
Briefly, seabream juveniles of approximately 3 g were purchased from a commercial 
hatchery (Les Poissons du Soleil, Balaruc-les-Bains, France) and initially were fed a 
commercial diet rich in FM and FO from first feeding until they reached ~24 g. At the 
start of the trial, 150 fish were randomly distributed in each of 18 x 1 m3 tanks (n = 3 per 
diet). The fish were fed two pellet sizes, firstly a 3 mm pellet (P1) for 56 days and, 
secondly a 4.5 mm pellet (P2) for 72 days. Therefore, three experimental periods were 
considered, namely P1, P2 and over the whole trial (OV), with the tank biomass being 
measured at 0, 56 and 128 days. At the end of P1 and P2, the fish biomass from each of 
the tanks was recorded and the fish counted. The fish were fed twice daily ad libitum and 
the delivered and wasted feed recorded for an accurate determination of biological FCR 




Table III.1. Gilthead seabream dietary fatty acid composition. 
Table III.1. Fatty acid composition and total fatty acids (g.Kg-1) of the experimental diets 
given as percentage of total fatty acids. Note fatty acids < 0.05 across all rows removed. 
 D1 D2 D3 D4 D5 D6 
Total lipid (%) 22.16 21.71 21.71 21.47 21.82 20.82 
% of total fatty acids       
14:0 0.55 1.07 1.47 2.10 3.34 5.73 
16:0 15.44 15.62 15.71 16.05 16.69 17.52 
18:0 2.53 2.62 2.67 2.80 3.04 3.43 
20:0 0.46 0.38 0.43 0.41 0.36 0.26 
22:0 0.23 0.23 0.22 0.21 0.19 0.16 
ΣSFA 19.35 20.04 20.64 21.70 23.75 27.22 
16:1n-7 0.51 1.12 1.48 2.20 3.65 6.71 
18:1n-9 47.13 43.91 41.89 37.57 29.37 12.38 
18:1n-7 2.47 2.55 2.58 2.69 2.77 2.99 
20:1n 0.93 0.97 0.98 1.04 1.11 1.29 
22:1n-11 0.08 0.14 0.19 0.28 0.43 0.75 
24:1n-9 0.14 0.17 0.19 0.23 0.29 0.47 
ΣMUFA 51.32 48.92 47.37 44.10 37.77 24.69 
18:2n-6 21.42 20.42 19.69 18.56 16.16 11.22 
18:3n-6 0.00 0.03 0.04 0.07 0.12 0.25 
20:2n-6 0.06 0.07 0.07 0.08 0.10 0.14 
20:4n-6 0.05 0.11 0.15 0.23 0.40 0.78 
22:5n-6 0.00 0.04 0.05 0.09 0.16 0.31 
Σ n-6 PUFA 21.52 20.67 20.01 19.03 17.01 12.90 
18:3n-3 6.05 5.69 5.52 5.03 3.99 1.76 
18:4n-3 0.08 0.30 0.44 0.70 1.23 2.40 
20:4n-3 0.03 0.08 0.11 0.18 0.32 0.62 
20:5n-3 0.70 1.96 2.73 4.32 7.48 14.34 
22:5n-3 0.11 0.26 0.35 0.53 0.91 1.71 
22:6n-3 0.63 1.47 1.98 3.06 5.23 9.89 
Σ n-3 PUFA 7.61 9.76 11.13 13.83 19.16 30.77 
EPA+DHA (%)1 0.22 0.57 0.78 1.10 1.91 3.22 
Total fatty acids (g.Kg-1) 168.49 165.14 164.70 148.28 150.12 133.34 
1These values are the predictor variable for all analyses in this publication, expressed in 





III.2.2 Growth performance  
Before undertaking the requirement analysis, the growth of S. aurata was 
benchmarked against the model of Lupatsch (2003b): 
Wt = [Wi0.486 + 0.01166 · e0.060·T ·days]2.058 
where Wt is the final weight (g) after days of growth/feeding, Wi is the initial weight (g) 
and T is the water temperature. This is an exponential model closely related to daily 
growth index but parameterised for a stock of gilthead seabream in the Red Sea (Lupatsch, 
Kissil et al. 1998, Lupatsch et al. 2003b). The fish weights attained in this trial were 
compared to those forecast by the model and expressed as a percentage of mass relative 
to the model (± %). Based on this growth model (at a single temperature), mass gain over 
time is exponential, but, assuming a constant temperature, the absolute growth rate (AGR, 
g fish-1) increases by the same amount every day (linear), and therefore new absolute 
growth rate data from two samplings can be used to provide an approximate estimate of 
when the fish would reach a market size (~400 g for gilthead seabream).  
III.2.3 Requirement analysis 
The predictor variable in the following analysis was EPA+DHA% of diet (as fed). 
To evaluate the requirements of gilthead seabream juveniles for EPA+DHA% of diet, a 
series of regression analyses were performed on WG (g), DGI and FCR, for the P1 (3 
mm), P2 (4.5 mm) and OV (both pellets) response data. All regression analyses were 
undertaken using the statistical package R (Venables, Smith 2015) (version 3.4.0, Vienna, 
Austria). The model parameters were obtained using the function nls(). Graphics were 




experimental data and the approach presented is empirical, as opposed to mechanistic. 
Preference was given to models with low error (residual sum of the squares, RSS), and 
that were a strong fit to the requirement region of the response. Suitable models were 
assessed diagnostically according to techniques described by Ritz and Streibig (2008). 
The four regression models used were: split linear model, split quadratic model, 
Gompertz model and four-parameter logistic (FPL) model, which are defined below. For 
the latter two models (asymptotic models) two requirement estimates are presented: 1) 
95% of the asymptote (National Research Council 2011), which is referred to as the “NRC 
criterion” and plotted as ▲ in the relevant figures and 2) the “elbow” calculation 
(Eickhardt 2017), defined in Figure III.1. Requirements and "Elbow" calculation, and 
plotted as ● in the relevant figures. Unless otherwise stated N = 18, which in regression 
is sufficient to detect very large (f2 = 0.5) effects in the response. 
III.2.3.1 Split linear model 
The first model applied to the responses was the so-called “broken line” or split 
regression model, in which the first segment is a linear model usually ascending 
(descending for FCR) to a maximum response, i.e. a horizontal segment (a mean). The 
requirement is defined as the intersection of these two segments. Split linear regression 
can be expressed as follows:  
f(x) = m · x +  c     for x < req 
f(x) =  m · req + c       for x > req   
where x is the percentage of EPA+DHA in the experimental diet, c is the model’s intercept 





Figure III.1. Requirements and "Elbow" calculation 
Figure III.1. The effect of nutrient level upon an animal response (a dose response curve). 
Low nutrient supply indicates deficiency (Def), prevention of deficiency indicates 
maintenance (Main), at the “elbow” or corner of the curve the nutrient level can be 
described as optimal (Opt) where additional supply does not elicit significant gains in the 
response and maximum (Max) performance, whereby further increases in nutrient level 
cannot increase the response level any further (further increases may become detrimental 
to the response level, toxicity). This publication proposes that the optimum requirement 
(X) can be determined using an “elbow” calculation. 1) A linear model is taken from the 
y minima to y maxima (- - -). 2) The maximum perpendicular distance between this line 
and the fitted values of the relevant nonlinear function is found. 3) The requirement (X) 
is taken to be the nutrient level at this point. This represents a “point of diminished 
returns”, whereby further gain in the response is small relative to additional nutrient level. 
However, the “elbow” calculation is still sensitive to experimental design and may not be 





III.2.3.2 Split quadratic model  
The second model applied to the data was the split quadratic model, in which the first 
segment is a quadratic function ascending to a maximum level of response, whereas the 
second segment is horizontal. The requirement is defined as the intersection of these two 
segments. Split quadratic regression can be expressed as follows:  
f(x) = m · x + (-0.5 · m / req) · x2 + c   for x < req 
f(x) = m · req + (-0.5·m / req) · req2 + c  for x > req 
where x is the percentage of EPA+DHA in the experimental diet, c is the model’s 
intercept, m is the rate constant and req is x at the breakpoint (the requirement).  
III.2.3.3 Gompertz model 
The first asymptotic function fitted to the response data was the Gompertz which can 
be defined as: 
f(x) = a · exp (b · c x) 
where x is the percentage of EPA+DHA in the experimental diet, a is the asymptote or Y 
maxima, b sets the displacement on the x-axis and c is the scaling parameter, setting the 
rate of growth towards the asymptote.  
III.2.3.4 Four parameter logistic model 





f(x) = b + (a-b) / (1 + exp((xmid-x)/c)) 
where x is the percentage of EPA+DHA in the experimental diet, a is the upper asymptote, 
b is the lower asymptote, xmid is the value of x at the infection point and c is the scaling 
parameter.  
III.2.4 Cost-benefit analysis 
To assess the economic implications of the experimental diets a simple cost benefit-
analysis was conducted. The economic analysis was based on a production plan of 10,000 
seabream juveniles starting at 24.34 g (mean weight of fish in this trial), at a constant 
temperature of 24°C, and growth forecast for 300 days of feeding. To estimate the future 
mean weight of the fish, the two sampling values for absolute daily gain (g fish-1 day-1) 
were used to predict the linear increase in daily gain, the latter being used to calculate 
daily mean weight. This assumption is reasonable at a constant water temperature as 
considered in this analysis (Lupatsch et al. 1998). Daily feed rates were calculated 
according to Lupatsch and Kissil (2003b) as: 
Feed (g fish-1 day-1) = 0.029 * Wt0.598 * e(0.057*T) 
where Wt is the average weight and T is the water temperature. This function marginally 
underestimated the actual feeding rates in this study, but extrapolation was required so an 
established equation for ad libitum feeding was chosen. Mortality was assumed to be 6 % 
over 300 d and feed waste assumed to be 5 % across the six different diets. Prices for the 
key commodities were found online and taken at their “Free-on-board” prices 
(Anonymous 2017a, Anonymous 2017b, Bacon 2017) and are reported in Euro (€). Feed 




oil (Crude lipid = 21%) and adjusted for the different oil prices at the ratios used in this 
study. 
III.3  Results 
III.3.1 Growth performance  
Table III.2 shows the mean initial weights, P1 weights, P2 weights, feed intake, DGI 
and FCR. During the feeding trial, weight of fish in all dietary groups increased. However, 
the increase in dietary EPA+DHA (particularly diets D5-D6) resulted in higher weight 
gain in gilthead seabream juveniles. All the experimental fish grew faster than predicted 
by the Lupatsch (2003b) model. 
III.3.2 Requirement analysis  
A series of regression analyses were conducted to explore different ways to 
determine the EPA+DHA requirement of juvenile gilthead seabream. All functions and 
their respective parameters are given in Table III.3. The requirement estimates derived 
from these models are given in Table III.4, along with measures of the model fit, the 
Akaike’s AIC and RSS. Below we present the EFA requirement estimations resulting 





Table III.2. Gilthead seabream biometric data. 
Table III.2. Mean (± SD) values for the dietary treatments for the biometric data analysed in this study (N=3) over the different feeding periods, P1, P2 
and OV. 
  D1  D2  D3  D4  D5  D6  
Initial Weight (g) 24.39 ± 0.27 24.28 ± 0.10 23.98 ± 0.12 24.63 ± 0.33 24.30 ± 0.10 24.53 ± 0.33 
Weight P1 (g) 83.75 ± 1.97 89.08 ± 0.69 89.58 ± 2.06 93.78 ± 1.67 98.00 ± 1.25 98.50 ± 0.80 
Weight P2 (g) 198.63 ± 1.30 219.41 ± 6.59 223.73 ± 5.03 241.30 ± 3.09 244.96 ± 3.98 248.31 ± 1.52 
Feed intake P1 (Kg) 10.52 ± 0.39 11.50 ± 0.03 11.64 ± 0.40 11.97 ± 0.13 12.14 ± 0.07 11.99 ± 0.36 
Feed intake P2 (Kg) 22.16 ± 0.24 24.47 ± 0.73 25.07 ± 0.43 26.68 ± 0.35 26.04 ± 0.53 26.35 ± 0.76 
Feed intake OV (Kg) 32.67 ± 0.54 35.98 ± 0.74 36.71 ± 0.77 38.65 ± 0.47 38.19 ± 0.58 38.34 ± 0.67 
FCR1 P1 1.19 ± 0.02 1.21 ± 0.01 1.20 ± 0.01 1.17 ± 0.01 1.11 ± 0.01 1.09 ± 0.00 
FCR P2 1.38 ± 0.03 1.37 ± 0.03 1.35 ± 0.04 1.29 ± 0.01 1.25 ± 0.02 1.24 ± 0.02 
FCR OV 1.33 ± 0.02 1.33 ± 0.02 1.31 ± 0.02 1.27 ± 0.01 1.22 ± 0.01 1.21 ± 0.01 
DGI1 P1  2.63 ± 0.04 2.80 ± 0.02 2.83 ± 0.05 2.91 ± 0.02 3.05 ± 0.02 3.06 ± 0.04 
DGI P2 2.02 ± 0.04 2.17 ± 0.07 2.21 ± 0.02 2.33 ± 0.00 2.28 ± 0.02 2.31 ± 0.01 
DGI OV 2.29 ± 0.01 2.44 ± 0.05 2.48 ± 0.04 2.58 ± 0.01 2.62 ± 0.02 2.63 ± 0.01 
Lupatsch (+%)3 42.30 ± 1.20 57.50 ± 4.80 62.20 ± 3.30 72.10 ± 1.20 75.70 ± 2.60 77.4 ± 1.10 
1Feed conversion ratio = (Feed fed (kg) – feed waste (kg)) / Δ Biomass (kg) 
2 Daily Growth Index = Final weight (g) 0.333 – Initial weight (g) 0.333 / Days feeding 
3 In terms of weight during the experimental period. The model is defined:  Wt = [Wi0.486 + 0.01166 · e0.060·T ·days]2.058 where Wt is the final 





Table III.3. Gilthead seabream model parameters. 
Table III.3. Model parameters fitted to the biometric data of Sparus aurata juveniles in 
this trial to derive estimates for the EPA+DHA requirement of this species. The four 
models presented are the split linear, split quadratic, Gompertz and the four parameter 
logistic (FPL) function. The models were applied to the overall data (OV, both pellet 
sizes), the 3 mm pellet size (P1, in the text) and the 4.5 mm pellet size (P2 in the text). 
The name of the parameter and the notation used in the text is indicated in the column 
headers. N = 18 except for the Gompertz model applied to FCR data, where N=15. 
Model type Metric Period Parameters 
   Plateau  Gradient Intercept Requirement 
    m c req 
Split regression WG (g) OV 222.22 47.13 165.25 1.21 
  3mm 78.81 11.02 57.61 1.47 
  4.5mm 148.38 36.03 107.62 1.13 
 DGI OV 2.63 0.33 2.23 1.20 
  3mm 3.05 0.32 2.59 1.46 
  4.5mm 2.30 0.32 1.96 1.09 
 FCR OV 1.21 -0.07 1.36 2.03 
  3mm 1.09 -0.06 1.23 2.50 
  4.5mm 1.25 -0.10 1.41 1.62 
   Plateau  Rate constant Intercept  Requirement 
    m c req 
Ascending  WG (g) OV 222.43 75.26 158.52 1.70 
polynomial  3mm 74.04 15.62 56.43 2.25 
  4.5mm 148.76 59.18 102.31 1.57 
 DGI OV 2.63 0.55 2.17 1.64 
  3mm 3.06 0.48 2.54 2.15 
 FCR OV 1.21 -0.11 1.37 3.03 
  3mm 1.02 -0.06 1.23 6.94 
  4.5mm 1.24 -0.13 1.42 2.71 
   Plateau  Displacement Scale parameter 
   a b c  
Gompertz WG (g) OV 224.42 -0.38 0.17  
  3mm 72.84 -0.31 0.28  
  4.5mm 149.99 -0.42 0.14  
 DGI OV 2.64 -0.22 0.16  
  3mm 3.08 -0.21 0.26  
  4.5mm 2.31 -0.23 0.10  
 FCR OV 1.20 0.23 0.26  
  3mm 1.06 0.21 0.47  
  4.5mm 1.24 0.26 0.20  
   Plateau  Bottom (b) Inflection Scale parameter 
   a b xmid c 
FPL WG (g) OV 223.00 150.65 0.45 0.32 
  3mm 74.62 24.75 -0.32 0.66 
  4.5mm 149.00 106.37 0.55 0.25 
 DGI OV 2.63 2.00 0.29 0.36 
  3mm 3.08 -6.10 -2.03 0.76 
  4.5mm 2.31 1.98 0.55 0.19 
 FCR OV 1.21 1.34 1.04 0.10 
  3mm 1.09 1.21 1.41 0.29 







Table III.4. Gilthead seabream requirement estimates 
1 Gom - Gompertz 
 
Table III.4. Requirement estimates for EPA+DHA (% of diet as fed) of juvenile gilthead seabream, Sparus aurata, from the models listed in 
Table III.3. The models were applied to the overall data (OV, both pellet sizes), the 3 mm pellet size (P1, in the text) and the 4.5 mm pellet 
size (P2 in the text). In the Gompertz and FPL models, the EPA+DHA estimate derived from the “elbow” calculation is given. The residual 
sum of the squares (RSS) and the Akaike information criterion (AIC) are also given as an indication of how well the models fit the 
experimental data. 
Metric Pellet Split 
linear 
RSS AIC Split 
quadratic 
RSS AIC Gom1 RSS AIC FPL  RSS AIC 
WG (g) OV 1.21 336.00 109.75 1.70 341.00 112.02 1.22 368.00 113.40 1.25 343.00 114.14 
 
3mm 1.47 38.20 70.61 2.25 33.50 70.24 1.34 33.10 70.00 1.37 32.90 71.92 
 
4.5mm 1.13 210.00 101.33 1.57 241.00 105.76 1.18 274.00 108.07 1.19 244.00 107.98 
DGI OV 1.20 0.016 -67.27 1.64 0.014 -69.86 1.18 0.015 -68.75 1.21 0.014 -67.60 
 
3mm 1.46 0.033 -56.22 2.15 0.027 -57.86 1.30 0.026 -58.72 1.30 0.026 -56.72 
 
4.5mm 1.09 0.027 -57.90 No fit- 
  
1.08 0.037 -52.20 1.09 0.033 -52.53 
FCR OV 1.97 0.0079 -80.19 3.03 0.0088 -78.25 1.53 0.0048 -70.09 1.55 0.0064 -81.76 
 
3mm 2.50 0.0062 -85.29 6.94 0.0071 -82.00 1.67 0.0021 -82.84 2.03 0.0037 -91.85 
 








III.3.2.1 Weight gain and daily growth index 
Using the split linear model to fit the WG data, the requirements were estimated as 
1.21, 1.47 and 1.13 EPA+DHA% of diet for OV, P1 and P2, respectively (Figure III.2A). 
Using the split linear model to fit the DGI data, the requirements were 1.20, 1.46 and 1.09 
EPA+DHA% for OV, P1 and P2, respectively (Figure III.2B). The requirement values 
agree between the two metrics of growth, WG and DGI. The distribution of error for P1, 
WG and DGI exhibited a curve. When using the split quadratic model for the WG data, 
the EFA requirements were estimated as 1.70, 2.25 and 1.57 EPA+DHA% for OV, P1 
and P2, respectively (Figure III.2C). The error distribution in the P1 data was better using 
the quadratic model. Using the split quadratic model to fit the DGI data, the requirements 
were 1.64 and 2.15 EPA+DHA% for OV and P1, respectively. This model failed to fit 
the DGI data of P2 due to the high DGI values attained with fish fed diet D4 (Figure 
III.2D). The OV and P2 data was best modelled by the split linear method, but the P1 data 
was best described by the split quadratic model (Table III.4). The asymptotic nonlinear 
models, namely the Gompertz and the four-parameter logistic (FPL) models, applied to 
the WG and DGI data are presented in Figure III.3. Using the Gompertz model and elbow 
calculation (Figure III.1) to fit the WG data, the EFA requirements were estimated as 
1.22, 1.34 and 1.18 EPA+DHA% for OV, P1 and P2, respectively. Considering the NRC 
recommendation of 95% of the maximum response, the EFA requirements were 
calculated as 1.13, 1.40 and 1.07 EPA+DHA% for OV, P1 and P2, respectively (Figure 
III.3A). With regards to the DGI data, the Gompertz function and the elbow calculation 






Figure III.2. Gilthead seabream split linear and quadratic regression 
Figure III.2. The split linear (A and B) and split quadratic (C and D) models applied to 
the weight gain (A and C) and daily growth index (B and D) data against EPA+DHA % 
of diet (as fed, x-axis). The raw data are marked with coloured spots, the relevant model 
fit with an unbroken line, 95 % prediction intervals (calculated by Monte-Carlo 
simulation) are shaded in colour. Colours for the different periods are as follows: the 
whole trial, OV =  ; the 3 mm pellet size, P1 =  and the 4.5 mm pellet size, P2 = . 
Note, in panel D the quadratic model would not fit the P2 data due to the high performance 





Figure III.3. Gilthead seabream asymptotic functions 
Figure III.3. The nonlinear Gompertz model (A and B) and four-parameter logistic model 
(FPL in the text, C and D) applied to the weight gain (A and C) and daily growth index 
(B and D) data against EPA+DHA % of diet (as fed, x-axis). The raw data are marked 
with coloured spots, the relevant model fit with an unbroken line, requirements with black 
symbols and the 95 % prediction intervals (calculated with 2nd order Taylor expansion) 
are shaded in colour. Symbols for the requirement estimates are as follows: Published = 
□, National Research Council = △ (NRC criterion in text) and Elbow = ○. Colours for the 
different periods are as follows: the whole trial, OV =  ; the 3 mm pellet size, P1 =   
and the 4.5 mm pellet size, P2 = . Note in panel D in P1, the error was not plotted for 
clarity because it was very wide, an indication that the curve for this data was over-




When the NRC criterion (95% of the maximum response) was applied to estimate 
EFA requirements from DGI data, much lower values were obtained, namely 0.79, 1.04 
and 0.64 EPA+DHA % for OV, P1 and P2, respectively (Figure III.3B). Using the FPL 
model to fit the WG data, EFA requirements were estimated as 1.25, 1.37 and 1.19 
EPA+DHA% (elbow calculation) and 1.01, 1.34 and 0.94 % of dietary EPA+DHA (NRC 
criterion) for OV, P1 and P2, respectively (Figure III.3C). For the DGI data, the EFA 
requirements were estimated as 1.21, 1.3 and 1.09 % (elbow calculation) and 0.77, 1.05 
and 0.68 % of dietary EPA+DHA (NRC criterion) for OV, P1 and P2, respectively (Figure 
III.3D). The fourth parameter allowed the model to fit the growth data well in OV and 
P1. However, parameter estimates for b and, or xmid had large standard errors, due to the 
absence of data for the lower part of the curve. It should be noted that for P1 the model 
parameters were not significant leading to wide prediction intervals (Figure III.3D). 
III.3.2.2 Feed conversion ratio 
The split linear and quadratic models provided requirement estimations that were 
high. This was due to the inadequacy of these models to fit the unusual distribution of the 
real-world FCR data. Therefore, the values are not discussed in detail here but are 
reported in Table III.4 and Figure III.4 A and B for completeness and to demonstrate the 
lack of fit. To fit the Gompertz models to the FCR data it was necessary to remove data 
of diet D1 (N = 15). Using the Gompertz curve to fit the FCR data, the EFA requirements 
were estimated as 1.53, 1.67 and 1.47 % (elbow calculation) and 1.15, 1.92 and 1.03 
EPA+DHA % (NRC criterion), for OV, P1 and P2, respectively (Figure III.4C). The 
removal of diet D1 data removed error and therefore the model is not comparable to the 




enough to fit these data without the removal of diet D1 data. With FCR as response, the 
EFA requirements were 1.55, 2.03 and 1.45 EPA+DHA % (elbow calculation) and 1.05, 
1.45 and 0.99 EPA+DHA % (NRC criterion) for OV, P1 and P2, respectively (Figure 
III.4D). The values attained for FCR were higher than for growth, and the FPL model was 
the only model to offer a satisfactory fit to the real-world data. 
III.3.3 Cost-benefit analysis 
The six diets were economically analysed in terms of a standardised production 
objective and recent costs and prices (June 2017) for the key dietary components and 
farm-gate value of gilthead seabream. The best performing diet in this analysis was D4 
(EPA+DHA = 1.1 %). The time to reach a harvest weight of 400 g was 182, 181 and 183 
days, respectively for diets D4-D6. These theoretical growth trajectories were plotted for 
300 days (Figure III.5). Diet D4 attained the highest value for margin over feeds, which 
is the price per Kg sea bream minus the value of its feed. The results of this analysis are 





Figure III.4. Gilthead seabream feed conversion ratio 
Figure III.4. The linear (A) and quadratic (B) split regression models applied to the FCR 
data against EPA+DHA % of diet (as fed, x-axis), the 95% prediction intervals (shaded 
colour) were calculated by Monte-Carlo simulation. The nonlinear Gompertz (C) and four 
parameter logistic (FPL in the text, D) applied the FCR data against EPA+DHA % of diet 
(as fed, x-axis), the 95% prediction intervals (shaded colour) were calculated by second-
order Taylor expansion. The raw data are marked with coloured spots, the relevant model 
fit with an unbroken line and requirements with black symbols. Symbols for the 
requirement estimates are as follows: Published = □, National Research Council =△ 
(NRC criterion in text) and Elbow = ○. Colours for the different periods are as follows: 
the whole trial, OV =  ; the 3 mm pellet size, P1 =   and the 4.5 mm pellet size, P2 = 




Table III.5. Cost-benefit analysis 
Table III.5. Summary of production economic analysis of Sparus aurata production in 
terms of feeding to a market size of 400 g. Mortality was assumed to be 6 % and 
production and feed waste 5%. Economically, there is no benefit in terms of time or 
margin in raising EPA+DHA beyond 1.1%, the level in D4. 
 Item D1 D2 D3 D4 D5 D6 
Fish oil (% inclusion) 0.0 1.8 2.6 4.4 8.0 14.8 
Rapeseed oil (% inclusion) 10.4 9.2 8.6 7.3 4.8 0.0 
Palm oil (% inclusion) 5.2 4.6 4.2 3.6 2.4 0.0 
Cost of oil (€ t-1) 689.05 782.26 830.17 926.51 1123.06 1513.00 
Feed cost (€ t-1) 936.84 950.72 957.80 971.84 1000.00 1054.16 
Results             
Days to reach 400g‡ 216 198 195 182 183 181 
Economic FCR 1.49 1.36 1.35 1.25 1.27 1.26 
Feed cost  
(€ Kg seabream-1) 1.31 1.21 1.2 1.13 1.18 1.24 
Margin over feed (€ Kg-1) 3.15 3.25 3.26 3.33 3.28 3.22 
Commodity Price Source 
EURO/Dollar (€/$) 0.89  
Fish oil (€) 1513.00 †https://hammersmithltd.blogspot.co.uk/ 
Rapeseed oil (€) 741.79 †http://www.indexmundi.com/commodities/ 
Palm oil (€) 583.36 †http://www.indexmundi.com/commodities/ 
Farm gate (€) 4.46 †https://www.eumofa.eu/ad-hoc-queries 
Market weight (g) 400.00 †https://www.eumofa.eu/ad-hoc-queries 
† All sources accessed 21/06/17 
‡ Calculated by a linear projection of absolute growth rate (g day-1) to generate a series 






Figure III.5. Simulated growth of gilthead seabream 
Figure III.5. Average weight of a fish plotted over days feeding on diets D1-D6. The 
values of weights are those predicted by the growth forecasts in the cost-benefit analysis, 
note the similarity in performance between the D4, 5 and 6 mean weights. D1 = ; D2 = 
; D3 =  ; D4 =   ; D5 =   ; D6 =   . 
 
III.4  Discussion 
The present study explored four different models and three performance responses 
that can be used to advance EPA+DHA requirement estimates. The experimental design 
involved diets formulated with commercially relevant oils and energy densities, and 
strong performance was observed from all dietary groups. There were two key 
conclusions from this study. Firstly, we showed for the first time in a single study, that 
the requirement for EPA+DHA is a function of fish mass (decreasing with increasing 
weight) and could therefore be modelled with data from more time points. Secondly, the 
current published requirement for EPA+DHA of 0.9 % (dry diet) appeared too low for 
juvenile gilthead seabream (Kalogeropoulos et al. 1992, National Research Council 




of 24-80 g, the diet (3 mm pellet) should contain at least 1.4 % for an optimum 
requirement but to achieve maximum performance (highest growth and feed conversion) 
the level is 2 %. This can be reduced in larger fish (80 – 250 g; 4.5 mm pellet) to 1.2 % 
for optimal requirement but 1.5 % to achieve maximum performance. The data suggested 
that the current published guidance (~1%) would become adequate at some body weight 
during this growth phase (P2). The previous requirement estimate for juvenile gilthead 
seabream employed smaller fish than this study (1.2 g) and used split linear regression to 
analyse weight gain (g). The reason for the previously estimated lower EFA requirement 
is related to the lower level of growth attained by the juvenile seabream in the earlier 
study (DGI: 0.74-0.87). In a further study in European seabass also employed split linear 
regression with DGI as the response and reported a requirement of 0.7 % LC-PUFA (of 
diet dry diet) for fish of 14 g initial weight (DGI: 0.84 – 1.0) (Skalli, Robin 2004). The 
different approaches presented in the present study also showed that there is no one model 
that suits every parameter or each of the experimental periods, as suggested previously 
(Baker 1986, Rodehutscord, Pack 1999). 
The higher EFA requirements, especially for DHA, of larval fish is relatively well 
understood (Izquierdo 1996, Sargent et al. 1997). However, the present study has shown 
a change in EFA requirement between two fish (pellet) sizes and, therefore demonstrated 
the existence of a relationship between fish mass and EFA requirement. It is likely that 
this relationship takes on a similar form to digestible protein (requirement = -a · fish mass 
(Kg)b) (Lupatsch et al. 2003b), to define this relationship the precise requirement for 
EPA+DHA would need to be known over a range of fish masses, ideally in a single 
experiment achieving optimal growth. Here, we only provide requirement estimates for 




fish weights can be estimated, with the value being approximately -1.8. Alternatively, if 
the requirement is viewed per unit energy (Glencross 2009) or lipid (Watanabe 1982) the 
decreasing requirement (% of diet) may be interpreted as a consequence of the rising 
energy (DE) demand for maintenance as the fish grows (Lupatsch 2005). Regardless of 
how the requirement is numerically expressed, or even understood, its fraction in the diet 
(% or g kg-1) still needs to be known to inform diet specification. The discussion below 
focuses on the strengths and weaknesses of the models.  
The first two models applied to the data were linear and quadratic split regression. 
Conceptually, these models derive the maximum requirement because the equation 
describes a model approaching a horizontal plateau, at this plateau the response is 
equivalent to the mean of the highest performing dietary groups. For this reason, it is 
critical for these techniques that the maximum response is known with at least two dietary 
treatments. The exception to this is where an effect of toxicity is observed at higher levels 
of nutrient supply. An example of this can be found in blackhead seabream 
(Acanthopagrus schlegelii) where high levels of n-3 LC-PUFA led to lower growth, and 
in this situation the authors used quadratic regression, without the horizontal segment 
(Jin, Lu et al. 2017). In the present study, we did not observe a detrimental effect of higher 
EPA+DHA levels, so quadratic regression was not appropriate. As split linear and 
quadratic define the requirement at the intersection of the model with the plateau, an 
unequivocal requirement is provided by application of the model (Glencross 2009). 
Linear split regression is the most frequently applied model in fish nutrient requirement 
studies (Kalogeropoulos et al. 1992, Skalli, Robin et al. 2006, Murillo-Gurrea, Coloso et 
al. 2001, Luzzana, Hardy et al. 1998, Mai, Lu Zhang et al. 2006). Quadratic split 




(Hernandez-Llamas 2009) but there are more examples in terrestrial animals (Hauschild 
et al. 2010). Interestingly, the split linear model had the best fit for WG response in OV 
and P2 data, and it produced EPA+DHA requirement estimates marginally higher than 
the two asymptotic models (Gompertz and FPL), this being somewhat unexpected as this 
method has been found to underestimate nutrient requirements (Shearer 2000, 
Hernandez-Llamas 2009). In the present study, the quadratic split regression gave higher 
estimates than the linear split regression. Neither of these methods seemed applicable to 
the FCR data due to the unusual shape of this response. As a result, the EPA+DHA 
requirements estimated with FCR as response variable were considerably higher than 
published requirement estimates for S. aurata (Kalogeropoulos et al. 1992) when any of 
the split regression models were used. Feed conversion/feed efficiency ratio is usually 
given in requirement papers, but rarely modelled as a parameter. An example with lysine 
requirements of the Japanese seabass (Lateolabrax japonicus) used split regression with 
feed efficiency (Mai et al. 2006).  
Asymptotic functions (such as the Gompertz and FPL) can often be a strong fit to 
real-world data (Mercer, May et al. 1989) since they adequately address the concept of 
the increase in the response slowing as the plateau is reached, which in economics, is 
referred to as the concept of diminishing returns (Spillman, Lang 1924).  A limitation of 
nonlinear models, however, stems from the fact that the nutrient requirement is defined 
arbitrarily at 0.95 · asymptote (Cowey 1992, National Research Council 2011). Our 
present results suggested that this method was highly sensitive to parameter selection and 
might lead to erroneous requirement estimates, at least in the context of EFA. Thus, the 
requirement estimates during the OV period for both growth responses (DGI and WG) 




· asymptote criterion, the proposed “elbow” calculation was developed as a means of 
defining a “point of diminishing returns” (Spillman, Lang 1924) or optimal requirement 
on a response curve. In nutrient requirement studies, it is important that both the deficient 
and excess part of the nutrient response curve are well-defined (Shearer 2000,  Glencross 
2009). It was anticipated that the elbow calculation would be less sensitive to the dietary 
levels of nutrient supply. Unfortunately, this is not the case and the elbow calculation still 
relies on the nutrient levels determined at the experiment’s conception. However, this 
calculation did seem useful in analysing the data obtained in this study as it gave similar 
requirement estimates for both metrics of growth and both models (albeit, marginally 
higher for the DGI parameter). This is due to its insensitivity to the scale of the response. 
However, it is advocated that the elbow calculation is only applied to asymptotic 
functions. 
The two asymptotic models used in the present study (Gompertz and FPL) have been 
used previously to fit nutrient responses in terrestrial animals (Gahl, Finke et al. 1991, 
Pesti, Vedenov et al. 2009) but, to our knowledge, have not been applied to fish. Other 
asymptotic functions (four and five-parameter saturation kinetics models) were used in a 
study investigating the tryptophan requirements of hybrid striped bass (Morone chrysops 
· M. saxatilis) finding requirements just over 2 g kg-1 when the asymptote was multiplied 
by 0.95 (Gaylord, Rawles et al. 2005). Two meta-analyses in fish have employed a variety 
of nonlinear models to previously published data and found that often the curves fit 
responses better, but that no one model was appropriate for all data sets (Rodehutscord, 
Pack 1999,  Shearer 2000). Therefore, we explored a range of nonlinear models and the 
two attaining the best fit were reported here. In the present study, the Gompertz model 




able to fit these data, but this model carried high uncertainty because it has parameters 
that are not covered by the data (b and xmid). To apply the Gompertz model to the FCR 
data it was necessary to disregard data for diet D1, and therefore it does not capture reality 
well, which created problems comparing fits as error associated with diet D1 was 
discarded. The only model that could describe the FCR response to the diets was the FPL 
model, as such requirements for FCR differed between the two asymptotic models and it 
is difficult to advance an estimate, but it can be said that the requirement to achieve the 
best FCR was higher than for the growth metrics. 
The economic analysis showed that there was no obvious economic benefit of 
increasing EPA+DHA beyond the level of that in diet D4 (1.1 % EPA+DHA) both in 
terms of margin over feed cost and time taken to grow to a market weight of 400 g. This 
type of analysis is highly sensitive to several factors. The first is the market price of the 
three oils used, fish, palm and rapeseed oils. The second is the method of growth 
projection. Over the first period of the experiment, diet D4 had absolute growth rate 
(AGR) values (mean = 1.23 g day-1) intermediate to diets D3 and D5, however, over P2 
the AGR values (mean = 2.05 g day-1) were equivalent to diets D5 and D6, and this meant 
that the linear projection of daily AGR was the steepest out of the six diets (this would 
not occur). This is a weakness in this method, but it does reveal that, at some point during 
P2, diet D4 had sufficient EPA+DHA and growth rates were on par with the fish 
consuming diets D5 and D6. This forecast, therefore lends support to the conclusion that 
the requirement reduces as fish increase in mass and at some bodyweight the current 
recommendations would be sufficient. This is in line with larvae and small juveniles 
having much higher relative requirement for LC-PUFA (Sargent et al. 2002, T. Takeuchi 




achieved by feeding 1.5 % EPA+DHA up to a size of 100 g and then reducing the level 
of FO equivalent to the values reported for the OV requirement, ~1.2 % EPA+DHA of 
diet.  
It is evident from these empirical data that the current requirement of 0.9 (dry weight) 
or ~1 % EPA+DHA is probably too low for juveniles of this species, especially when 
considering fish of 25 – 80 g. The present study has demonstrated that no model is a fit 
for each situation and the NRC definition of a requirement at 95 % of a response 
maximum does not seem to be appropriate for EPA+DHA requirements. One reason for 
this is that the models suggest that n-3 LC-PUFA (i.e. EPA and DHA) are not completely 
essential to growth (all models have positive intercepts, implying that there is no 
maintenance demand and no weight loss), at least over the timescale of this study. 
Interestingly, results modelling the turnover of individual fatty acids in Asian seabass 
(Lates calcarifer) suggested zero maintenance requirement for EPA and DHA (Salini, 
Poppi et al. 2016). Therefore, multiplying the optimum response by 0.95 can give a result 
that is too low on the response curve. The elbow-calculation was applied to determine a 
point on an asymptotic response curve that was less sensitive to the design of the 
experiment although, unfortunately, it is not completely insensitive to experimental 
design. The calculation, however, does bisect the curve well and the data demonstrated it 
returned values that agreed with each other across models and metrics. However, its 
application was not appropriate unless the maximum response and deficient response was 
well defined, and we only advocate its use for asymptotic models. The elbow calculation 
defines a point on the curve that obeys the concept of diminishing returns and, further 
increases in dietary EPA+DHA levels lead to little gain in the response and, therefore, 




In summary, the key conclusions of this work are that 1) S. aurata juveniles of 25 g 
– 80 g (3 mm pellet) have a higher requirement for EPA+DHA of at least 1.4 % of diet 
but perhaps as high as 2% if FCR is considered, 2) the requirements for EPA+DHA are a 
function of fish mass, the implication of this being that requirements could be modelled 
but the trial would need a larger number of sampling points than the two reported here 
and, 3) the exact definition of EPA+DHA requirement is a question of context; 
maintenance, optimum production, maximum performance, health, well-being or product 











IV. Application of robust nonlinear regression to determine the 
requirements of juvenile European seabass (Dicentrarchus 







The long-chain polyunsaturated fatty acids (LC-PUFA), EPA and DHA are essential 
to marine fish species, such as European seabass (Dicentrarchus labrax), for optimal 
growth and health. Vegetable oils (VO) are added to fish feed formulations to increase 
the diet’s energy density while “sparing” protein for growth. This higher dietary lipid 
level may influence the requirement for essential fatty acids (EFA). This formulation 
practise has been introduced since the EPA and DHA requirements were defined in most 
cultured fish species and, therefore, EFA requirements need to be reassessed in many 
farmed species. This study was carried out to reassess the requirement of EPA+DHA in 
juvenile European seabass. Six diets were formulated with graded levels of EPA+DHA 
(0.2 – 3.1 % of diet as fed) and fed to triplicate groups of European seabass as two pellet 
sizes (3 mm and 4.5 mm) for 127 days. For each pellet size, the biometric data (weight 
gain and daily growth index) were analysed by three different robust nonlinear regression 
strategies, namely split linear, split quadratric and the Gompertz function. The FCR data 
was also considered in the analysis. Over the whole experimental period (two pellet sizes) 
the current published requirement (1% of diet) appeared too low and should be increased 
to at least 1.1 - 1.2% diet (as fed). However, when the first pellet size for fish of 25 – 80 
g was considered, the requirement was 1.3 – 1.5 % diet (as fed). The experimental diets 
did not have large effects on FCR, particularly during the feeding of the 4.5 mm pellet. 
The growth data was best fit using the Gompertz function. In accordance to the earlier 
study in gilthead seabream (Chapter III) it was demonstrated that the requirement for EFA 
falls as the fish increases in weight. However, in European seabass the effects of size on 





Fish oils are rich in LC-PUFA of the n-3 series. The two principal n-3 LC-PUFA are 
EPA and DHA. For many fish, especially marine species, these two fatty acids are 
regarded as EFA due to the absence of functional pathways to synthesise n-3 LC-PUFA 
from ALA (18:3n-3) ( Castro et al. 2016). Therefore, EPA and DHA need to be supplied 
preformed to most marine fish species to ensure wellbeing and normal growth (Oliva‐
Teles 2012, Tocher, Glencross 2015). Arachidonic acid (20:4n-6) is also an important 
EFA and, although usually found at lower levels in FO compared to EPA and DHA, is a 
key component of diets for larvae and broodstock (Bell, Sargent 2003). Currently, FO is 
the main source of n-3 LC-PUFA in marine fish diets but in the future, wild caught fish 
will be unable to supply demands of aquaculture and nutraceutical industries (Quaas, 
Reusch et al. 2016, Cashion, Le Manach et al. 2017, Fisheries 2016). Therefore, efforts 
are currently underway to develop new sources of these crucial EFA. Possible future 
sources of EFA are algal derived oils (Barclay, Weaver et al. 2010, Sprague, Walton et 
al. 2015) and genetically modified crops (Qi, Fraser et al. 2004, Ruiz‐Lopez, Haslam et 
al. 2014, Betancor, Sprague et al. 2015). However, the finite nature of FO and the 
technical sophistication of novel EFA sources means that a firm understanding of EFA 
requirements for all cultured fish are required to utilise all sources of EFA as efficiently 
as possible (Glencross 2009). 
Current aquafeeds are rich in dietary energy to support rapidly growing finfish, this 
is supplied as dietary oil to “spare” higher value protein for growth (Sargent et al. 2002). 
Typically, this is a combination of VO with FO added to cover primarily the requirements 




lipid content) of the diet (Glencross, Smith 2001, T. Takeuchi, Watanabe 1982). 
Furthermore, the FM content (which contains some n-3 LC-PUFA) of aquafeeds is also 
under pressure due to the same reasons outlined above for FO, which will further reduce 
the EFA content of a feed. Therefore, the feed ingredients that contain EPA and DHA are 
being reduced while dietary energy is increased by the addition of VO that lack LC-
PUFA, which may affect the requirement. Due to these developments, it is necessary to 
redefine the EFA requirements of European seabass and other species of fish (National 
Research Council 2011). 
The European seabass is an important cultured species, farmed primarily in 
Mediterranean countries, such as Greece and Turkey. Previous research concluded that 
the n-3 LC-PUFA requirement of European seabass was 0.7 % of diet (dry wt.) (Skalli, 
Robin 2004). The fish in this trial achieved DGI values of 0.9 - 1.1, using fish in the 15-
35 g range (Skalli, Robin 2004). Today, with improved nutritional knowledge, higher 
energy diets, and improved genetic stock, it is possible to attain higher DGI, especially in 
small fish (Torrecillas et al. 2017) and, therefore, the EFA requirement for European 
seabass should be revisited. Many studied species have been shown to require n-3 LC-
PUFA at ~1 % of diet, for example Atlantic salmon (Salmo salar), Asian seabass (Lates 
calcarifer), turbot (Psetta maxima) and starry flounder (Platichthys stellatus) (Lee et al. 
2003, Gatesoupe et al. 1977,  Glencross, Rutherford 2011,  Glencross et al. 2014). 
However, some species, for example yellowtail flounder (Pleuronectes ferrugineus) a 
higher requirement of 2.5% of diet has been reported (Whalen et al. 1998). 
In Chapter III, four regression models were compared to analyse response data 




were two key conclusions: firstly, that the requirement for EPA+DHA declines as the 
seabream grows, which means a requirement for EFA is dynamic and a function of fish 
mass; secondly, that the precise number determined is sensitive to both model selection 
and the parameter used as a response variable. This study will employ similar 
methodological approaches as described in Chapter III, applied in this occasion to data 
collected from the European seabass growth trial run as described in Section II.2. Due to 
the differences between the gilthead seabream (Chapter III) and European seabass 
(present chapter) biometric data, the FPL function was not useful for the European 
seabass data and so the results are not presented. The first aim of the present study was to 
establish requirement estimates for EPA+DHA for juvenile European seabass. The 
second aim was to establish if the dynamic nature of the EPA+DHA requirement found 
in gilthead seabream is applicable to European seabass juveniles, which would imply that 
this extends to more species of fish.  
IV.2 Methods 
IV.2.1 Diets, fish husbandry and sampling 
The diets and trial design has been described in Section II.2. Briefly, to empirically 
determine the EFA requirements for EPA+DHA, six experimental diets were formulated 
to deliver a gradient of EPA+DHA (D1-D6; 0.21-3.31% of diet), to juvenile European 
seabass. The diet formulations and measured proximate compositions are detailed in 
Table II.3 and fatty acid compositions in Table IV.1. The graded levels of EFA were 
achieved by blending commercially available oils (FO, rapeseed oil and palm oil). Other 
ingredients were selected to meet the known nutrient requirements of this species 




of 150 juvenile European seabass (~ 23 g) for a period of 127 days. The diets were 
delivered as two pellet sizes, firstly, P1 a 3.0 mm pellet for 56 days and secondly, P2 a 
4.5 mm for 71 days. Therefore, three experimental periods were considered, namely P1, 
P2 and over the whole trial (OV), with the tank biomass being measured at 0, 56 and 127 
days. The fish were fed twice daily ad libitum and delivered and wasted feed weighed for 
an accurate determination of biological FCR.  
IV.2.2 Growth performance and feed conversion 
Before undertaking the requirement analysis, the growth of D. labrax was 
benchmarked against the model of Lupatsch (2005): 
Wt = [Wi0.483 + 0.009418 · e0.065 ·T · days]2.070 
where Wt is the final weight (g) after days of growth/feeding, Wi is the initial weight (g) 
and T is the water temperature. This is an exponential model closely related to daily 
growth index, but parameterised for a stock of European seabass in the Red Sea (Lupatsch 
2005). The fish weights attained in this trial were compared to those forecast by the model 
and expressed as a percentage of mass relative to the model (± %). The FCR data were 
modelled with OLS linear regression and the existence of a relationship supported by F-
test of the model’s gradient term. 
IV.2.3 Requirement analysis 
To estimate the EFA requirements of juvenile European seabass, three nonlinear 
regression models were applied to WG and DGI data, for the P1 (3 mm), P2 (4.5 mm) 




percentage of EPA+DHA. The data contained some outliers, so a robust approach was 
used in this study for all models, so they were comparable. Robust regression 
automatically detects and weights outliers; thus, the assumptions for normality of error 
are relaxed. When using robust regression, the usual ordinary least squares (OLS) are 
replaced with iterated reweighted least squares (IRLS), if the algorithm detects no outliers 
these are equivalent to OLS and parameter estimates are identical to an OLS fit. An M-
estimator algorithm was used to obtain all parameter estimates. Figure IV.1 illustrates the 
rational for this approach. The implication of this approach will be dealt with in the 
discussion. All regression analyses were undertaken using the statistical package R 
(Venables, Smith 2015) (version 3.4.0, Vienna, Austria). The model parameters were 
obtained using the function nlrob(), from the package robustbase (Rousseeuw et al. 2015). 
The package robustbase contains the commands to call robust nonlinear fits to derive 
parameters. Model diagnostics were carried out according to techniques described by Ritz 
and Streibig (2008). 
The three regression models used were: split linear model, split quadratic model and 
Gompertz model. The Gompertz curve is an asymptotic equation and therefore two 
requirement estimates are given based on the model. The first is calculated by multiplying 
the asymptote by 0.95 (National Research Council 2011), which in the text is referred to 
as the “NRC criterion” and the second is the “elbow” calculation described in Chapter 
III. Unless otherwise stated N = 18, which in regression is sufficient to detect very large 
(f2 = 0.5) effects in the response. The existence of a response was further supported by 





Table IV.1. European seabass analysis of dietary fatty acids. 
Table IV.1. Total lipid, total fatty acids (g.Kg-1) and fatty acid composition of the six 
experimental diets, D1 – D6, given as percentage of total fatty acids. Note fatty acids < 
0.05 % across all rows removed. 
 D1 D2 D3 D4 D5 D6 
Dietary Lipid (%) 21.44 20.73 21.79 21.04 20.60 20.88 
% of total fatty acids       
14:0 0.57 0.85 1.42 2.15 3.31 5.87 
16:0 15.60 15.70 15.77 16.50 16.89 17.74 
18:0 2.55 2.66 2.70 2.86 3.04 3.43 
20:0 0.46 0.44 0.43 0.40 0.37 0.27 
22:0 0.23 0.22 0.23 0.21 0.31 0.16 
24:0 0.15 0.15 0.15 0.14 0.14 0.27 
ΣSFA 19.56 20.01 20.69 22.26 24.06 27.74 
16:1n-9 0.06 0.06 0.06 0.07 0.08 0.11 
16:1n-7 0.53 1.21 1.55 2.24 3.59 6.53 
18:1n-9 46.57 42.49 41.08 36.63 28.92 12.36 
18:1n-7 2.45 2.53 2.53 2.64 2.73 2.93 
20:1n 0.94 0.96 1.00 1.02 1.11 1.28 
22:1n 0.09 0.16 0.19 0.25 0.42 0.74 
24:1n-9 0.13 0.17 0.17 0.20 0.27 0.40 
ΣMUFA 50.77 47.58 46.58 43.04 37.11 24.35 
18:2n-6 21.89 21.30 20.25 19.31 17.25 12.37 
18:3n-6 0.00 0.02 0.05 0.07 0.12 0.24 
20:2n-6 0.06 0.06 0.07 0.08 0.10 0.13 
20:3n-6 0.00 0.00 0.00 0.00 0.08 0.14 
20:4n-6 0.05 0.12 0.16 0.24 0.39 0.76 
22:5n-6 0.00 0.04 0.06 0.09 0.15 0.30 
Σ n-6 PUFA 21.99 21.55 20.59 19.78 18.09 14.00 
18:3n-3 5.99 5.63 5.39 4.87 3.88 1.76 
18:4n-3 0.05 0.34 0.46 0.70 1.19 2.32 
20:3n-3 0.00 0.00 0.00 0.00 0.02 0.06 
20:4n-3 0.00 0.09 0.12 0.18 0.31 0.60 
20:5n-3 0.71 2.21 2.86 4.27 7.21 13.77 
22:5n-3 0.11 0.28 0.36 0.53 0.87 1.65 
22:6n-3 0.62 1.64 2.07 3.04 5.03 9.51 
Σ n-3 PUFA 7.48 10.19 11.26 13.59 18.51 29.67 
EPA+DHA (%)1 0.21 0.58 0.82 1.13 2.04 3.10 
Total fatty acids (g.Kg-1) 155.93 150.36 167.13 155.01 166.70 133.0 
1These values are the predictor variable for all analyses in this publication, expressed in 





Figure IV.1. Introducing robust nonlinear regression. 
Figure IV.1. A comparison of two fitting methods for the same data (●). The red line is 
an ordinary least squares (OLS) fit (called using the function nls()), and the black line an 
iterated reweighted least squares (IRLS) fit (called using the function nlrob()). The latter 
function is a robust method that derives a more conservative estimate of the requirement 
by limiting the influence of unusual observations. In this example the two highest 
observations in the response have too great an effect on the parameters, the influence of 
this approach was to provide a moderately more conservative (higher) requirement 
estimate. 
 
IV.2.3.1 Split linear model 
The first model applied to the responses was the so-called “broken line” or split linear 
model, in which the first segment is a linear model ascending to a maximum response, 
i.e. a horizontal segment (a mean). The requirement is defined as the intersection of these 
two segments. Split linear regression can be expressed as follows:  
f(x) = m · x + c     for x < req 




where x is the percentage of EPA+DHA in the experimental diet, c is the model’s intercept 
and m is the gradient (of the first segment) and req is x at the breakpoint (the requirement).  
IV.2.3.2 Split quadratic model  
The second model applied to the data was the split quadratic model, in which the first 
segment is a quadratic function ascending to a maximum level of response, whereas the 
second segment is horizontal. The requirement is defined as the intersection of these two 
segments. Split quadratic regression can be expressed as follows:  
f(x) = m · x + (-0.5 · m / req) · x2 + c   for x < req 
f(x) = m · req + (-0.5·m / req) · req2 + c for x > req 
where x is the percentage of EPA+DHA in the experimental diet, c is the model’s 
intercept, m is the rate constant and req is x at the breakpoint (the requirement).  
IV.2.3.3 Gompertz model 
The asymptotic Gompertz function was fitted to the response data, which can be 
defined as: 
f(x) = a · exp (b · c x) 
where x is the percentage of EPA+DHA in the experimental diet, a is the asymptote or Y 
maxima, b sets the displacement on the x-axis and c is the scaling parameter, setting the 





IV.3.1 Growth performance  
The biometric data analysed in this paper are summarised as means (±SD) in Table 
IV.2. Regardless of diet, all experimental groups increased in weight, from an initial 
weight of ~23 g to final weights ranging between 133.5 – 156.7 g, with fish consuming 
D1 (the VO diet) gaining less weight than fish consuming D4 - D6. Accordingly, DGI 
values ranged between 1.78 – 1.99. The effect size (difference between D1 – D6) is not 
very large, an important point that will form part of the discussion. The range of FCR 
values were 1.26 – 1.22, the higher values attained for the VO diets, D1 - D4. When 
compared to the Lupatsch model, all experimental groups outperformed the model, D1 
by 7.57 % and D6 by 26.20 %. Thus, all groups attained good performance in this trial. 
IV.3.2 Requirement analysis  
A series of regression analyses were performed on the biometric data from this trial. 
The split linear and quadratic and Gompertz model were applied to the three experimental 
periods, P1, P2 and OV for the WG and DGI data. It should be noted that the presentation 
of the P2 data is only to demonstrate the time effects, each dietary treatment has already 
diverged when they begin feeding on this pellet and therefore requirement derived from 
P2 are not valid estimates. All model parameters, requirement estimates, IRLS and AIC 




Table IV.2 European seabass biometric data. 
Table IV.2. Mean (± SD) values for the performance of European seabass (Dicentrarchus labrax) juveniles analysed in this study (n = 
3) over the three experiment periods, P1 P2 and OV. 
 D1  D2  D3  D4  D5  D6  
Initial Weight (g) 22.96 ± 0.92 23.26 ± 0.78 22.59 ± 0.93 23.93 ± 1.05 22.96 ± 0.51 23.18 ± 0.68 
Weight P1 (g) 72.34 ± 1.27 75.02 ± 2.59 76.78 ± 1.23 80.07 ± 1.8 78.93 ± 1.02 81.24 ± 0.67 
Weight P2 (g) 133.53 ± 2.55 145.69 ± 2.94 146.07 ± 3.46 154.15 ± 5.1 153.28 ± 2.46 156.66 ± 2.93 
Feed intake P1 (Kg) 8.75 ± 0.29 9.06 ± 0.07 9.25 ± 0.03 9.71 ± 0.3 9.58 ± 0.12 9.77 ± 0.15 
Feed intake P2 (Kg) 11.56 ± 0.48 13.60 ± 0.98 13.72 ± 0.24 14.25 ± 0.64 14.24 ± 0.37 14.13 ± 0.4 
Feed intake OV (Kg) 20.31 ± 0.23 22.66 ± 0.92 22.97 ± 0.26 23.96 ± 0.94 23.82 ± 0.49 23.90 ± 0.55 
DGI1 P1 2.36 ± 0.05 2.43 ± 0.04 2.54 ± 0.09 2.55 ± 0.12 2.58 ± 0.02 2.64 ± 0.06 
DGI P2 1.33 ± 0.07 1.48 ± 0.11 1.46 ± 0.06 1.49 ± 0.04 1.50 ± 0.02 1.48 ± 0.05 
DGI OV 1.78 ± 0.04 1.89 ± 0.05 1.92 ± 0.05 1.95 ± 0.08 1.97 ± 0 1.99 ± 0.03 
FCR2 P1 1.19 ± 0.02 1.19 ± 0.03 1.15 ± 0.03 1.17 ± 0.03 1.14 ± 0.02 1.12 ± 0.03 
FCR P2 1.31 ± 0.02 1.34 ± 0.05 1.35 ± 0.05 1.34 ± 0.02 1.32 ± 0.01 1.30 ± 0.02 
FCR OV 1.26 ± 0.02 1.27 ± 0.01 1.26 ± 0.04 1.26 ± 0.02 1.24 ± 0.01 1.22 ± 0.01 
Lupatsch (+%)3 7.57 ± 2.50 17.37 ± 2.94 17.77 ± 3.41 24.19 ± 5.01 23.46 ± 2.41 26.20 ± 2.87 
1 Daily Growth Index = Final weight (g) 0.333 – Initial weight (g) 0.333 / Days feeding 
2 Feed conversion ratio = (Feed fed (kg) – feed waste (kg)) / Δ Biomass (kg) 
3 In terms of weight during the experimental period. The model is defined:  Wt = [Wi0.486 + 0.01166 · e0.060·T ·days]2.058 where Wt is the final 





IV.3.2.1 Weight gain and daily growth index 
Using the split linear model to fit the WG data, the requirement estimates were 1.21, 
1.34 and 1.00 for the OV, P1 and P2 data, respectively. Using the split linear model to fit 
the DGI data the requirement estimates were 1.04, 1.56 and 0.87 for the OV, P1 and P2 
data, respectively. These data are shown in Figure IV.2 (A and B). Using the split 
quadratic model to fit the WG data, the requirement estimates were 1.64, 1.93 and 1.33 
for the OV, P1 and P2 data, respectively. Using the split quadratic model to fit the DGI 
data, the requirement estimates were 1.84, 3.14 and 0.82 for the OV, P1 and P2 data, 
respectively. 
The Gompertz function was also fitted to WG and DGI data. As mentioned in the 
methods, two calculations of the requirement are given, namely the NRC criterion and 
the elbow calculation. Using the Gompertz model to fit the WG data, the NRC criterion 
requirement estimates were 0.89, 1.19 and 0.73 and the elbow calculation were 1.15, 1.31 
and 1.01 for the OV, P1 and P2 data, respectively. Interestingly, the latter elbow values 
agree with the values derived from split linear regression. Using the Gompertz model to 
fit the DGI data, the NRC criterion requirement estimates were 0.68, 1.23 and 0.41 and 
the elbow calculation were 1.21, 1.41 and 0.85 for the OV, P1 and P2 data, respectively. 
For the NRC criterion, only in P1 do the derived requirement estimates agree across the 
WG and DGI data because this calculation is sensitive to the scale of the response variable 
(y-axis). The elbow calculation achieves reasonable agreement across the WG and DGI 
data. In terms of model fit, the Gompertz function fit the data best (attained the lowest 
values for IRLS and AIC) in all cases except the P1 DGI data, where the split quadratic 







Table IV.3. European seabass model parameters and requirement estimates. 
Table IV.3. Model parameters fitted to the biometric data of European seabass (Dicentrarchus labrax) juveniles in this trial to derive estimates 
for the EPA+DHA requirement of this species. The three models presented are the split linear, split quadratic and Gompertz function. The 
models were applied to the overall data (OV, both pellet sizes), the 3 mm pellet size (P1, in the text) and the 4.5 mm pellet size (P2 in the 
text). The name of the parameter and the notation used in the text is indicated in the column headers. The iterated reweighted least squares 
(IRWS) and Akaike information criteria (AIC) as a means of comparing fit quality (for like Metrics and Periods) (N = 18). 
Model type Metric Period Parameters Fit 
    Plateau  Gradient Intercept Requirement IRLS AIC 
        m c req     
Split  WG (g) OV 131.98 19.88 107.93 1.21 287.46 108.95 
linear  3 mm 56.92 6.57 48.12 1.34 38.58 72.8 
  4.5 mm 74.85 16.24 58.61 1.00 213.03 103.56 
 DGI OV 1.98 0.22 1.75 1.04 0.04 -49.34 
  3 mm 2.61 0.18 2.33 1.56 0.07 -40.49 
    4.5 mm 1.49 0.23 1.29 0.87 0.07 -41.74 
   Plateau  Rate constant Intercept  Requirement IRLS AIC 
        m c req     
Split  WG (g) OV 131.76 33.04 104.67 1.64 256.16 106.88 
quadratic  3 mm 56.90 9.89 47.36 1.93 38.32 72.68 
  4.5 mm 74.81 27.93 56.24 1.33 212.91 103.55 
 DGI OV 1.99 0.26 1.75 1.84 0.03 -54.83 
  3 mm 2.63 0.19 2.33 3.14 0.06 -42.3 
    4.5 mm 1.49 0.68 1.21 0.82 0.07 -41.2 
   Plateau  Displacement Scale parameter Requirement IRLS AIC 
      a b c Elbow     
Gompertz WG (g) OV 132.48 -0.26 0.16 1.15 234.73 105.31 
  3 mm 57.77 -0.2 0.32 1.31 27.42 66.66 
  4.5 mm 75.07 -0.35 0.07 1.01 208.69 103.19 
 DGI OV 1.99 -0.14 0.22 1.21 0.03 -55.61 
  3 mm 2.66 -0.14 0.44 1.41 0.07 -41.98 










Figure IV.2. European seabass requirement models. 
Figure IV.2. The split linear (A and B) and Gompertz (C and D) models applied to the 
weight gain (A and C) and daily growth index (B and D) data against EPA+DHA % of 
diet (as fed, x-axis). The raw data are marked with coloured spots, the relevant model fit 
with an unbroken line, 95 % prediction intervals (calculated by Monte-Carlo simulation 
in A and B and by second order propagation in C and D) are shaded in colour. Colours 
for the different periods are as follows: the whole trial, OV =  ; the 3 mm pellet size, 
P1 =   and the 4.5 mm pellet size, P2 = .  The National Research Council (△, NRC 





IV.3.2.2 Feed conversion ratio 
The feed conversion data (estimated as FCR) only exhibited small effect sizes. 
Furthermore, different regressions had to be applied to each period due to the shape of 
the data changing as the experiment progressed. It was possible to model the OV data 
with a split linear model, and the requirement derived from this model was 1.04 % 
EPA+DHA. However, this estimate had quite large standard error and therefore a high 
degree of uncertainty. The P1 data was fit with a linear model, which has no breakpoint 
and therefore a requirement cannot be estimated. However, the gradient term was small. 
Neither of these models had a significant gradient term for the P2 data and, therefore, in 
P2 this data set is best described by its mean. These analyses are illustrated in Figure IV.3 
and the parameters given in Table IV.4. Therefore, a dietary effect on FCR exists, but it 
is more important when the fish are smaller (P1). 
Table IV.4. European seabass FCR parameters 
Table IV.4. Parameters for the analysis of the FCR data: OV by split linear regression, 
P1 by linear regression, and P2 by a single term model (the mean). These data are 
illustrated in Figure IV.3. 
Model Metric Period Plateau  Gradient Intercept Requirement 
        m c req 
Split linear FCR OV 1.27 -0.02 1.29 1.04 
Linear  P1 na
1
 -0.02 1.19 na 





Figure IV.4. European seabass feed conversion ratio analysis 
Figure IV.3. The feed conversion ratio (FCR) data from this trial (coloured points) plotted 
against dietary EPA+DHA. In the case of the OV data it was possible to fit a split 
regression function, and this is plotted with Monte-Carlo prediction intervals. For P1, a 
linear fit was possible, and this is plotted with standard error. In P2, neither of these fits 
described the data better than the global mean (P > 0.05) and therefore a single term model 
(the mean) is plotted with standard error for consistency. Colours for the different periods 
are as follows: the whole trial, OV =  ; the 3 mm pellet size, P1 =  ; and the 4.5 mm 
pellet size, P2 = . Despite the small effect size in FCR there is a significant relationship 
in P1 and OV, but this is diminished by P2.  
Figure IV.3. European seabass feed 





Using a dose-response experiment and a variety of regression strategies, this study 
set out to provide new EPA+DHA requirement estimates for European seabass juveniles. 
In accordance with previous work on gilthead seabream (Chapter III), it was demonstrated 
that the EPA+DHA requirement for the European seabass also fell as the fish increased 
in weight. Practically, this means that EFA requirements should be viewed as dynamic 
figures and each pellet size could have an optimum quantity of EFA to achieve optimum 
performance for the size of the fish. The EFA dietary specification could fall with 
increasing pellet size, which would preserve the use of marine oils in aquafeeds fed to 
larger fish. 
A study in gilthead seabream with very similar dietary design was carried out in 
parallel to the present study providing excellent opportunity for direct comparison. The 
most obvious difference between the two data sets is that the gilthead seabream grew 
faster achieving DGI values of 2.3 – 2.6, which is considerably higher than the 1.8 – 2.0 
reported here for European seabass. In the European seabass, the measured effect size 
(difference between D1 – D6) available to analyse in the data was lower compared to that 
of gilthead seabream. This meant that outliers had a stronger impact on these data, which 
necessitated a robust statistical approach. This approach was usually on the conservative 
side (i.e. gave an estimate slightly higher than an OLS fit), but usually less than 10% 
higher. The outliers in the dataset were tanks performing better than expected from the 
other replicates in D3 and D4. These diets were supplied with EPA+DHA levels, 0.82 % 
and 1.13 % for D3 and D4, respectively, close to the requirement estimates given for the 




For juvenile European seabass the current published dietary requirement is 0.7 % 
dietary n-3 LC-PUFA (Skalli, Robin 2004), although the NRC (2011) gives a value of 
1% and cites Coutteau et al. (1996). From the data reported here two new 
recommendations for minimum requirements can be made for European seabass of 23 g 
(3 mm pellet) and 80 g (4.5 mm pellet). European seabass requires approximately 1.3 – 
1.5 % EPA+DHA (as fed) as an optimum requirement to achieve good growth from 23 – 
80 g. After this size the OV requirement estimate can be considered, with most estimated 
values being between 1.1 - 1.2 % EPA+DHA. During P2 (4.5 mm) the requirement falls 
further and the ~1% of diet recommended for most cultured species would become 
sufficient to support optimal growth (National Research Council 2011). However, the 
presence of outliers and the smaller effect size in growth cast more uncertainty of the 
growth performance of European seabass in response to the dietary EPA+DHA gradient. 
Interestingly, these figures are only marginally lower than those derived from the study 
in gilthead seabream (Chapter III). This may indicate that, rather than the species itself, 
body mass and growth rate are more important in determining a requirement for EFA in 
marine fish, although further studies would be required to validate this statement. Studies 
regarding the amino acid requirements in pigs also show that lysine requirements per unit 
dietary energy also fall as the pig increases in weight through different body mass ranges 
(26 – 106 Kg) (Hauschild et al. 2010). Similar findings have been also made in ducks 
(Timmler, Rodehutscord 2003). Consequently, the dynamic EFA requirement could be 
viewed as an indirect result of the fishes rising demand for energy (which causes an 
increase in absolute feed intake). While further studies are required to test this hypothesis, 
if confirmed, it would then be reasonable to express EFA requirements per unit protein 




previously suggested (Glencross, Smith 2001). In this study EPA and DHA are 
considered as a single nutrient. In these diets, the DHA:EPA ratio ranged between 0.87 – 
0.69, from D1 – D6, therefore the diet containing the lowest level of LC-PUFA (D1) had 
the highest ratio. This study cannot offer advice on the most suitable ratio of DHA:EPA 
for juvenile European seabass and, to my knowledge, no studies have been conducted in 
juveniles of this species. However, a study in the Japanese seabass (Lateolabrax 
japonicus) from 10 – 65 g showed that the best ratio was 2. This is considerably higher 
than the ratios of the diets used in the present study and, so it must be accepted that an 
additional gain in performance may have been realised with higher dietary levels of DHA 
relative to EPA, which would lead to lower requirement estimates for EPA+DHA. A 
further study in juvenile blackhead seabream (Acanthopagrus schlegelii) did not find any 
significant effects of the DHA:EPA ratio, but SGR was marginally higher than other 
treatments (0.65 – 2.67) with a dietary DHA:EPA ratio of 1.6 (Jin, Monroig et al. 2017). 
Previous studies defining the EFA requirements of fish have shown mixed results. 
Many species such as Atlantic salmon (Salmo salar), Asian seabass (Lates calcarifer), 
turbot (Psetta maxima), starry flounder (Platichthys stellatus), Korean rockfish (Sebastes 
schlegeli) silvery black porgy (Sparidentix hasta) and red drum (Sciaenops ocellatus) 
have been reported to have n-3 LC-PUFA requirements of ~1 % of diet (Lee et al. 2003, 
Lochmann, Gatlin 1993, Gatesoupe et al. 1977,  Glencross, Rutherford 2011,  Glencross 
et al. 2014, Mozanzadeh, Marammazi et al. 2015). However, like reported for gilthead 
seabream (Chapter III), yellowtail flounder (Pleuronectes ferrugineus), Japanese flounder 
(Paralicthys olivaceus), silver bream (Rhabdosargus sarba), and striped jack 
(Pseudocaranx dentex) have been shown to require n-3 LC-PUFA at a higher dietary level 




1994). Some of the former and latter species are phylogenetically close (e.g. silvery black 
porgy and silver bream) and have similar trophic habits. As the n-3 LC-PUFA 
requirement appears to be a function of fish mass, this may explain the different n-3 
LC-PUFA requirements reported in species that share close phylogeny and feeding habit 
(e.g. black porgy and silver bream). However, smaller fish were used in former trials that 
investigated the n-3 LC-PUFA requirements in European seabass (Skalli, Robin 2004) 
and gilthead seabream (Kalogeropoulos et al. 1992), in these cases the lower requirement 
estimates can be related to the lower growth rates attained in these experiments. Studies 
in the Asian seabass (L. calcarifer) have examined the effect of dietary EPA (Salini, Wade 
et al. 2016) and DHA (Glencross, Rutherford 2011) gradients in isolation from one 
another. Moreover, these studies employed a pair feeding regime (all treatments supplied 
with an equal ration). In both studies, neither EPA or DHA had a stimulatory effect on 
growth of juvenile Asian seabass in isolation. A positive control treatment in the DHA 
study (Glencross, Rutherford 2011) supplied additional EPA and this did have a positive 
influence on fish growth rates. This raises the question that in the EPA (and ARA) 
experiment, dietary DHA may have been limiting and in the DHA experiment dietary 
EPA may have been limiting. However, in the context of paired feeding regimes 
LC-PUFA effects on growth may be negligible, leading to the conclusion that LC-PUFA 
enhance physiological processes but only lead to performance increases when feed is 
supplied to satiation. 
Further discrepancies in EFA requirement estimates may be caused by selection of 
models that do not suit the shape of the response variable (Shearer 2000). As such, a 
requirement estimate derived from an empirical analysis of biometric data is affected by 




selected by the authors, as well as the feeding ecology and phylogeny of the species in 
question. As aquaculture is a rapidly developing food production sector, technical 
knowledge is also rapidly developing. Any advancement in fish nutrition, husbandry or 
breed development that leads to improved performance will elevate the demands for key 
nutrients to support that gain. Therefore, no requirement should be viewed as a static 
dietary percentage, but rather as a figure that supports a certain level of animal 
performance at a certain animal mass. 
In all the models reported here, except the P1 DGI data, the Gompertz function fit 
the data the best as indicated by the IRLS and AIC values in Table IV.3. In the case of 
the P1 DGI data, the split quadratic model achieved a marginally better fit to the data. 
However, the EPA+DHA requirement estimate was much higher due to the ascending 
curve fitting all the data points. This emphasises two points: firstly, the data are best 
modelled by curves; secondly, in P1 some improvement in performance was achieved by 
the EFA level of D5 and D6. In gilthead seabream for comparison (Chapter III), the OV 
and P2 data were often best fit using the split linear model, whence several approaches 
should be explored to find a function that best suits the data (Shearer 2000, Hernandez-
Llamas 2009). When an asymptotic function is used there is no obvious breakpoint and 
therefore some criterion is required to determine where upon the response curve to place 
the requirement. In Chapter III, the proposed “elbow” calculation (Eickhardt 2017) for 
establishing a “point of diminishing returns” (Spillman, Lang 1924) was found to be less 
sensitive to the selected response parameter/variable and to the scale (y-axis) of the 
parameter/variable. However, the “elbow” method is a geometric calculation, based on 
the shape of the relationship, and the precise value given still depends on the experimental 




“elbow” calculations used in the present trial could be that the demonstration of 
deficiency in this experiment is not strong due to the small effect size in growth and FCR 
responses. Therefore, in this case, with the European seabass dataset it could be argued 
that this method may have marginally overestimated the requirement for EPA+DHA. 
However, the estimates derived from the “elbow” calculation gave very similar estimates 
to the split linear model.  
In the gilthead seabream (Chapter III), the FCR data could be modelled effectively 
using the four-parameter-logistic function. However, in the present study there were no 
large effect sizes for the FCR data. Therefore, it must be concluded that EPA+DHA has 
less effect on FCR in European seabass than in gilthead seabream. There was a FCR 
response in the P1 data, but this took the shape of a straight line. Therefore, the conclusion 
for the P1 data is that the highest level of EPA+DHA gave the lowest FCR values. The 
OV FCR data could be fit with a split linear model and a requirement was derived at just 
over 1 % EPA+DHA, however, this value had wide uncertainty. The P2 data showed no 
relationship between dietary EPA+DHA and FCR. Despite the smaller effect of 
EPA+DHA on FCR in European seabass it was certainly present at the first sampling 
(P1), whence further supporting the notion that the requirement was falling as fish 
increased in weight. The parameter FCR has rarely been modelled in the context of n-3 
LC-PUFA requirements, one example is use of split linear model in the silvery black 
porgy. In this study the authors found that the requirement, in terms of FCR (0.6 % diet) 
was lower than for growth (0.8 % diet) (Mozanzadeh et al. 2015). Feed efficiency ratio 
(FER, inverse of FCR) has also been modelled with split regression in Japanese seabass 
(Lateolabrax japonicus) to establish lysine requirements. The authors found that the 




response than when SGR was considered (2.49% dry diet) (Mai et al. 2006). Whence, 
whether growth or FCR give a higher requirement can vary depending on the dataset, so 
both should be considered. 
EPA and DHA are well known to be absolutely critical in larval and juvenile nutrition 
while fish tissues are developing rapidly (Sargent et al. 1997, Rainuzzo, Reitan et al. 1997, 
Watanabe 1993). The conclusions drawn from the present study are consistent with this 
and emphasise that LC-PUFA are best provided earlier in fish development to support 
rapid growth stages. It is known that LC-PUFA particularly DHA, are retained in the 
polar fatty acids of crucial tissues such as brain and retina (Mourente, Tocher et al. 1991, 
Sargent, Bell et al. 1993) However, it has been demonstrated in Asian seabass (L. 
calcarifer) between 10 g – 450 g have no maintenance requirement for EPA or DHA 
(these fatty acids are not catabolised in response to starvation), this would suggest that 
the role of EPA and DHA is primarily structural (Salini et al. 2016). Interestingly, when 
exogenous feeding begins in the marine fish larvae, these crucial tissues (eyes, brain and 
notochord) form a much greater proportion of the body mass, compared to when the fish 
has grown to the size of an adult (Rainuzzo et al. 1997). Therefore, the dynamic nature of 
EFA requirements can be partially explained by the changing allometry that occurs 
throughout fish ontogeny. 
In summary this study and the data in Chapter III present evidence of the dynamic 
nature of EPA+DHA requirements. It is very likely that these conclusions partially 
explain the range of LC-PUFA requirements reported for fish species of similar habit 
(National Research Council 2011). For European seabass from 23 – 80 g an optimum 




requirement of 1.1 – 1.2 % EPA+DHA (as fed) can be recommended. At some point in 
the latter period the requirement would fall to the current recommendations (National 
Research Council 2011). These data are highly relevant to the formulation of aquafeeds 










V. The compositional and metabolic responses of gilthead 
seabream (Sparus aurata) to a gradient of dietary long-chain 





The replacement of fish oil (FO) with vegetable oil (VO) in high energy feed 
formulations reduces the availability of n-3 LC-PUFA to marine fish such as gilthead 
seabream, one of the main species cultured in the Mediterranean. The aim of the present 
study was to examine compositional and physiological responses to a dietary gradient of 
n-3 LC-PUFA. Six isoenergetic and isonitrogenous diets (D1-D6) were fed to triplicate 
groups of seabream, with the added oil being a blend of FO and VO to achieve a dietary 
gradient of n-3 LC-PUFA. Fish were sampled after four months feeding, to determine 
biochemical composition, liver and mid-intestine fatty acid concentrations and lipid 
metabolic gene expression. The results indicated a disturbance to lipid metabolism, with 
fat in the liver increased and fat deposits in the viscera reduced. Liver and mid-intestine 
fatty acid profiles were altered towards the fatty acid compositions of the diets. There was 
evidence of endogenous modification of dietary PUFA in the liver which correlated with 
the expression of fatty acid desaturase 2 (fads2). Expression of sterol regulatory element-
binding protein 1 (srebp1), fads2 and fatty acid synthase (fas) increased in the liver, while 
peroxisome proliferator-activated receptor alpha 1 (ppara1) pathways appeared to be 
supressed by dietary VO in a concentration-dependent manner. These findings suggested 
that suppression of beta-oxidation and stimulation of srebp1-mediated lipogenesis may 
play a role in contributing toward steatosis in fish fed n-3 LC-PUFA deficient diets. These 






Sustainable expansion of aquaculture requires reduction in the use of FM and FO in 
aquafeed formulations (Glencross 2009, Pike, Jackson 2010, Merino et al. 2012, Tacon, 
Metian 2015). Both raw materials, particularly FO, are rich in the two key n-3 LC-PUFA, 
EPA and DHA recognised as EFA for the majority of marine fish species (Tocher 2015). 
DHA is an essential component of neural and retinal membranes (Gawrisch et al. 2003) 
and both EPA and DHA are precursors for an extensive range of autocrine signalling 
molecules (e.g. eicosanoids, resolvins, protectins, etc.) (Serhan, Chiang et al. 2008). 
Dietary deficiency of n-3 LC-PUFA has impacts on the health (Oliva‐Teles 2012), 
metabolism (Tocher 2003, Jordal, Torstensen et al. 2005), composition (Izquierdo et al. 
2005, Benedito-Palos, Navarro et al. 2008) and growth (Kalogeropoulos et al. 1992) of 
marine fish.  
Typically, an aquafeed for a given marine fish species contains a combination of 
FO to supply essential n-3 LC-PUFA and VO that, while devoid of LC-PUFA, supply 
dietary energy (Sargent et al. 2002, National Research Council 2011). While freshwater 
fish and salmonids are largely able to effectively utilise dietary VO to satisfy their EFA 
requirements, marine carnivorous fish are not (Tocher 2015). In terms of fatty acid 
composition, the key effects of high inclusion levels of VO are an increase in C18 
unsaturated fatty acids (ALA, LOA and oleic acid) in the fish tissues at the expense of 
LC-PUFA that is reflective of the altered composition of the dietary fatty acids (Turchini 
et al. 2010). With regards to lipid metabolism, some studies have observed that inclusion 
of dietary VO leads to reduced fatty acid catabolism and the accumulation of lipid in the 




2017). Studies examining the influence of VO on lipid biosynthesis have yielded 
conflicting results with some reporting increased gene expression (Morais et al. 2011, Jin 
et al. 2017) and others reporting decreased enzyme activity (Menoyo, Izquierdo et al. 
2004) although, in mammals, EPA has been shown to supress lipogenesis (Y. Takeuchi, 
Yahagi et al. 2010).  
Lipid homeostasis is maintained in animals through a balance of catabolic and 
anabolic processes. Fatty acids and cholesterol can be synthesised de novo by pathways 
that are activated by sterol regulatory element binding proteins (Srebp) 1 and 2, 
respectively. Srebp are transcription factors involved in energy homeostasis and have 
many target genes with examples of those in lipid metabolism including fatty acid 
synthase (fas) and fatty acid desaturase 2 (fads2), the latter being key enzymes in the LC-
PUFA biosynthesis pathway (Daemen, Kutmon et al. 2013, C. Castro, Corraze et al. 
2016). Fatty acids are catabolised by the β-oxidation pathway in either mitochondria or 
peroxisomes, and expression of genes encoding proteins involved in these pathways are 
regulated by, among others, peroxisome proliferator-activated receptors (Ppar) (Mandard, 
Müller et al. 2004). Upon binding ligands and retinoid X receptor, Ppars bind to 
peroxisome proliferator response elements in the promoter regions of target genes, many 
of which are involved in β-oxidation, such as carnitine palmitoyl transferase I (cpt1a) and 
liver-type fatty acid binding protein (fabp1), both proteins  involved in the intracellular 
transport of fatty acids destined for catabolism (Mandard et al. 2004, Leaver, Villeneuve 
et al. 2008). 
Despite recent advances in our knowledge regarding the impacts of dietary VO some 




precise concentrations of dietary nutrients or are genes activated/deactivated at thresholds 
of nutrient supply? Furthermore, are lipid metabolic processes related to tissue 
compositions, which are themselves reflective of diet? Therefore, the present study aimed 
to examine the impact of modern (high lipid, low FM) aquafeed formulations across a 
gradient of n-3 LC-PUFA, achieved by blending commercially available oils (FO, 
rapeseed oil and palm oil), on the biochemical composition of body compartments, fatty 
acid compositions and gene expression in the liver and mid-intestine of a marine teleost, 
the gilthead seabream (Sparus aurata). 
V.2 Methods 
V.2.1 Fish husbandry and diets 
The diets and trial design has been described in Section II.2. Briefly, 150 juvenile 
seabream were randomly distributed between 18 x 1 m3 tanks. Initially, the fish were fed 
with commercial fry feeds rich in FM and FO until they reached ~24 g. After acclimation, 
each tank was assigned one of six isoenergetic and isonitrogenous diets and the fish were 
fed for 18 weeks. The six diets were formulated to deliver specific levels of LC-PUFA 
by progressively replacing FO with blends of RO and PO, whereas the other dietary 
ingredients were selected to meet the known nutrient requirements of seabream (Oliva-
Teles et al. 2011) (Table II.2). The experimental diets were numbered to reflect the 
VO/FO inclusion so that diet D1 contained the VO blend as sole exogenously added oil 
source, diet D6 contained only FO and diets D2 - D5 contained graded levels of VO and 
FO (Table II.2). The fatty acids that increased with dietary FO were: 16:1n-7, 24:1n-9, 
20:3n-6, 20:4n-6, 20:4n-3, 20:5n-3, 22:5n-3 and 22:6n-3, while 20:0, 22:0, 18:1n-9, 





Fish were sampled at the initiation of the trial and at termination after being 
euthanised with a lethal dose of benzocaine (Centrovet, Kalagin, Santiago, Brazil). Five 
whole fish and three eviscerated carcasses, liver and viscera were sampled from each tank 
for compositional analysis. Three fish per tank were also sampled for gene expression 
and fatty acid composition taking samples of liver and mid-intestine. Samples for RNA 
analysis were incubated with 1 mL RNAlater® at 4 °C for 24h (Sigma-Aldrich, UK) 
before storage at -70°C, while samples for fatty acid analysis were immediately frozen 
and stored at -20 °C before shipment on dry ice to the Institute of Aquaculture, University 
of Stirling. 
V.2.3 Proximate composition 
Feed samples were ground prior to analyses. Whole fish, carcass and viscera samples 
were homogenised in a blender (Waring Laboratory Science, Winsted, CT, USA) to 
produce pates. Proximate compositions of feeds and fish were determined according to 
standard procedures (Horwitz 2000). Moisture contents were obtained after drying in an 
oven at 110 °C for 24 h and ash content determined after incineration at 600 °C for 16 h. 
Crude protein content was measured by determining nitrogen content (N × 6.25) using 
automated Kjeldahl analysis (Tecator Kjeltec Auto 1030 analyser, Foss, Warrington, 
U.K) and total lipid content determined as described below.  
V.2.4 Fatty acid analysis  
The total lipids were extracted from liver and mid-intestine samples according to 




mid-intestine total lipid samples were determined as described in Sections II.3.2.2 and 
II.3.2.3, according to methods described by Christie (2003). Tissue fatty acid levels were 
expressed as mg g-1 of tissue and estimated using the response of the internal standard. 
The coefficient of variation estimated using mg DHA g-1 over a subset of 20 samples was 
2.80 ± 2.51 %. 
V.2.5 RNA extraction 
Total RNA was extracted from ~100 mg of liver and mid-intestine tissue according 
to the method described in Section II.3.3.1. The concentration and quality were verified 
spectrophotometrically and by agarose gel electrophoresis to visualise the presence of 
18S and 28S ribosomal subunits (Section II.3.3.4). Extracts were stored at -70 °C until 
cDNA synthesis. 
V.2.6 cDNA synthesis 
Reverse transcription was performed using a High Capacity Reverse Transcription 
kit according to the kit manufacturer’s protocol (Applied Biosystems) as described in 
Section II.3.3.2. A no template control (NTC) reaction and reverse transcriptase-free 
reactions were prepared as blank and negative controls. A pool of cDNA samples was 
created for serial dilutions, calibrator samples and primer validations. Samples of cDNA 
were diluted 20-fold with nuclease-free water as template for qPCR, and stored at -20 °C.  
V.2.7 Gene expression analysis 
Relative gene expression was determined for candidate genes involved in key lipid 




qPCR were designed using Primer3 through the NCBI database’s “Primer-BLAST” 
against known gene sequences including sequences from the S. aurata expressed 
sequence tag (EST) NCBI database that were confirmed to be the gene of interest by 
BLAST searches, as described in Section II.3.3.6. Primer sequences for genes in the 
present study are given in Table V.1. Gilthead seabream primer sequences.Primers were 
tested to confirm that they functioned optimally at annealing temperatures of 60 °C and 
that a single amplicon of appropriate length was visualised on agarose gel (Section 
II.3.3.4). Duplicated qPCR reactions were carried out on 96-well plates using a Biometra 
TOptical Thermocycler (Analytik Jena) instrument according to the conditions described 
in Section II.3.3.3. As there were 54 samples per tissue (6 treatments, N = 9) two plates 
were run per gene with treatments equally represented on both plates. A single master 
mix was used for all the reactions required per gene and both plates were run 
consecutively. Data were acquired through the software package qPCRsoft 3.1 (Analytik 










where E is the determined efficiency, ref is the geometric mean of four reference genes, 
goi is the gene of interest and Ct is the threshold cycle. Gene expression data are presented 
as log2 expression ratios (Hellemans, Vandesompelle 2011). The average intra assay 





Table V.1. Gilthead seabream primer sequences. 
Table V.1. Primer sequences used for gene expression analysis by quantitative reverse-
transcriptase PCR. Amplicon sizes (base pair) and GenBank accession numbers also are 
provided. 
Transcript Sequence (5'-3') Amplicon(bp) Accession no 
fads2 F:GCAGGCGGAGAGCGACGGTCTGTTCC 72 AY055749 
 R:AGCAGGATGTGACCCAGGTGGAGGCAGAAG  
elovl5 F:CCTCCTGGTGCTCTACAAT 112 AY660879 
 R:GTGAGTGTCCTGGCAGTA   
cpt1a F:GTGCCTTCGTTCGTTCCATGATC 82 JQ308822 
 R:TGATGCTTATCTGCTGCCTGTTTG   
srebp1 F:AGGGCTGACCACAACGTCTCCTCTCC 77 JQ277709 
 R:GCTGTACGTGGGATGTGATGGTTTGGG   
pparα1 F:TCTCTTCAGCCCACCATCCC 116 AY590299 
 R:ATCCCAGCGTGTCGTCTCC   
fabp1  F:CATGAAGGCGATTGGTCTCC 165 KF857311  
 R:GTCTCCAAGTCTGCCTCCTT   
srebp2  F:GCTCACAAGCAAAATGGCCT 240 AM970922.1 
 R:CAAAACTGCTCCCTTCCCCA   
fas F:TGCCATTGCCATAGCACTCA 172 JQ277708.1 
 R:ACCTTTGCCCTTTGTGTGGA   
actb F:TCCTGCGGAATCCATGAGA 50 X89920 
 R:GACGTCGCACTTCATGATGCT   
ef1α F:ACGTGTCCGTCAAGGAAATC 109 AF184170 
 R:GGGTGGTTCAGGATGATGAC   
tuba1α F:ATCACCAATGCCTGCTTCGA 214 AY326430.1 
 R:CTGTGGGAGGCTGGTAGTTG   
rplp0 F:GAACACTGGTCTGGGTCCTG 159 AY550965.1 






V.2.8 Statistical analysis  
Three individuals from each tank were randomly sampled giving 54 fish in total, this 
is the minimum number of fish to detect medium effect sizes (f 2 = 0.15; power = 0.8) by 
ordinary least squares regression. Proximate composition, fatty acid and gene expression 
data were analysed using linear regression to identify the existence of trends across the 
experimental diets. Trends were reported as significant if the slope was significantly 
different (P < 0.05) to 0. For fatty acid profiles of tissues (N = 54) the first step of analysis 
was to reduce the dimensions of the data by principal component analysis (PCA), which 
enabled the identification of fatty acids that were correlated with each other and that 
should be analysed further. For further details see Section II.4.2. 
V.3 Results 
V.3.1 Proximate composition of gilthead seabream 
Significant effects of diet on proximate compositions of gilthead seabream were 
observed in liver, mid-intestine and viscera. In liver and mid-intestine, total lipid contents 
increased from 18.6 – 31.8 % diet (R2 = 67.8, P < 0.001) and 8.6 – 13.9 % (R2 = 67.8, P 
< 0.001), respectively, as dietary VO increased from 0 – 15.6 % of diet. In viscera (minus 
liver), total lipid content decreased from 53.5 – 45.2 % (R2 = 24.0, P < 0.001) as dietary 
VO increased in the diet. The lipid contents of whole fish and carcass were unaffected by 
dietary treatment (P > 0.05). Protein and ash contents were not affected in any body 
compartment examined in the present study (P > 0.05). A summary of these data is 




V.3.2 Fatty acid composition of liver and mid-intestine 
Fatty acid profiles of total lipid of two major lipid metabolic sites, namely liver and 
mid-intestine, were determined and further analysed by PCA. In both the liver and mid-
intestine the first principal component (PC1) was correlated to dietary FO and explained 
57.5 % and 60.1 % of the variance in fatty acid compositions, respectively (Figure V.1 
and Figure V.2). The fatty acids associated with FO, namely 14:0, 16:1n-7, 20:4n-3, 
20:5n-3, 22:5n-3 and 22:6n-3, had positive correlations to PC1, and those associated with 
VO, specifically 18:1n-9, 18:2n-6 and 18:3n-3, a negative correlation to PC1 in liver and 
mid-intestine. PC2 accounted for 15.3 % and 15.5 % of the variance in liver and mid-
intestine fatty acid profiles, respectively. The contributions of the fatty acids towards PC2 
differed between liver and mid-intestine. In liver, 20:2n-6 and 20:1 had a positive 
influence on PC2, and Iso 18:2n, Iso 20:2n, 18:3n-6, 20:3n-6 a negative influence. In the 
case of mid-intestine samples, 18:0, 20:0 and 22:0 had a positive influence, and 18:1n-7 
a negative influence on PC2 while Iso 18:2n and Iso 20:2n were not detected. It was also 
apparent from biplots that there was considerable overlap between the fatty acid profiles 
of liver and mid-intestine of fish consuming diets D1 - D4, although fatty acid profiles 
from individuals fed on diets containing the highest inclusion levels of FO (D5 and D6) 
formed clearly separated groups (Figure V.1 and Figure V.2). PCA indicated that the n-3 
LC-PUFA (20:3n-3, 20:4n-3, EPA, DPA and DHA) were all correlated with each other 
in both liver and mid-intestine and therefore these fatty acids were summed as a single 
variable reflecting their origin from FO. Absolute levels of tissue n-3 LC-PUFA were 
strongly related to dietary n-3 LC-PUFA in liver (R2 = 0.75, P < 0.001) and mid-intestine 
(R2 = 0.87, P < 0.001) (Figure V.3). Absolute levels of monounsaturates (MUFA) 




(R2 = 0.76, P < 0.001) (Figure V.4). Contents of MUFA in liver were typically 75 - 175 
mg g-1 in fish fed diets D1 - D4, and < 50 mg g-1 in fish consuming the FO diet (D6). 
 
 
Figure V.1. Gilthead seabream PCA of liver fatty acids. 
Figure V.1. Graphical representation of principal components analysis (PCA) of fatty acid 
profiles from liver (n=54) of fish fed experimental diets (D1 - D6). For explanation of 
figures see section II.4.2.1. The fatty acid profiles of fish consuming diets D5 and D6 
formed succinct groups to the right of the plot and they were well defined by PC1. The 
fatty acid profiles of fish consuming diets D1 - D4 were negatively correlated to PC1 and 
there was considerable overlap (variability) between the dietary treatments. PC2 
accounted for 15.3 % of the total variance and was important to distinguish individual 
liver fatty acid profiles of fish consuming diets D1 - D3. Several points can be made to 
describe the data, the fatty acids derived from fish oil (e.g. 22:6n-3) were strongly 
correlated to PC1, the main fatty acids from vegetable oil (e.g. 18:1n-9) were negatively 
correlated to PC1. Several fatty acids were best explained by a combination of PC1 and 
PC2, including Iso 18:2n and Iso 20:2n, and it can be said that these fatty acids are 
important to distinguish liver fatty acid profiles from fish consuming diets D1 - D4. D1 





Figure V.2. Gilthead seabream PCA of mid-intestine fatty acids. 
Figure V.2. Graphical representation of principal components analysis (PCA) of fatty acid 
profiles from mid-intestine (n=54) of fish fed experimental diets (D1 - D6). The fatty acid 
profiles of fish consuming diets D5 and D6 formed succinct groups to the right of the 
plot. The fatty acid profiles of fish consuming diets D1 – D3 were negatively correlated 
to PC1 and there was considerable overlap in the points. PC2 separated the fatty acid 
profiles vertically and explained 15.5 % of the variance, two outliers appeared in D3 and 
these samples contained unusually high levels 20:0 and 22:0 and, other than these 
samples, the variance was quite evenly distributed amongst the diets when compared to 
liver. The arrows indicate how the fatty acids contributed to the formation of PC1 and 
PC2 and thus the formation of plot A. D1 = ○ ; D2 = △ ; D3 = ㍸ ; D4 = + ;  D5 = ⊠ ; 




Two fatty acids, Iso 18:2n and Iso 20:2n, were identified in liver in spite of their 
absence in diets and mid-intestine, so they were plotted against dietary VO. Levels of Iso 
18:2n increased with the dietary VO (R2 = 0.81, P < 0.001) (Figure V.5A). The level of 
Iso 18:2n was correlated (R2 = 0.41, r = 0.64, P < 0.001) to the log2 expression of fads2 
(Figure V.5B). Dietary levels of saturates were relatively stable across the experimental 
diets (32 - 36 g kg-1). Despite this low range, livers of fish fed diet D1 (VO rich) contained 
50 - 70 mg g-1 saturates and those of fish fed diet D6 (FO rich) ranged between 10 - 40 
mg g-1, and there was a significant relationship with dietary saturates (R2 = 0.27, P < 
0.001) (data not shown). Examination of percentage data indicated that absolute levels of 
saturates was mainly associated with the increasing lipid level of the liver, lower levels 
of saturates were observed in the mid-intestine (15 – 35 mg g-1). Quantitatively, palmitic 
acid was the dominant saturated fatty acid in both tissues and only 14:0 increased with 
dietary FO. Liver and mid-intestine fatty acid data are summarised in the Appendix, 






Figure V.3. Gilthead seabream liver and mid-intestine LC-PUFA 
Figure V.3. Levels of n-3 long-chain (≥ C20) polyunsaturated fatty acids (LC-PUFA) in 
gilthead seabream liver (A) and mid-intestine (B) against the dietary levels of n-3 LC-
PUFA. Note the natural logarithm (ln) transformation applied to the data in panel A 
indicating that in liver this relationship was not linear. Both models were linear ordinary 
least squares fits with the standard error shaded in grey (n=54). Diet 1 = ○ ; Diet 2 = △ ; 
Diet 3 = ㍸ ; Diet 4 = + ;  Diet 5 = ⊠ ; Diet 6 = ✳ 
 
Figure V.4. Gilthead seabream liver and mid-intestine MUFA. 
Figure V.4. Levels of monounsaturated fatty acids (MUFA) in gilthead seabream liver 
(A) and mid-intestine (B) against the dietary levels of MUFA. Both are quadratic ordinary 
least squares fits with the standard error shaded in grey (n=54). Diet 1 = ○ ; Diet 2 = △ ; 






Figure V.5. Gilthead seabream liver Iso 18:2n and fads2 expression 
Figure V.5. Levels of Iso 18:2n, which is not present in the diets, in gilthead seabream 
liver against dietary vegetable oil (A), and the level of fads2 expression correlated (r = 
0.64; P < 0.001) with the levels of Iso 18:2n in liver (B). The model applied in A is a 
quadratic ordinary least squares fit with the standard error shaded in grey (n=54). Note 
the transformation (x0.25) applied to the Iso 18:2n data. Diet 1 = ○ ; Diet 2 = △ ; Diet 3 = 
㍸ ; Diet 4 = + ; Diet 5 = ⊠ ; Diet 6 = ✳ 
 
V.3.3 Gene expression 
Genes representing lipid metabolic pathways were assayed by qPCR, and the 
expression of target genes plotted against dietary VO and, although variability (R2 = 19 – 
52 %), between individuals was high, significant trends showed that the diets had an 
impact on the regulation of lipid metabolism. Negative trends were found in the liver 
between dietary VO and the expression of pparα1 (R2 = 0.32, P < 0.001) and its target 
genes cpt1α (R2 = 0.26, P < 0.001) and fabp1 (R2 = 0.19, P < 0.001) (Figure V.6). The 
level of variation in the mid-intestine prevented the application of suitable models to the 




and srebp1 (R2 = 0.37, P < 0.001) and its target genes fas (R2 = 0.42, P < 0.001) and fads2 
(R2 = 0.52, P < 0.001) (Figure V.7). Effects of VO on the expression of srebp2 and elovl5 
in liver were not detected (data not shown). However, in mid-intestine, the effect on 
srebp1 expression was not as strong and linear (R2 = 0.23, P < 0.001), but srebp2 showed 
a strong up-regulation in fish fed diets D1 and D2 (R2 = 0.49, P < 0.001) and elovl5 was 
responsive to dietary VO (R2 = 0.26, P < 0.001) (Figure V.8). Effects of VO on the 

























Figure V.6. Hepatic gene expression of 
ppara1 (A), cpt1a (B) and fabp1 (C) 
against dietary vegetable oil. Data are log2 
(expression ratios) normalised to four 
reference genes and then to the calibrator 
sample. Fitted lines are linear functions 
with the standard error highlighted in grey 
(n=54). Diet 1 = ○ ; Diet 2 = △ ; Diet 3 = 
㍸ ; Diet 4 = + ;  Diet 5 = ⊠ ; Diet 6 = ✳ 
  























Figure V.7. Hepatic gene expression of 
srebp1 (A), fas (B) and fads2 (C) against 
dietary vegetable oil. Data are log2 
(expression ratio) normalised to four 
reference genes and then to the calibrator 
sample. Fitted lines are second order 
quadratic functions with the standard error 
highlighted in grey (n=54). The similarity 
between the responses is striking. Diet 1 = 
○ ; Diet 2 = △ ; Diet 3 = ㍸ ; Diet 4 = + ;  
Diet 5 = ⊠ ; Diet 6 = ✳ 
  





















Figure V.8. Mid-intestine gene expression 
of srebp1 (A), srebp2 (B) and elovl5 (C) 
against dietary vegetable oil. Data are log2 
(expression ratio) normalised to four 
reference genes and then to the calibrator 
sample. Fitted lines are linear fits for 
srebp1 and elovl5 and a second order 
quadratic function is fitted to srebp2. The 
model standard errors are highlighted in 
grey (n=54). Diet 1 = ○ ; Diet 2 = △ ; Diet 
3 = ㍸ ; Diet 4 = + ;  Diet 5 = ⊠ ; Diet 6 = 
✳ 
  





Replacement of FO by alternative oils in aquafeeds has been an extensively 
investigated research topic over the last two decades (Turchini et al. 2010). The most 
common FO alternatives are VO, for example rapeseed oil or soya bean oil, which are 
devoid of essential LC-PUFA and, consequently, their use has important implications, 
not only on the nutritional value of the product for consumers (Henriques, Dick et al. 
2014, Sprague, Dick et al. 2016, Shepherd, Monroig et al. 2017), but also effects on 
metabolism and fish health (Glencross 2009). We employed a dietary gradient of LC-
PUFA to span the EFA requirements reported for a commercially relevant teleost, the 
gilthead seabream (Oliva-Teles et al. 2011) and show how this gradient modifies the 
composition and the expression of lipid metabolic and regulatory genes in gilthead 
seabream juveniles. 
The results of the present study show that dietary provision of n-3 LC-PUFA below 
the reported requirements for gilthead seabream (NCR, 2011) led to alterations in lipid 
metabolism as indicated by increased lipid in liver and decreased lipid in viscera. The 
visceral cavity is the lipid storage site in this species (McClelland, Weber et al. 1995). 
These results were in agreement with previous studies regarding increased hepatic lipid 
content as a result of dietary deficiency of EPA and DHA in gilthead seabream 
(Kalogeropoulos et al. 1992, Ibeas et al. 1996, Caballero et al. 2004) and other fish species 
(Glencross 2009, Tocher, Bell et al. 2001). Interestingly, increased lipid contents in liver 
have been also described when dietary lipid was increased to boost the energy content of 
the diet (Vergara, López-Calero et al. 1999). The range of values for hepatic total lipid 




(wet wt), in gilthead seabream fed graded levels of soya bean oil (Kalogeropoulos et al. 
1992). This may be due to the larger size of the fish in the present trial (24-230g) whereas 
the previous study used fry (1.2-12.4g), the longer feeding period of four months in the 
present study, or the higher crude lipid levels in the diets. In the previous study there was 
a threshold level of soya bean oil (~ 50 % of oil) that increased hepatic lipid content 
whereas data in the present study suggested VO increased hepatic lipid in a concentration-
dependant manner (linear increase).  
Quantitatively, the main fatty acids driving the increased liver lipid were oleic acid, 
LOA and ALA, all major constituents of rapeseed oil used in the experimental diets. Such 
accumulation of dietary fatty acids observed in liver, occurring as well in mid-intestine, 
has been commonly reported in FO replacement studies in gilthead seabream 
(Kalogeropoulos et al. 1992, Montero, Robaina et al. 2001, Benedito-Palos et al. 2008). 
Interestingly, in fish fed VO, two fatty acids, namely Iso 18:2n and Iso 20:2n, that were 
not present in the diets, were found in the liver. The presence of Iso 18:2n is likely to be 
the result of 6 desaturation of 18:1n-9, with Iso 20:2n being the elongation product of 
Iso 18:2n. Fads2 is typically a 6 desaturase in marine teleosts (C. Castro et al. 2016) 
and, although its activity towards 18:1n-9 has not been demonstrated in gilthead seabream 
(Zheng, Seiliez et al. 2004), it is highly likely that Fads2 activity was responsible for 
observed production of Iso 18:2n in liver. Indeed, this is consistent with increased 
expression of fads2 in liver of fish fed high VO diets, a regulatory mechanism often 
reported in literature not only on desaturases, as observed herein, but also elongases such 
as elovl5 (Jin et al. 2017). Interestingly, an up-regulation of hepatic elovl5 was not 
observed, that would support the production of Iso 20:2n mentioned above. Instead, 




previous studies on seabream ( Castro et al. 2016). Hepatic fads2 expression was variable 
between individual fish fed diets with high VO inclusion (D1 - D4). The PCA analysis 
showed that this was also the case for the fatty acid profiles of fish consuming these diets 
and that Iso 18:2n and Iso 20:2n were important fatty acids in driving this variability. 
Furthermore, the level of Iso 18:2n was strongly correlated to the level of fads2 transcripts 
in the liver. It may be possible to exploit this individual variability in response to VO to 
select seabream that are better adapted to diets that are rich in VO, as has been described 
previously in Atlantic salmon (Salmo salar) (Morais et al. 2011). 
In addition to the distinctive patterns of fads2 and elovl5 expression described 
above, the regulatory mechanisms by which dietary fatty acids modulate metabolic 
responses in liver and mid-intestine appear to differ. In liver, srebp1, but not srebp2, was 
increased in gilthead seabream fed diets D1 - D3, with a threshold between diets D3 and 
D4. In mid-intestine, both srebp1 and srebp2 expression were increased with dietary VO. 
Srebp signalling is responsible for maintaining lipid levels in balance and, although there 
is some overlap between the functions of Srebp1 and Srebp2, the former is mainly 
associated with fatty acid/lipid synthesis, whereas the latter is associated with cholesterol 
synthesis in mammals (Pai, Guryev et al. 1998, Amemiya-Kudo, Shimano et al. 2002, 
Daemen et al. 2013) and fish (Carmona-Antoñanzas, Tocher et al. 2014). While the up-
regulation of srebp1 has been often associated with increased expression of fads2 in 
response to VO-rich diets (Morais et al. 2011, Jin et al. 2017), the up-regulation of srebp2 
in mid-intestine suggested putative activation of cholesterol biosynthesis. Dietary 
cholesterol was corrected for but VO are known to contain a range of phytosterols that 
may interfere with cholesterol metabolism (Leaver et al. 2008, Morais, Pratoomyot, 




The fas gene is also regulated by Srebp1 (Daemen et al. 2013) and its product, Fas, 
is an enzyme complex responsible for de novo synthesis of saturated fatty acids (Smith 
1994, Chirala, Wakil 2004). Despite the inclusion of 20 % lipid in the diets, the inclusion 
of VO resulted in up-regulation of fas in liver. There have been reports of VO increasing 
fas expression in Atlantic salmon (Morais et al. 2011) and blackhead seabream 
(Acanthopagrus schlegelii) (Jin et al. 2017). Nevertheless, this is not always supported 
by measurements of Fas activity in gilthead seabream fed diets with 80 % of dietary FO 
replaced with linseed oil (Menoyo et al. 2004). However, in turbot (Scophthalmus 
maximus), Fas activity was stimulated by dietary VO although the differences were not 
significant (Regost, Arzel et al. 2003). It is unclear what exactly is responsible for the 
apparent discrepancy between these results. However, the increased expression of srebp1 
in response to dietary VO, particularly notable in liver, suggested increased regulatory 
activity of Srebp1 towards potential target genes including fas and thus increasing their 
transcription. The patterns of dietary regulation of srebp1 and fas share a similar shape in 
liver (modelled by quadratic functions) suggesting co-regulation. Their up-regulation in 
response to dietary VO indicated that de novo lipogenesis may contribute to increased 
lipid deposition, as suggested previously by Morais et al. (2011) when studying 
diet/genotype interactions in Atlantic salmon.  
Beyond the anabolic processes described above, the impact of dietary VO was 
further evidenced in lipid catabolic processes such as β-oxidation. Generally, the 
expression of catabolic genes (pparα1 and cpt1α) in liver and, to some extent, in mid-
intestine, decreased with increasing dietary VO. The reduction in catabolic gene 
expression is coherent with the observed increased hepatic lipid levels associated with 




Bulchandani 2006, Shearer, Savinova et al. 2012) and Atlantic salmon (Morais et al. 
2011) that revealed that dietary FO increased the expression of pparα and the activity of 
β-oxidation enzymes. In contrast, a recent study demonstrated expression of pparα1 and 
its target cpt1α were increased in liver of gilthead seabream fed diet containing both wild-
type Camelina sativa oil (a low LC-PUFA diet) and containing genetically-modified 
camelina oil (containing n-3 LC-PUFA), although both these diets contained sufficient 
FM to satisfy EFA requirements (Betancor, Sprague et al. 2016). Dong et al. (2017) have 
recently shown that pparα1 expression in response to VO was different in three species 
of fish. The authors observed, dietary VO increased expression of pparα1 and pparα2 in 
rainbow trout (Oncorhynchus mykiss) and decreased expression of pparα2 in Japanese 
seabass (Lateolabrax japonicus) but had no effect in livers of yellow croaker 
(Larimichthys crocea). This finding complicates the regulation of lipid homeostasis but 
means that lipid catabolic processes can be regulated by a broad range of endogenous 
stimuli.  
In conclusion, the present study demonstrated that diets deficient in essential LC-
PUFA can cause alterations to lipid metabolism, fatty acid composition of liver and the 
regulation of genes involved in lipogenesis and catabolism. Despite the high energy (high 
lipid) diets used in the present study, expression of lipogenic genes such as fas involved 
in de novo biosynthesis was increased by dietary VO. In contrast, pparα1 and its target 
cpt1α were down-regulated and the expression was linear and therefore appeared to be 
modulated in a concentration-dependant manner. However, the expression of srebp1 and 
its gene targets was modelled by a curve, which was indicative of a threshold 
concentration at which gene expression was activated. Overall, the results reported in the 




found in FO have a stimulating effect on β-oxidation and an inhibitory effect on de novo 
lipogenesis. These opposing biochemical activities would be expected to contribute 
towards the increased hepatic lipid observed in fish fed increasing VO in the present study 
and others investigating EFA nutrition. These physiological effects of VO have direct 







VI. Dietary n-3 LC-PUFA gradients in the European seabass 
(Dicentrarchus labrax); effects on composition and 





Replacement of fish oil (FO) with vegetable oil (VO) in energy-rich aquafeeds 
reduces the availability of omega-3 (n-3) long-chain polyunsaturated fatty acids (LC-
PUFA) to marine fish, such as European seabass, a major cultured finfish in the 
Mediterranean. The aim of the present study was to examine the compositional and 
physiological responses of European seabass to a dietary gradient of n-3 LC-PUFA. Six 
isoenergetic and isonitrogenous diets (D1-D6) were fed to triplicate groups of juvenile 
European seabass (23 g), with the added oil being a blend of FO and VO to achieve a 
dietary gradient of n-3 LC-PUFA (0.23 – 3.40 % of diet as fed). Fish were sampled after 
four months feeding to determine biochemical composition, fatty acid concentration and 
lipid metabolic gene expression in liver and mid-intestine. The only effect on proximate 
composition was an increase in hepatic lipid, while diet modified fatty acid composition 
of both tissues. Production of LC-PUFA biosynthesis intermediates was observed in both 
tissues with some bias observed to n-6 fatty acids. Only two genes in liver were 
moderately influenced by dietary VO (fads2 and igf1) while, in mid-intestine, genes 
involved with lipogenesis (srebp1, srebp2 and fas) and LC-PUFA biosynthesis (fads2 and 
elovl5) were markedly upregulated in response to dietary VO. No differences were found 
in the expression of genes related to β-oxidation (pparα, cpt1α and fabp1). Overall, the 
transcriptional response in mid-intestine was much more pronounced than in liver. These 






Expansion in global aquaculture has placed increasing demand on marine raw 
materials, especially FM and FO (Shepherd, Pike et al. 2005, Tacon, Metian 2015, 
Shepherd et al. 2017), resulting in their increasing replacement with plant-based 
ingredients in aquafeeds (Kaushik 1990, Turchini et al. 2010). FO and, to a lesser extent, 
FM, are rich in LC-PUFA, including EPA and DHA that are regarded as EFA for marine 
fish as they cannot be biosynthesised endogenously (Tocher, Glencross 2015). Both EPA 
and DHA play critical roles in vertebrate physiology as structural components of 
biomembranes and as autocrine signal molecules (Gawrisch et al. 2003, Serhan et al. 
2008). Fish consuming EFA-deficient diets present a range of pathologies including 
steatosis (Watanabe 1982, Caballero et al. 2004), shock syndrome (Lochmann, Gatlin 
1993) and reddening of fins (Tacon 1996). Currently, the aquafeed sector relies heavily 
on FO to supply EFA in diets for carnivorous marine fish (National Research Council 
2011), whereas dietary VO supplies energy required for rapidly growing fish (Sargent et 
al. 1999). However, dietary VO has been shown to have important influences on fish 
composition and physiology (Glencross 2009), with fatty acid compositions of tissues 
altered towards that of the diet, showing increased levels of C18 MUFA and PUFA that 
are abundant in VO (Turchini et al. 2010). Although many vertebrates can synthesise LC-
PUFA from 18:3n-3 and 18:2n-6, most carnivorous marine fish cannot due to incomplete 
or insufficient activity of the LC-PUFA biosynthesis pathway (Shepherd et al. 2017). The 
pathway involves desaturation and elongation of C18 PUFA substrates and, while some 
enzymes are present in marine fish, such as fatty acid desaturase 2 (Fads2) and elongation 
of very long chain fatty acids 5 (Elovl5), others such as a Δ5-desaturase are not ( Castro 




Fish can biosynthesise fatty acids and cholesterol, with the pathways known to be 
regulated by sterol regulatory element binding proteins (Srebp) 1 and 2, respectively 
(Carmona-Antoñanzas et al. 2014). Srebp are transcription factors regulating energy 
homeostasis and have many target genes including those involved in lipogenesis such as 
fatty acid synthase (fas), as well as fads2 (Daemen et al. 2013, C. Castro et al. 2016, 
Minghetti, Leaver et al. 2011). Excess dietary lipids must be stored as triacylglycerol or 
catabolised by β-oxidation, both processes regulated by peroxisome proliferator-activated 
receptors (Ppar) (Mandard et al. 2004). Target genes of Ppar include, fatty acid binding 
proteins (Fabp) and carnitine palmitoyl transferase I (Cpt1α), proteins involved in 
transport of fatty acids destined for breakdown via β-oxidation (Mandard et al. 2004, 
Leaver et al. 2008). Genes involved in lipid catabolism are also known to be impacted by 
dietary VO with some studies reporting reduced catabolism (β-oxidation) contributing to 
excess lipid deposition in liver of many species, including Atlantic salmon (Salmo salar) 
(Morais et al. 2011), gilthead seabream (Houston et al. 2017) and blackhead seabream 
(Acanthopagrus schlegelii) (Jin et al. 2017). However, in European seabass, pparα 
expression was unaffected by VO (Geay et al. 2010). Studies on lipogenic processes have 
also yielded conflicting results, with lipogenic genes increased by dietary VO in Atlantic 
salmon (Morais et al. 2011), European seabass (Geay et al. 2010), gilthead seabream 
(Houston et al. 2017) and blackhead seabream (Jin et al. 2017), but reduced enzyme 
activity has also been reported in gilthead seabream (Menoyo et al. 2004). 
Although many studies have investigated the impact of dietary VO in fish, major 
questions remain including: 1) are differences in gene expression dependent on precise 
concentrations of dietary nutrients or are genes activated/deactivated at certain dietary 




the present study was to determine the effects of a gradient of dietary n-3 LC-PUFA in 
the context of modern feed formulations (high lipid and low FM) on tissue compositions 
and expression of lipid metabolic genes in European seabass. The tissues being liver and 
mid-intestine, both important sites of lipid and fatty acid metabolism. 
VI.2 Methods 
VI.2.1 Fish husbandry and diets 
The experimental diets and trial design are detailed in Section II.2. European seabass 
juveniles (~3 g) were purchased from a commercial hatchery and transported to the 
BioMar FTU (Hirtshals, Denmark). Subsequently, 150 fish were distributed randomly 
between 18 x 1 m3 tanks, and fed a commercial diet until they reached a size of ~23 g. 
Six experimental diets were formulated at the BioMar Tech-Centre (Brande, Denmark) 
to achieve specific levels of LC-PUFA by progressively replacing FO with blends of RO 
and PO (Table II.3). All other dietary ingredients were selected to meet the known 
nutrient requirements of European seabass (National Research Council 2011). The 
experimental diets were numbered to reflect the VO/FO inclusion so that diet D1 
contained the VO blend as sole exogenously added oil source, diet D6 contained only FO, 
and diets D2 - D5 contained graded levels of VO and FO. The dietary fatty acid profiles 
are given in Table IV.1. The feeding trial started in April 2014 and ran for 18 weeks, 
initially feeding a 3 mm pellet (8-weeks) and then with a 4.5 mm pellet to the end of the 
trial. Fish were fed to satiation twice per day using automatic feeders and uneaten feed 





The tank biomass was weighed before and after the trial so that mean weight and 
specific growth weight (SGR) could be calculated. After four months feeding, five whole 
fish and three eviscerated carcasses, liver and viscera (minus liver) were sampled from 
each tank for compositional analysis. Livers were also weighed to determine hepato-
somatic index (HSI). Liver and mid-intestine samples were sampled from three fish per 
tank for gene expression and fatty acid analysis. Further details of sampling can be found 
in Section II.2 
VI.2.3 Proximate composition 
Proximate composition analyses were carried out according to standard procedures 
(Horwitz 2000), as described in Section II.3.1. Total lipid content was carried out 
according to Folch (1957) as described in Section II.3.2.1. 
VI.2.4 Lipid extraction and fatty acid analysis 
Total lipid for fatty acid analyses was extracted from tissues according to Folch et al. 
(1957). Fatty acid composition of liver and mid-intestine samples were determined as 
described in Sections II.3.2.2 and II.3.2.3, according to methods described by Christie 
(2003). Tissue fatty acid levels were expressed as mg g-1 of tissue and estimated using the 
response of the internal standard. The coefficient of variation estimated using mg DHA 




VI.2.5 RNA extraction 
Total RNA was extracted from ~100 mg of liver and mid-intestine tissue according 
to the method described in Section II.3.3.1. The concentration and quality were verified 
spectrophotometrically and by agarose gel electrophoresis to visualise the presence of 
18S and 28S ribosomal subunits (Section II.3.3.4). Extracts were stored at -70 °C until 
cDNA synthesis. 
VI.2.6 cDNA synthesis 
Reverse transcription was conducted using a High Capacity Reverse Transcription 
kit (Applied Biosystems) according to the manufacturer’s protocol and as described in 
Section II.3.3.2. Each tissue was run in a single run and included a no template control 
(NTC) and reverse transcriptase-free reactions as blank and negative controls, 
respectively. Reverse transcription was performed on a Biometra Thermocycler (Analytik 
Jena). A pool of cDNA samples was created for serial dilutions, calibrator samples and 
primer validations. Samples of cDNA were diluted 20-fold with nuclease-free water as 
template for qPCR, and stored at -20 °C.  
VI.2.7 Gene expression analysis 
Gene expression was determined for candidate genes involved in key selected 
pathways by quantitative real time PCR (qPCR). Primers for qPCR were designed using 
Primer3 using the National Centre for Biotechnology Information (NCBI) database’s tool 
“Primer-BLAST” against known gene sequences. Three genes, namely srebp2, fas and 
ppara1, were sequenced as part of this work and sequences deposited in NCBI with 




Lightcycler-480 instrument (Roche Diagnostics Corp, USA), as described in Section 
II.3.3.3. Triplicated qPCR reactions were carried out on 384-well plates. Data were 
acquired through the instrument’s software and calculations for sample expression ratios 









where E is the determined efficiency, ref is the geometric mean of four reference genes, 
goi is the gene of interest and Ct is the threshold cycle. The genes of interest were 
normalised to the geometric mean of four reference genes, elongation factor 1α (ef1α), 
beta-actin (β-act), alpha-tubulin (tuba1α) and ribosomal protein P0 (rplp0), whose 
expression was not influenced by dietary treatment. Gene expression data are presented 
as log2 expression ratios (Hellemans, Vandesompelle 2011). The average intra assay 
coefficient of variation was 0.31 ± 0.25 % at the level of threshold cycle (Ct). 
VI.2.8 Statistical analysis  
Three individuals from each tank were randomly sampled giving a total of 54 fish, 
this being the number of fish to detect medium effect sizes (f 2 = 0.15; power = 0.8) by 
OLS regression. For fatty acid profiles of tissues (n = 54) a PCA was first run to explore 
the dataset. The fatty acid profiles of the diets were supplied to PCA as supplementary 
individuals (they were not used to generate the PC scores but allocated scores after 
analysis). Fatty acids and gene expression data were further analysed using regression. 
Some variables including final weight, SGR and HSI were analysed by one-way ANOVA 




model). Where differences were identified, Tukey’s HSD tests were used to determine 
which groups differed. For further details see Section II.4.2. 
Table VI.1. European seabass primer sequences 
Table VI.1. Primer sequences used for gene expression analysis by quantitative reverse-
transcriptase PCR. Amplicon sizes (base pair) and GenBank accession numbers also are 
provided, accession numbers beginning with “MF” were sequenced for this study. 
Transcript  Sequence (5'-3') Amplicon (bp) Accession no. 
cpt1α F: AGGCTAGGTGAGATTCGGGT 204 KF857302.1 
 R: ACTGGACAATCCTTCGGCTG   
elovl5 F: GCCGTACCTTTGGTGGAAGA 234 FR717358.1 
 R: GATACGGGAGAGCCGTTCTG   
fabp1 F: CCGGCTCAAAGGTCCTCATT 223 FL486710.1 
 R: TACATGCGTTTGCTCGTCCT   
fads2 F: TGTATGGCCTGTTTGGCTCG 152 EU439924.1 
 R: GGTGGCTTGTAACTGCATGG   
fas F: CGTCAAGCTCTCCATCCCTG 238 MF566098 
 R: GGTGGTGTCTAGGCAGTGTC   
igf1 F: ACAAAGTGGACAAGGGCACA 138 AY800248.1  
 R: CCGTGTTGCCTCGACTTGA   
pparα F: ATGGTGACTATCCGGAGCCCG 216 AY590300 
 R: ACTTCAAGAGAGTCACCTGGTCAT   
pparα1 F: GGATGACAGTGACCTGGCTC 211 MF566100 
 R: ATGCTCAGTGACTAGCTGCC   
scd F: CATCGACGGTGGAGGATGTT 155 FN868643.1  
 R: TGACGTCGATGCATTGGGAA   
srebp1 F: CACTCCAAGTGGTGGTCCTC 189 FN677951.1  
 R: TTCTGGCTTGGACAGCAGAG   
srebp2 F: CGTGTGACTTGGGAACCAGA 192 MF438039 
 R: AAGAGTGAGCCAGATTCGCC   
act-b F: GTGGCTACTCCTTCACCACC 181 AJ537421.1  
 R: CGGAACCTCTCATTGCCGAT   
ef1α F: GGAGTGAAGCAGCTCATCGT 199 AJ866727.1  
 R: AGCCCATCTTTACACTGCCC   
tuba1α F: CAAGAGGGCTTTCGTCCACT 115 FM001820.1 
 R: GTCAGTGCCCACCTCTTCAT   
rplp0 F: CAGGCTCTGGGTATCACCAC 197 FM018449.1 






3.1 Proximate composition  
Significant effects of dietary VO on the proximate composition of seabass juveniles 
were only observed in liver, which was associated with an increase in hepatosomatic 
index (HSI) from 2.3 to 3.5 in fish fed diets D6 and D1, respectively (P < 0.001). In liver, 
there was a significant increase in lipid content ranging between 27.6 and 44.9 % (R2 = 
66.4, P < 0.001), while there were significant decreases in moisture (R2 = 60.4, P < 0.001), 
ash (R2 = 46.6, P = 0.0011) and protein (R2 = 53.0, P < 0.001). The total lipid content of 
the mid-intestine ranged between 3.9 and 10.6 %, but was not significantly affected by 
diet (P > 0.05). The lipid contents of whole fish and carcass were unaffected by dietary 
VO (P > 0.05), and protein and ash contents were not affected in whole body, carcass or 
viscera (P > 0.05). A summary of these data is presented in the Appendix, Table A4. 
VI.3.1 Fatty acid composition of liver and mid-intestine 
The fatty acid profiles of two major lipid metabolic sites, namely liver and mid-
intestine, were determined. Firstly, PCA was used to reduce the dimensions of the data. 
In the liver, principal component 1 (PC1) and principal component 2 (PC2) explained 
47.6 and 22.2 % of the variance, respectively (Figure VI.1). Fatty acids that were 
correlated to PC1 were 16:1n-7, 18:1n-7, 18:4n-3, 20:5n-3, 22:5n-3, 22:6n-3 and 20:4n-
6, and fatty acids with negative correlations to PC1 included 18:1n-9, Iso 18:2n, 18:3n-3, 
18:2n-6 and 18:3n-6. There was considerable overlap in the individual plot for hepatic 
fatty acid profiles and, interestingly, the diets (plotted in Figure VI.1A as supplementary 





Figure VI.1. European seabass PCA of liver fatty acids. 
Figure VI.1. Graphical representation of principal components analysis (PCA) of fatty 
acid profiles from liver (n=54) of fish fed experimental diets (D1-D6). For explanation 
see section II.4.2.1. The profiles of the experimental diets (D1-D6) are plotted as 
supplementary to the analysis. Note the concentration of the points to the centre of the 
plot and the considerable overlap in the profiles of fish consuming D1-D4. The spread of 
the dietary PC scores, both on P1 and P2 indicates that the dietary fatty acid profiles were 
more variable than the livers’. Panel B shows all the variables (fatty acids) used to 
construct the PC. Note that the major fatty acids from FO are the biggest contributors to 
positive scores for PC1, with 18:1n-9 being the most important for negative scores. 18:3n-
3 and 18:2n-6 point to the top left of the circle indicating that these fatty acids also make 





In the mid-intestine fatty acid profiles, PC1 and PC2 accounted for 61.1 and 14.8 % 
of the variability, respectively. In addition to the fatty acids making strong contributions 
to PC1 in the liver, the saturated fatty acids (SFA) 14:0 and 16:0 were also important in 
forming PC1 in mid-intestine (Figure VI.2). As described in liver, negative contributions 
to PC1 were driven by levels of 18:1n-9, Iso 18:2n, 18:3n-6, 18:3n-3 and 18:2n-6. In 
mid-intestine, the dietary profiles aligned well on PC1, but were separated (negatively) 
on PC2 (Figure VI.2). The fatty acids making positive contributions to the formation of 
PC2 were 18:0, 16:1n-9, 20:2n-6 and 20:3n-6, these fatty acids having percentage levels 
in the tissue that would not be expected when considering simply their percentage in the 
experimental diets.  
Absolute levels of n-3 LC-PUFA were strongly related to dietary levels in both the 
liver (R2 = 87.6, P < 0.001) and mid-intestine (R2 = 82.4, P < 0.001) (Figure VI.3). The 
mid-intestine showed higher proportions of n-3 LC-PUFA than liver. Absolute levels of 
SFA in liver were negatively influenced by dietary levels (R2 = 36.4, P < 0.001) and 
ranged between 73.1 - 116.7 mg g-1. However, in mid-intestine, SFA levels were not 
affected by diet (P > 0.05), with mean levels being 12.2 (± 3.2) mg g-1. Absolute levels 
of MUFA in liver (R2 = 59.2, P < 0.001) and mid-intestine (R2 = 14.1, P = 0.010) increased 
with dietary supply, primarily dominated by the levels of 18:1n-9. This increase was 
particularly marked in liver (106.4 – 242.2 mg g-1, derived from fitted values), but less so 
in the mid-intestine (11.5 – 15.9 mg g-1) (Figure VI.4). Absolute levels of n-6 PUFA were 
affected by dietary level in liver (R2 = 50.2, P < 0.001) and mid-intestine (R2 = 20.8, P = 





Figure VI.2. European seabass PCA of mid-intestine fatty acids. 
Figure VI.2. Graphical representation of principal components analysis (PCA) of fatty 
acid profiles from mid-intestine (n=54) samples of European seabass fed experimental 
diets (D1 - D6). Panel A is a biplot of the first two principal components (PC1 and PC2) 
of the mid-intestine fatty acid profiles. The fatty acid profiles of fish consuming diets D5 
and D6 formed succinct groups to the right of the plot in Panel A. In the mid-intestine, 
the supplementary diets separate mainly on PC2 and not PC1 indicating that the fatty 
acids associated with PC2 are the variables separating the diet profiles from the mid-
intestine fatty acid profiles. Note that the fatty acids important in assigning positive scores 
to PC2 included Iso 18:2n, 18:3n-6, 20:2n-6 and 20:3n-6. D1 = ○; D2 = △; D3 = ㍸; D4 
= +; D5 = ⊠; D6 = ✳. 
The absolute levels of fatty acids in liver and mid-intestine are summarised in the 
Appendix, Tables A5 and A6, respectively. Fatty acid intermediates of LC-PUFA 
biosynthesis were found to be elevated in both tissues beyond their dietary concentration, 
particularly in the case of n-6 PUFA intermediates. The tissue content of the Δ6 
desaturation product 18:3n-6 showed an opposing gradient to that of the experimental 
diets (liver: R2 = 54.3, P < 0.001; mid-intestine: R2 = 38.4, P < 0.001). With regards to 
18:4n-3, the n-3 pathway equivalent to 18:3n-6, there was no significant dietary gradient 




0.545; mid-intestine: R2 = 65.1, P < 0.001). Despite not being present in the diets, another 
Δ6 desaturation product, Iso 18:2n, was detected in both liver and mid-intestine, and its 
levels were positively related to dietary VO (liver: R2 = 56.7, P <0.001; mid-intestine: R2 
= 21.8, P <0.001). It is interesting to note that 20:3n-3 was not detected in these tissues, 
but the n-6 pathway equivalent (20:2n-6) was found in both tissues at proportions higher 
than that of the diet. The levels of 20:2n-6 (liver: R2 = 12.9, P <0.001; mid-intestine: R2 
= 0.8, P <0.266) and 20:3n-6 (liver: R2 = 0.6, P = 0.31; mid-intestine: R2 = 0.9, P = 0.013) 
remained relatively constant across the experimental diets in both tissues. The high lipid 
level in the liver diluted the key LC-PUFA, (EPA, DHA and arachidonic acid, ARA 
20:4n-6), yet the mid-intestine retained these fatty acids in fish fed VO diets (D1-D3). 
VI.3.2 Gene expression 
Candidate genes were analysed for their level of expression using relative qPCR, 
with the results presented as log2 expression ratios in the relevant Tables and Figures. In 
liver, the expression levels of only fads2 and igf1 were found to be influenced by dietary 
VO. The effects on fads2 and igf1 expression were only moderate (R2 = 18.1 and 11.2, 
respectively), with fads2 presenting a positive relationship and igf1 a negative 






Figure VI.3. European seabass LC-PUFA in liver and mid-intestine. 
Figure VI.3. Levels of n-3 long-chain (≥ C20) polyunsaturated fatty acids (LC-PUFA) in 
European seabass liver (A) and mid-intestine (B) against the dietary levels of n-3 LC-
PUFA. The black line is a model derived by robust linear regression analysis (n=54) and 
the standard error of the model’s fitted values shaded in grey. Natural logarithm (ln) 
transformation was applied to the data, but the data are plotted in their real dimensions. 
Liver, ln(y) = 0.870ln(x) – 0.339 and mid intestine, ln(y) = 0.416ln(x) + 0.603. Diet 1 = 





Figure VI.4. European seabass MUFA in liver and mid-intestine. 
Figure VI.4. Levels of monounsaturated fatty acids (MUFA) in European seabass liver 
(A) and mid-intestine (B) against the dietary levels of MUFA. The solid lines are the 
model fits, with the standard error shaded in grey. Best fits were found to be a quadratic 
and linear function for the liver (y = 359.81 – 11.069x + 0.121x2) and mid-intestine (y = 
8.401 + 0.094x) data, respectively. Diet 1 = ○; Diet 2 = △; Diet 3 = ㍸; Diet 4 = +; Diet 




Table VI.2. European seabass gene expression results. 
Table VI.2. Statistical treatment of liver and mid-intestine gene expression data using 
robust linear regression 




error R2 Pr(>F) 
Liver pparα -0.529 ± 0.253  0.031 ± 0.024 1.688 0.201 
 cpt1α -0.455 ± 0.185 0.019 ± 0.016 1.368 0.237 
 fabp1 -0.205 ± 0.089 0.001 ± 0.010 -1.949 0.935 
 srebp1 0.004 ± 0.224 0.009 ± 0.024 -1.684 0.712 
 srebp2 -0.539 ± 0.331 0.014 ± 0.034 -1.457 0.690 
 fas 0.078 ± 0.227 -0.019  ± 0.024 -0.605 0.439 
 scd -0.147 ± 0.244 0.010 ± 0.026 -1.514 0.709 
 fads2 -0.844 ± 0.136 0.059 ± 0.014 18.078 <0.001 
 elovl5 -0.242 ± 0.473 -0.041 ± 0.044 0.372 0.350 
  igf1 0.418 ± 0.171 -0.045 ± 0.016 11.215 0.008 
Mid  pparα 0.163 ± 0.143 -0.028 ± 0.013 9.705 0.030 
intestine pparα1 0.282 ± 0.206 0.033 ± 0.019 8.822 0.094 
 cpt1α 0.232 ± 0.244 -0.029 ± 0.022 1.550 0.200 
  scd -0.167 ± 0.236 0.009 ± 0.022 -1.637 0.680 
 
In mid-intestine, most tested genes were found to be influenced by the experimental 
diets. However, pparα, pparα1, cpt1α and scd were not influenced by dietary VO (Table 
VI.2). Three of the genes, namely srebp1, srebp2 and fas, were best fitted by quadratic 
functions (Figure VI.5; panels A, B and C), displayed similar relationships with dietary 
VO, and their expression correlated with each other (srebp1:srebp2: r = 0.76, P <0.001; 
srebp1:fas: r = 0.73, P <0.001; fas.srebp2: r = 0.71, P <0.001, Figure VI.5, panel D). 
Furthermore, the expression level of srebp1 was found to be negatively correlated (r = -
0.55, P <0.001) with the tissue level of n-3 LC-PUFA (Figure VI.5, panel E). The 
expression of fads2 (R2 = 53.7, P <0.001) and elovl5 (R2 = 17.8, P <0.001) in mid-intestine 
increased with dietary VO. The best fit for fads2 was achieved with a single term 
quadratic function and elovl5 a linear model (Figure VI.6; panels A and B). The 
expression of fads2 and elovl5 were correlated (r = 0.71, P < 0.001, Figure VI.6, panel 




products including Iso 18:2n (r = 0.43, P = 0.0013) and 18:3n-6 (r = 0.47, P < 0.001). No 
correlations between elovl5 expression and its potential elongation products were found. 
VI.4 Discussion 
Replacement of FO has been an important area of research, particularly with the 
growth of aquaculture (Turchini et al. 2010), and increasing proportions of VO have been 
used in feeds of farmed fish species as pressure is placed on limited marine fisheries 
resources (National Research Council 2011,  Glencross 2009, Tocher, Glencross 2015). 
In the present trial, juvenile European seabass were fed high fat (21 %), low FM (12.5 %) 
feeds with a dietary gradient of FO and, therefore, LC-PUFA, and we report the impact 
this had on tissue composition and gene expression. During the trial, all experimental 
groups increased in weight despite the provision of diets with very low levels of LC-
PUFA (Skalli, Robin 2004), however, only fish fed 100 % VO showed statistically lower 
weight than fish fed the other diets. The SGR values reported in the present study are 
above those reported in several previous studies indicating a strong performance of the 
fish was attained (Montero et al. 2005, Mourente, Bell 2006, Richard, Mourente et al. 
2006), although they were below a recent study, albeit with smaller seabass for a shorter 
time period (Torrecillas et al. 2017). 
The impact of dietary VO on proximate compositions was an increase in lipid content 
in liver (27.6 – 44.9 %), which was accompanied by an increase in HSI. These data agree 
with a recent study in European seabass juveniles with a body weight of 40 – 60 g fed a 
similar gradient of LC-PUFA (Torrecillas et al. 2017). The dietary effect of VO on the 
hepatic lipid level was the same in gilthead seabream (18.6 – 31.8 %) (Houston et al. 




seabass livers. In wild European seabass, the liver’s lipid content was dependent on 
season and ranged between 4 – 28 % (Yıldız, Şener et al. 2007), therefore the data in the 
present study are mostly higher than these values (except in D5 and D6). The higher range 
in hepatic lipid values reported in gilthead seabream (Houston et al. 2017) may suggest 
that seabream are more sensitive to dietary VO. However, an alternative explanation is 
that the dietary effects, in seabass, could be obscured by an effect of high dietary lipid. 
Diet had a strong influence on the fatty acid compositions of both tissues as observed 
in previous studies (Mourente, Bell 2006, Montero et al. 2005). Oleic acid dominated 
hepatic fatty acid composition, but levels of 18:2n-6 and 18:3n-3 also increased nearly 
three-fold with increasing dietary VO. The PCA gives each fatty acid equal weight and, 
when analysed in this way, the fatty acid profiles of the liver were separated by diet, but 
in diets D1-D4 there was considerable overlap. The diets did not align with the liver fatty 
acid profiles indicating that the diet fatty acid profiles were more heterogeneous. The key 
LC-PUFA in the seabass livers appeared to be heavily diluted by other fatty acids in all 
diets (indicated by the higher spread of the diets along PC1 than the seabass liver 
samples). The mid-intestine samples aligned well with their respective diets (along PC1) 
indicating that the fatty acid composition more closely resembled the respective dietary 









Figure VI.5. European seabass, mid-intestine expression of lipogenic transcripts 
Figure VI.5. Expression of srebp1 (A), srebp2 (B) and fas (C) against dietary vegetable 
oil (VO) in the mid-intestine of European seabass fed experimental diet D1-D6. Data are 
log2 expression ratios normalised to the expression of four reference genes and then to 
the calibrator sample. The fitted lines are quadratic functions describing the relationship 
between dietary VO and log2 expression ratio (srebp1, y = 0.0500 – 0.1205x + 0.0117x2; 
srebp2, y = -0.3341 – 0.0643x + 0.0092x2 and fas, y = -1.0311 – 0.0593x + 0.0092x2). 
Standard errors of the model’s fitted values are highlighted in grey. Panel D shows the 
high level of correlation between the expression of srebp1 (x axis), fas (○) and srebp2 
(△). Panel E shows the correlation between srebp1 expression and the tissue content of 
n-3 long-chain (≥ C20) polyunsaturated fatty acids (LC-PUFA). Diet 1 = ○; Diet 2 = △; 

















Figure VI.6. Expression of fads2 and 
elovl5 in the mid-intestine of European 
seabass fed experimental diets, D1-D6, 
plotted against dietary vegetable oil (VO). 
Data are log2 expression ratios normalised 
to the expression of four reference genes 
and then to the calibrator sample. The 
fitted line for fads2 is a single term 
quadratic function (y = -1.0686 + 
0.0086x2) and, for elovl5 a linear function 
(y = -0.9728 + 0.0876x). The standard 
errors of the model fitted values are shaded 
in grey. Panel C illustrates the correlation 
between fads2 and elovl5 expression. Diet 
1 = ○; Diet 2 = △; Diet 3 = ㍸; Diet 4 = +; 
Diet 5 = ⊠; Diet 6 = ✳. 
  




There is evidence (pathway intermediates) in the fatty acid data of stimulation of the 
LC-PUFA biosynthesis pathway by dietary VO, particularly in n-6 PUFA (18:3n-6, 
20:2n-6 and, to a lesser extent, 20:3n-6), and Iso 18:2n was also observed despite its 
absence in the diets, as previously observed in European seabass (Torrecillas et al. 2017). 
This points to increased desaturase and elongase activity in liver and mid-intestine 
(Mourente, Dick 2002). Interestingly, evidence of significant production of 20:3n-3 and 
20:4n-3 is absent in the seabass data reported in the present study, and previously 
(Torrecillas et al. 2017), suggesting a possible preference in elongation activity towards 
n-6 substrates. Conversely, in recently reported data in European seabass, 18:4n-3 was 
increased more so than n-6 PUFA, however the diets in that study used linseed oil, which 
was richer in 18:3n-3 than 18:2n-6 (Torrecillas et al. 2017). Taken together these results 
suggest that Fads activity in European seabass shows no major preference towards n-3 or 
n-6 substrates in vivo. Indeed, in the related Japanese seabass (Lateolabrax japonicus), 
when dietary 18:3n-3 was supplied at a higher level than 18:2n-6, the Δ6-desaturase 
product 18:4n-3 appeared in liver at a higher proportion than in the diet (18:3n-6 was not 
reported) (Xu, Dong et al. 2014). These conclusions contrast with previous study in 
gilthead seabream where production of 18:4n-3, 20:3n-3 and 20:4n-3 was observed, 
revealing an important difference in LC-PUFA biosynthesis in these two species (Chapter 
V). There was no evidence in the present study for the Δ-5 desaturation necessary to form 
ARA or EPA, supporting previous work that European seabass is unable to biosynthesise 
these fatty acids in measurable quantities (Mourente et al. 2005, Almaida-Pagán, 
Hernández et al. 2007, Vagner, Santigosa 2011, Tocher 2003). Two studies have 
described the function of European seabass Fads2 (fatty acid desaturase) expressed in 




preference for 18:3n-3 (González-Rovira et al. 2009) while the other found no preference 
for either substrate (Santigosa et al. 2011). The in vivo data reported here, agree with the 
latter findings.  
In the present study, the expression of several genes related to lipid metabolism is 
reported and, previously, some of these genes were also assayed in gilthead seabream 
using similar methodologies and experimental design (Chapter V). In both species, 
expression ratio data were variable and, where a dietary relationship was found, often R2 
values were low, indicating that dietary VO was not the sole source of variability in the 
data. In the liver of seabass, only two genes responded to the dietary gradient of VO, igf1 
and fads2. This was surprising as we previously observed trends in most of the genes 
analysed here in gilthead seabream liver (Chapter V). The moderate negative relationship 
between igf1 and dietary VO suggests that VO may suppress circulating levels of insulin-
like growth factor 1 (IGF1). The IGF signalling system is involved in vertebrate growth 
(Wood, Duan et al. 2005), and previous work in fish has usually associated this response 
with dietary protein or fasting, for example in barramundi (Lates calcifer) (Matthews, 
Kinhult et al. 1997) and coho salmon (Oncorhynchus kisutch) (Duan, Duguay et al. 1993). 
Use of probiotics was shown to increase igf1 expression and this was associated with 
higher weight gain in European seabass juveniles (Carnevali, de Vivo et al. 2006). 
However, the effect of dietary VO on igf1 expression, to our knowledge, has not been 
previously published. The increase in fads2 expression, and stability in elovl5 expression, 
is consistent with the fatty acid compositional data discussed above. Previous studies of 
fads2 and elovl5 found upregulation of both transcripts in response to dietary VO (C. 
Castro, Corraze et al. 2015), however we did not observe an increase in elovl5 expression. 




Santigosa 2011, Xu et al. 2014) and the weak linear relationship found in the liver in the 
present study suggests that the response of this transcript to diet is concentration-
dependent. The moderate response of fads2 in the liver partially agrees with results 
obtained for desaturation activity in European seabass hepatocytes, which showed no 
influence of 60% replacement of dietary FO with VO (Mourente, Dick 2002). Two further 
dietary patterns in gene expression were observed in seabream liver, but not in seabass 
liver. Firstly, lipogenic transcripts (fas and srebp1) were stimulated by dietary VO and 
showed very similar responses to that of fads2 (Chapter V). Secondly, there was evidence 
that dietary VO downregulated several transcripts involved in β-oxidation (pparα, cpt1α) 
(Chapter V). A previous study examining the dietary regulation of pparα in Japanese 
seabass found that dietary VO tended to reduce the expression of ppara2 with mixed 
results for pparα1 (Dong et al. 2017). These same authors, also compared their data to 
two other species, rainbow trout (Oncorhynchus mykiss) and yellow croaker 
(Larimichthys crocea), and this gene responded differently in all three species (Dong et 
al. 2017). This indicates that the transcriptional response of pparα (1 and 2) is highly 
species specific. Overall, the transcriptional response of the European seabass liver to 
dietary VO was less pronounced than that of gilthead seabream. 
In the European seabass mid-intestine, several lipogenic genes were found to be 
responsive to diet. Some upregulation was observed in elovl5 and fads2, with the pattern 
observed in fads2 suggesting activation at a certain dietary threshold, but the data for 
elovl5 were too variable to comment in this regard. However, there was reasonable 
correlation between these two transcripts suggesting that they were responding to the 
same stimuli. The different dietary effects on these transcripts observed between the liver 




tissues. There was high variability in the fatty acid profiles of livers of fish consuming 
diets D1-D4, if these transcripts are responding according to this lipid micro-environment 
(which is variable) then gene expression will be highly variable too. Interestingly, it had 
been previously reported that, albeit still at low levels, desaturation activity is higher in 
European seabass enterocytes (from pyloric caeca) than in hepatocytes, and the gene 
expression data reported here are consistent with this finding (Mourente et al. 2005).  
The lipogenic gene transcript levels were also stimulated by dietary VO in seabass 
mid-intestine (srebp1, srebp2 and fas), furthermore their expressions were highly 
correlated with one another. This pattern of response to diet was very similar to 
observations in seabream mid-intestine (Chapter V). It is interesting to note that stearoyl-
CoA-desaturase (SCD) did not respond to diet, possibly suggesting that its regulation is 
by separate mechanisms to the fas transcript. Furthermore, the high correlations between 
srebp1, srebp2 and fas, suggest a response to the same dietary stimuli. The response of 
srebp1 and srebp2 points to a stimulation of fatty acid and cholesterol synthesis. The 
experimental diets were balanced for cholesterol, so the upregulation of srebp2 may be 
related to the presence of dietary phytosterols originating from VO (Leaver et al. 2008). 
Alternatively, srebp2 transcription may be coupled to the stimulation of srebp1. 
Stimulation of cholesterogenic transcripts, srebp2 targets, has been reported previously 
in European seabass (Geay, Ferraresso et al. 2011), in a study where the diets were not 
corrected for cholesterol.  
In summary, the proximate composition of European seabass was unaltered by the 
experimental diets, although the lipid content of liver was increased. Tissue fatty acid 




considerable variability observed between individual fish. The fatty acid profiles of liver 
were dominated by oleic acid, which diluted the PUFA. The mid-intestine on the other 
hand, retained higher proportions of PUFA, a likely reflection of the lower triacylglycerol 
level of the tissue. Parts of the LC-PUFA biosynthesis pathway were stimulated by dietary 
VO, however there was no evidence of the critical Δ5 desaturation necessary to produce 
EPA or ARA. Effects on hepatic lipid metabolism were limited to a moderate 
upregulation of fads2 but, in the mid-intestine, more lipogenic transcripts were responsive 
to diet. No evidence was found of any dietary influence on transcripts involved with 
β-oxidation. Reasons for differences between gilthead seabream and European seabass 
are unclear but point to a higher sensitivity of gilthead seabream to dietary VO than 
European seabass. These findings provide data and insights that are relevant to the 
















The present study has re-evaluated EFA requirements of gilthead seabream and 
European seabass, which are important cultured species in the Mediterranean Sea. Over 
recent years, aquafeed formulations for finfish have reduced the quantity of FO and 
increased the energy density of the diet by the addition of VO, and thus it was necessary 
to reconsider the question of EFA requirements (National Research Council 2011). Using 
a dose-response design, a gradient of dietary EPA and DHA was delivered to both species 
for four months with a mid-point sampling, at the change of pellet size (3 mm to 4.5 mm). 
High growth rates were achieved in both species; however, the seabass grew slower than 
the seabream. The analysis of biometric data in Chapters III and IV revealed the body 
weight dependent nature of the EPA+DHA requirement, which has not been previously 
documented in similar studies. Furthermore, the effect of the dietary EPA+DHA gradient 
on the composition of body compartments, fatty acid composition and expression of lipid 
metabolism genes was investigated in Chapters V and VI. The following text discusses 
the key findings of the project with an emphasis on comparisons between the two species 
and uniting the first (Chapters III and IV) and second (Chapters V and VI) halves of the 
thesis. 
VII.2 EPA+DHA requirements, growth and FCR 
The present study has shown that the current published EFA requirements for both 
species are too low (Kalogeropoulos et al. 1992, Skalli, Robin 2004). In both species, 
analysis of the growth and FCR data showed that the requirement was higher during the 




a similar recommendation of 1.30 - 1.50 % EPA+DHA can be advanced for both species. 
Overall, for fish of > 80 g (4.5 mm pellet) the requirement can be reduced to 1.20 – 1.25 
% EPA+DHA for seabream and 1.10 – 1.20 % EPA+DHA for seabass. These figures 
suggest that the EFA requirement appears to be falling more rapidly in the seabass, though 
it should be noted that this species grew slower, which may explain this difference. These 
requirement estimates are based on biometric data derived from the 3 mm pellet and over 
the whole trial. If the 4.5 mm pellet data is considered, the fish have diverged in weight 
during the first half of the experiment. Therefore, it is not sensible to derive a requirement 
from these data. The 4.5 mm pellet data was presented to demonstrate the temporal 
effects. The requirement estimates for the 4.5 mm are in line with the current published 
levels of ~ 1.0 % LC-PUFA (Kalogeropoulos et al. 1992, Coutteau et al. 1996, Skalli, 
Robin 2004, National Research Council 2011). In seabass, the effect on growth almost 
diminished completely, and the value seems to be ~ 0.8 % EPA+DHA.  
In the discussion section of Chapter III, it was postulated that the form of the 
relationship between fish mass and the dietary requirement for EPA+DHA would likely 
take the form: requirement = -a · fish mass (Kg)b, similar in nature to the relationship of 
dietary protein to fish mass (Lupatsch et al. 2003b). Although this thesis, does not provide 
sufficient data for formal analysis there are potentially three geometric mean weights that 
could be considered to examine this relationship. Figure VII.1 shows the available 
EPA+DHA requirement data (3 mm, 4.5 mm and over the trial) plotted over the geometric 
mean weight of the fish during these experimental feeding periods. For comparative 
purposes the suggested dietary protein levels, for both species have been plotted using 
data for gilthead seabream (Lupatsch 2003) and European seabass (Lupatsch 2005). 




parallel trajectories with dietary protein, we can begin to speculate that it is more sensible 
to define the ratio of all nutrients with dietary protein (which is dependent on somatic 
growth rate) because it would seem this is constant over fish mass. The energy demand 
of fish (and animals) increases as they grow and causes them to consume more feed, 
therefore satisfying the animal’s protein, and in our case EFA, requirements with lower 
proportions of the latter nutrients in the diet (Glencross, Bermudes 2012). In the author’s 
mind, expressing a nutrient demand for EPA+DHA per unit energy complicates the 
reasoning, as the declining relative requirements are a consequence an animal’s 
increasing demand for energy. The data presented in this thesis, suggest that nutrients 
supplied with the metabolic fate of somatic growth are supplied in a similar ratio with one 
another across animal weights, therefore, why express them per unit energy? Why not 
define their ratios for each species and dilute this basal diet with components (lipid/more 
protein) to satisfy the rising energy demand? This line of reasoning reverses the current 
process of diet formulation, where feeds are formulated after the energy content has been 
determined for an animal size (pellet size). To provide an alternative phrasing, give the 
animal the building blocks it needs to build more animal and, as it grows boost this base 






Figure VII.1. The requirements for EPA+DHA over geometric weight of gilthead 
seabream and European seabass. Dietary protein (DP) recommendations for these species 
a plotted for comparison. Note there appears to be a consistent ratio (parallel 
relationships) between dietary protein and the EPA+DHA requirements.  
Figure VII.1. The nature of EPA+DHA requirements. 
 The FCR data revealed important differences between the two species. Firstly, the 
effect of the diets on FCR in seabream were stronger than in seabass. In fact, only the 
seabass FCR data over the whole trial could be used to suggest a requirement in terms of 
FCR and this was 1.04 % EPA+DHA. There was an effect on FCR for the 3 mm pellet 
but it could only be modelled with a straight line. The seabream FCR data displayed an 
unusual shape that could only be accommodated by the FPL model. The cause of the 
unusual shape of the FCR data is the lower than expected FCR of fish consuming D1 and 
this is possibly explained by the slower growth of this group meaning a lower level of 
feed intake. For the 3 mm pellet, the EFA requirement derived from FCR data was 2.0 % 
EPA+DHA, and this fell to 1.5 % EPA+DHA over the whole trial. Therefore, EFA are 
much more important in terms of determining feed efficiency in seabream than seabass. 


































































the effect of dietary EPA+DHA was stronger in gilthead seabream. It is widely accepted 
that larval diets should contain high levels of EFA, especially DHA, to ensure good 
survival, growth and vitality (Izquierdo 1996, Sargent et al. 1997, Tocher 2010). The 
present findings extend this view to juvenile fish and EFA are most important in rapidly 
growing larval and juvenile stages. The practical implications of this are that as the fish 
grows the FO content of the diet can be reduced to preserve the use of this expensive and 
limited raw material (Shepherd, Jackson 2013, Tacon, Metian 2015). 
There are two important caveats that should be acknowledged. Firstly, the 
experimental design treated EPA and DHA as though they represent a single nutrient. 
This was the result of selecting commercial oils to formulate the experimental diets. The 
DHA:EPA ratio is also known to be important to optimise fish performance (Rainuzzo et 
al. 1997, Sargent et al. 1999). In the dietary design the DHA:EPA ratio was 0.87 – 0.69, 
D1 having the highest ratio and D6 the lowest. Studies into the ideal DHA:EPA ratio for 
juvenile seabream indicate that it is about 0.5 (Ibeas et al. 1996), yet in larvae the ideal 
ratio is 2.0 (Rodriguez et al. 1998). Given the present findings it is reasonable to conclude 
that this ratio also declines as larvae/juveniles increase in weight but the herein 
experimental design does not allow comment on the ideal DHA:EPA. It should be 
acknowledged that a higher ratio may have reduced the requirement estimates, 
particularly for the 3 mm pellet size. A South American FO was used, so the DHA:EPA 
ratios in these trials represented the most widely used commodity in aquafeeds. 
Secondly, ARA was not controlled in this experiment and exhibited a gradient in 
parallel to the other LC-PUFA, but at lower levels (D1 – D6: 0.07 – 1.01 g Kg-1 ARA per 




stages of gilthead seabream (Bessonart, Izquierdo et al. 1999, Koven, Barr et al. 2001) 
and European seabass (Atalah, Hernández‐Cruz et al. 2011). A recent study in juvenile 
seabass (14 – 45 g) suggested a requirement, in terms of growth, for ARA between 0.1 – 
0.2 g Kg-1 dry diet (Torrecillas, Román et al. 2017). Therefore, D1 and D2 in the present 
study may have also been deficient in ARA. Therefore, it must be conceded that dietary 
ARA may have had an influence in the data attained for both trials (Fountoulaki, Alexis 
et al. 2003). The question of juvenile ARA requirements warrants investigation with a 
dose response experiment in both species. 
The cost-benefit analysis for gilthead seabream was conducted to explore the 
economic implications of the experimental diets in terms of economic gain over feed 
(Chapter III). D4 (1.1 % EPA + DHA) was the highest performing diet in this regard. 
Considering the other conclusions of the chapter, it is reasonable to conclude that the best 
feeding strategy in terms of economic gain would be achieved by feeding EFA at the 
requirement levels of the fish then reducing EFA to D4 levels when the requirement had 
fallen to the level of ~1.0 % EPA+DHA. Indeed, the growth trajectory of D4 will have 
been overestimated because these fish were fed a diet that was deficient in EFA for the 3 
mm pellet but at some fish weight during the latter part of the experiment (4.5 mm pellet) 
this diet had sufficient EFA to support growth at the level observed in D5 and D6 (these 
fish had growth rates that accelerated during the trial). However, this analysis was 
conducted in terms of laboratory-reared fish at their thermal optimum, so is highly 
theoretical. The cost-benefit analysis for European seabass was not informative so it was 




An important law in nutritional studies is the Liebig principal, which states that a 
plant or animal’s performance will be limited by the first deficient nutrient. In animal 
production, performance is related not only to nutrition but also the rearing environment 
and genetic characteristics of the population. As modern intensive aquaculture is still 
younger than terrestrial livestock farming, the potential gains available in fish breeding 
are as high as 12% per generation (Gjedrem, Robinson 2014). Future improvements in 
stock selection will need to be balanced with new definitions of nutrient requirements as 
any gains in animal performance will have nutritional consequences. Nutrient 
requirements are dynamic and interrelated and need to be evaluated periodically in line 
with cross-disciplinary developments that improve culture performance. 
VII.3 Composition of the fish and key tissues 
In Chapters V and VI, the composition of body compartments and fatty acid profiles 
of the liver and mid-intestine of the fish after consuming the experimental diets for four 
months was presented. Generally, the proximate composition of the whole body and 
eviscerated carcass was unaffected by the diet in both species. The liver lipid level 
increased in both species with the addition of dietary VO, from 18.6 to 31.8 % in seabream 
and 27.6 to 44.9 % in seabass. Visceral lipid deposition declined with increasing VO in 
seabream from 53.5 to 45.2 %, although this relationship was not as strong as in the liver. 
There was no effect on visceral lipid levels in seabass. When seabream and seabass are 
compared, level of lipid in liver and viscera was markedly higher across all dietary groups 
in seabass. High liver lipid (or steatosis) is a known characteristic in marine fish fed diets 
deficient in EFA (Spisni, Tugnoli et al. 1998) and high energy diets (Vergara et al. 1999). 




energy content of the diets. In seabream, but not seabass, the lipid level of the mid-
intestine was also influenced by dietary VO. In these trials, dietary VO appeared to have 
more of an impact on overall lipid deposition in seabream than seabass. 
The fatty acid composition of the liver and mid-intestine was modified toward the 
composition of the diets in both species, supporting previous findings (Kalogeropoulos et 
al. 1992, Torrecillas et al. 2017, Wassef, Wahbi et al. 2012, Montero et al. 2005). The 
main fatty acids that increased with dietary VO, in decreasing order, were: oleic acid, 
LOA and ALA. This is the expected order from the experimental diets. The SFA were 
balanced in the dietary design and therefore increased where an effect on the total lipid 
content of the tissue was found, mainly the liver. 
In the liver of both species, there was evidence for the stimulation of the LC-PUFA 
biosynthesis pathways. In liver of seabream, there was significant production of n-3 
(18:4n-3; 20:3n-3; 20:4n-3 and 22:5n-3) and n-6 (18:3n-6; 20:2n-6 and 20:3n-6) 
intermediate fatty acids. In liver of seabass, only 18:4n-3 appeared at a higher level than 
in D1 in fish that consumed this diet, interestingly 20:3n-3 was not detected, and n-6 
(18:3n-6; 20:2n-6 and 20:3n-6) intermediates were found to be produced. When 
compared, the levels of 18:3n-6 production by seabream and seabass are similar, but 
elongation products only occurred at a very low level in the seabass liver. Therefore, the 
response of the LC-PUFA biosynthesis pathway to diets with low LC-PUFA was more 
pronounced in seabream, especially when elongation activity is considered. Furthermore, 
the n-6 LC-PUFA biosynthetic pathway was more apparent in seabass. Recently, a study 
with linseed oil found that n-3 intermediates were produced in juvenile seabass livers, but 




PUFA synthesis in seabass showed no preference for n-3 or n-6 substrates. There was 
little evidence of activity of LC-PUFA biosynthesis in the mid-intestine of seabream, with 
levels of most fatty acid intermediates explained by their respective levels in the diets. 
The seabass mid-intestine fatty acid profiles indicated that production of LC-PUFA 
intermediates was similar both qualitatively and quantitatively to the seabass liver. In both 
species, Iso 18:2n was detected in both tissues despite the absence of this fatty acid in the 
diet, this being a Δ6 desaturase product of 18:1n-9. However, its elongation product, Iso 
20:2n was only observed in seabream. Whence important differences exist between the 
two species and the two tissues in the operation of this pathway. Supporting previous 
work, there was no evidence that either species can perform the critical Δ5 desaturation 
required to produce EPA or ARA (Tocher 2010). The levels of LC-PUFA were negatively 
affected by dietary VO in both tissues (liver and mid-intestine) and species. The higher 
accumulation of other fatty acids (16:0 and 18:1n-9) in livers, diluted these important 
fatty acids. The mid-intestine, however, retained LC-PUFA at higher proportions than 
would be expected from their proportions in the diet. 
VII.4 Lipid metabolic gene expression 
A range of genes involved in lipid metabolism were assayed in samples of the liver 
and mid-intestine taken at the end of the trials and presented in Chapters V and VI. The 
data were variable indicating that where dietary effects were observed, diet was not the 
sole source of variation and other factors not controlled by the experiment influenced the 
level of expression, in agreement with previous gene expression studies (Morais et al. 
2011, Jordal et al. 2005, Panserat, Hortopan et al. 2009). The regression design employed 




effects. Nevertheless, some patterns in gene expression were observed and it was possible 
in some genes to correlate this to the fatty acid micro-environment of the tissue. The 
biological processes selected for study were β-oxidation, lipogenesis, intra-cellular 
transport and LC-PUFA biosynthesis. Evidence for dietary modulation of β-oxidation 
was only found in the seabream liver, where a subtle downregulation in pparα, cpt1α and 
fabp1 was observed in response to dietary VO. Downregulation of pparα in response to 
dietary VO has been observed in Atlantic salmon (Morais et al. 2011), but results in other 
species (rainbow trout, Japanese seabass and large yellow croaker) have been mixed 
(Dong et al. 2017). Indeed, no effect of diet was found in seabass liver and mid-intestine 
samples. If downregulation of transcripts involved in β-oxidation in liver equates to lower 
catabolism of fatty acids, this may be a contributing factor toward the increased fat 
deposition observed in the liver. 
In the seabream liver and mid-intestine of both species, VO led to an upregulation of 
transcripts involved with lipogenesis. Therefore, lipogenic processes may be increased in 
the liver and mid-intestine in seabream and, the mid-intestine in seabass. It has been 
advanced in fish that the presence of dietary DHA downregulates lipogenic processes in 
fish (Leaver et al. 2008, Thomassen, Rein et al. 2012). In seabream liver, the effect was 
only measurable in D1 and D2, two diets that were severely deficient in EFA, the 
nonlinear nature of the relationship with dietary VO suggests that the upregulation of 
srebp1 and fas expression occurs at a dietary threshold. However, the high variability 
prevents speculation as to what this level may be. The dietary pattern of fads2 and fas 
expression were remarkably correlated to srebp1 expression and, in turn, srebp1 
expression was negatively correlated to the tissue levels of n-3 LC-PUFA in the liver of 




However lines of evidence in salmon head kidney cell line (SHK-1) indicate that fads2 
and fas are targets of Srebp1, but interestingly, elovl5 was not, indicating that fish elovl5 
may be regulated by different mechanisms compared to mammals (Minghetti et al. 2011, 
Carmona-Antoñanzas et al. 2014). Interestingly, at least in mammals, Srebp1 is known to 
regulate its own transcription, therefore alteration of the expression of srebp1 suggests its 
activation (Daemen et al. 2013). An increase in the synthesis of de novo fatty acids would 
also be expected to contribute to increased lipid content of the liver, and perhaps the lipid 
content of the mid-intestine that was found in seabream. Upregulation of the srebp2 
transcript with dietary VO was limited to the mid-intestine in both species. Dietary VO 
has been shown to affect cholesterol metabolism in Atlantic salmon (Leaver et al. 2008) 
and European seabass liver (Geay et al. 2011). Cholesterol formed part of the 
micronutrient supplement in the dietary design so that it was balanced across the 
experimental diets. The upregulation of srebp2 may therefore be the result of phytosterols 
introduced to the diets with dietary VO. In mammals, phytosterols are not absorbed by 
the gut and inhibit cholesterol uptake (Ostlund Jr 2004), this effect has not been 
demonstrated in fish, but may explain the upregulation of srebp2 observed here. The 
absence of a dietary effect in the liver suggest that the overall cholesterol status was not 
strongly affected by the diets. 
Two genes involved in LC-PUFA biosynthesis, fads2 and elovl5, were assayed in the 
liver and mid-intestine. Fads2 was upregulated in both liver and mid-intestine of both 
species by dietary VO. In seabream the strongest response was found in the liver and a 
moderate increase observed in the intestine. In seabass this was reversed and a stronger 
response of fads2 was observed in mid-intestine, with a more modest effect observed in 




seabass mid-intestine. The fads2 data are in line with the statement made in the previous 
section that LC-PUFA biosynthesis was more strongly affected in the seabream liver. 
Furthermore, correlations were able to be made between the level of fads2 expression and 
the level of Fads2 products (e.g. Iso 18:2n and 18:3n-6) in the liver of seabream, but only 
in the mid-intestine in seabass. However, despite the absence of a dietary effect on elovl5, 
elongation products were still found in the fatty acid composition, suggesting an 
underlying activity of this protein with little dietary influence. 
Chapters III and IV demonstrated that EFA requirements are higher in smaller fish 
and decline as the fish grows. Chapters V and VI related dietary compositional changes 
to the transcriptional response in liver and mid-intestine. Therefore, it must be conceded 
that the gene expression samples taken in these trials were taken at the point when the 
requirement for EFA was the lowest. For this reason, it is difficult to use the gene 
expression data to complement the requirement estimates for EFA. Overall, the lipid 
metabolic genes seemed to be more responsive to diet in the seabream liver, but the 
mid-intestine was more responsive to diet in the seabass. Srebp1, fas and fads2 responded 
in similar ways and this response was negatively correlated with the tissue content of LC-
PUFA. 
VII.5 Key conclusions 
The requirement for EPA+DHA declines as fish weight increases. 
Based on growth, the current published EFA requirements are too low for both species to 




At a size range of 24 – 80 g, the period when a 3 mm pellet is consumed, the optimum 
requirement for growth is 1.3 – 1.5 % EPA+DHA, for both species. 
Beyond ~80 g (4.5 mm pellet) seabream require 1.20 – 1.25 % EPA+DHA, whereas 
seabass require 1.10 – 1.20 % EPA+DHA. 
Seabream of 24 – 80 g require 2.0 % EPA+DHA to minimise FCR. Above 80 g this falls 
to 1.5 % EPA+DHA. 
Taking 95% of the asymptote is not a satisfactory method of deriving a requirement level, 
it is sensitive to parameter selection (WG or DGI). 
The effect on FCR in seabass diminishes quickly, but is present in P1, but no breakpoint 
was found. The OV estimate of EPA+DHA requirements for FCR was lower than the 
estimates for growth, so the growth data should be used to inform nutrient specification, 
not FCR. 
The nutrient response curve for EFA changes shape as the fish grow, particularly in 
seabream, changing from a curve to a more angular relationship as growth accelerates in 
fish that satisfy their requirement over time feeding. This required different functions to 
fit the data. 
Therefore, no requirement should be viewed as a static dietary percentage, but rather as 
an amount that supports a certain level of animal performance at a certain animal mass. 





Lipid content in liver was increased in both species, with seabream also exhibiting lower 
visceral lipid deposition. Lipid level of the mid-intestine was also elevated in seabream 
but not seabass. This must be interpreted in the context of the high energy diets. 
Fatty acids in both liver and mid-intestine were modified towards dietary profiles. 
The stimulation of LC-PUFA biosynthesis modulated fatty acid profiles. The seabream 
showed preference for n-3 substrates, the seabass did not exhibit this preference. The 
mid-intestine in seabream appeared to be less active in this regard, but both tissues in 
seabass were sites of desaturation and elongation. 
The transcriptional machinery of lipid metabolism was more responsive to dietary VO in 
seabream, especially in liver, where a subtle downregulation of β-oxidation and 
stimulation of lipogenesis and LC-PUFA biosynthesis was observed. The mid-intestine 
of seabass was more responsive to dietary VO than the liver. 
The transcriptional response could be correlated to the fatty acid profile of the tissue; 
expression of srebp1 was negatively correlated with tissue LC-PUFA, and fads2 was 
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Table A1. Proximate composition of body compartments in S. aurata presented as wet weight (g Kg-1), means and standard deviations (N=3). 
Superscript letters indicate Tukey’s HSD1 after ANOVA (P < 0.05).  
Whole Bodies Initial D1  
  D2  
  D3  
  D4  
  D5  
  D6  
  Pr(>F) 
Protein wet  148.7 154.8 ± 9.7  159.1 ± 5.3  157.0 ± 7.4  157.1 ± 4  155.3 ± 2.6  164.1 ± 9.4  0.782 
Lipid  103.5 181.2 ± 11.7  172.7 ± 9.3  188.4 ± 15.1  176.1 ± 6.5  164.6 ± 6.4  166.9 ± 16.4  0.371 
Ash wet  27.4 14.3 ± 1.6  16.3 ± 0.7  16.6 ± 1.8  15.5 ± 0.7  16.3 ± 0.5  17.3 ± 1.3  0.264 
Moisture  692.8 627.3 ± 9.2  628.7 ± 2.3  623.2 ± 0.9  631.4 ± 15.2  633.9 ± 2.2  637.4 ± 7.1  0.562 
Carcass                                         
Protein wet  179.2 ± 11.7  173.7 ± 2.2  171.2 ± 1.7  182.6 ± 10.7  172.7 ± 3.1  160.7 ± 6.5  0.123 
Lipid   162.7 ± 7.3 
a 149.7 ± 9.1 ab 151.8 ± 9.6 ab 129.5 ± 8.8 b 154.6 ± 10 ab 139.9 ± 10.1 ab 0.044 
Ash wet  32.1 ± 2.9  27.3 ± 4.7  26.2 ± 4.3  31.2 ± 4.4  29.5 ± 4.5  36.1 ± 6.1  0.361 
Moisture   612.9 ± 15.2  639.4 ± 2.5  625.3 ± 10.6  630.7 ± 2.6  623.8 ± 21.8  622.3 ± 7.1  0.425 
Viscera                                         
Protein wet   69.2 ± 8.9  62.9 ± 3.3  64.4 ± 6.2  51.4 ± 10.3  62.8 ± 11.1  63.1 ± 4.9  0.419 
Lipid   448.8 ± 23.2  450.9 ± 14.4  452.6 ± 36  502.2 ± 59.9  514.5 ± 45.6  525.1 ± 47.8  0.261 
Ash wet   6.7 ± 0.5  7.3 ± 1.1  8.9 ± 0.1  6.6 ± 0.7  8 ± 1.7  6.4 ± 0.4  0.114 
Moisture   475.3 ± 15.9  478.9 ± 16.3  474.1 ± 32.6  439.8 ± 50.4  414.6 ± 33.6  405.5 ± 43.4  0.186 
Liver                                         
Protein wet   101.4 ± 13.4  95.3 ± 2.7  103.3 ± 5.6  107.0 ± 11.1  99.3 ± 1.6  101.9 ± 5.9  0.776 
Lipid   323.7 ± 6.3 
a 317.8 ± 31.8 ab 311.0 ± 22.8 ab 233.1 ± 30.7 bc 220.1 ± 22.8 c 186.2 ± 31.8 c < 0.001 
Ash wet   6.4 ± 1  6.1 ± 1.9  6.9 ± 0.8  7.6 ± 0.9  7.8 ± 0.8  8.2 ± 1.7  0.517 
Moisture    473.2 ± 7.2 d 486.5 ± 23.1 bcd 498.7 ± 19.8 bd 550.9 ± 16.6 abc 554.6 ± 24.3 ab 568.8 ± 24.1 a 0.0014 














Table A2. Lipid and fatty acids in the liver of S. aurata as mg g-1 fatty acid per tissue. Data are summarised as mean and standard deviation 
(N=3·3). Superscripts indicate Tukey’s HSD1 after ANOVA (P < 0.05).  
  D1  
  D2  
  D3  
  D4  
  D5  
  D6  
  Pr(>F) 
Total lipid                    
Lipid (%) 29.9 ± 0 6 a 26.8 ± 4.5 a 25.4 ± 4.7 a 29.9 ± 5.1 a 24.4 ± 6.5 a 13.1 ± 4.4 b < 0.001 
Fatty acid                    
14:0 2.8 ± 0.7 b 2.6 ± 0.6 b 2.8 ± 0.7 b 3.8 ± 0.8 ab 4.5 ± 1.3 b 3.8 ± 1.5 ab 0.001 
16:0 38.6 ± 9.1 a 34.5 ± 6.5 a 34.2 ± 7.4 a 40.1 ± 5.7 a 33.6 ± 9.6 a 18.4 ± 6.4 b < 0.001 
18:0 12.7 ± 2.8 a 11.5 ± 2.3 a 10.7 ± 1.9 a 12.5 ± 1.6 a 10.5 ± 3.6 ab 6.8 ± 2.6 b < 0.001 
20:0 0.4 ± 0.1 a 0.4 ± 0.1 a 0.4 ± 0.1 a 0.5 ± 0.1 a 0.4 ± 0.1 a 0.2 ± 0.1 b < 0.001 
22:0 0.2 ± 0.1 ab 0.3 ± 0.1 a 0.3 ± 0.0 a 0.3 ± 0.0 a 0.2 ± 0.1 a 0.1 ± 0.0 b < 0.001 
16:1n-9 2.0 ± 0.6 a 1.4 ± 0.3 bc 1.4 ± 0.3 bc 1.5 ± 0.3 ab 1.0 ± 0.3 cd 0.5 ± 0.2 d < 0.001 
16:1n-7 4.3 ± 1.2 bc 4.2 ± 0.9 c 4.6 ± 1.2 bc 6.5 ± 1.2 ab 7.0 ± 2.0 a 5.7 ± 2.2 abc < 0.001 
18:1n-9 109.0 ± 25.6 a 90.9 ± 18.6 ab 87.6 ± 19.7 ab 96.7 ± 15.5 a 63.4 ± 19.1 b 20.9 ± 9.2 a < 0.001 
18:1n-7 8.1 ± 1.9 a 7.3 ± 1.5 a 7.1 ± 1.7 ab 8.9 ± 1.2 a 7.4 ± 2.3 a 4.5 ± 1.8 b < 0.001 
20:1n 3.4 ± 1.0 a 3.6 ± 0.9 a 3.5 ± 1.0 a 4.6 ± 1.3 a 3.1 ± 1.2 a 1.5 ± 0.7 b < 0.001 
22:1n 1.0 ± 0.4 ab 1.0 ± 0.3 ab 1.0 ± 0.2 ab 1.4 ± 0.4 a 1.1 ± 0.4 ab 0.7 ± 0.2 b 0.003 
24:1n-9 1.0 ± 0.2  0.9 ± 0.2  0.9 ± 0.2  1.0 ± 0.4  0.9 ± 0.3  0.6 ± 0.2  0.061 
Iso 18:2n 2.7 ± 1.0 a 1.5 ± 0.6 b 1.2 ± 0.4 b 0.9 ± 0.3 bc 0.4 ± 0.2 cd 0.2 ± 0.1 c < 0.001 
18:2n-6 33.4 ± 8.4 a 29.9 ± 7.6 a 29.9 ± 7.5 a 33.7 ± 8.1 a 23.9 ± 6.6 a 9.7 ± 3.7 b < 0.001 
18:3n-6 2.4 ± 1.0 a 1.3 ± 0.7 b 1.2 ± 0.5 bc 0.8 ± 0.3 bcd 0.4 ± 0.2 cd 0.2 ± 0.1 d < 0.001 
Iso 20:2n 2.2 ± 0.7 a 1.6 ± 0.4 b 1.4 ± 0.4 b 1.3 ± 0.4 b 0.7 ± 0.2 cd 0.2 ± 0.1 c < 0.001 
20:2n-6 1.3 ± 0.4 ab 1.3 ± 0.4 ab 1.3 ± 0.4 ab 1.6 ± 0.5 a 0.9 ± 0.3 bc 0.4 ± 0.2 c < 0.001 
20:3n-6 1.2 ± 0.4 a 0.9 ± 0.3 a 0.9 ± 0.3 a 0.8 ± 0.2 a 0.5 ± 0.2 b 0.2 ± 0.1 b < 0.001 
20:4n-6 0.1 ± 0.1 d 0.3 ± 0.0 c 0.4 ± 0.0 c 0.6 ± 0.1 b 0.7 ± 0.2 ab 0.8 ± 0.2 a < 0.001 
18:3n-3 6.7 ± 1.9 ab 6.3 ± 1.8 ab 6.2 ± 1.7 ab 7.3 ± 2.1 a 4.8 ± 1.3 b 1.3 ± 0.5 c < 0.001 
18:4n-3 0.7 ± 0.2 ab 0.6 ± 0.2 b 0.6 ± 0.2 b 0.8 ± 0.3 ab 1.1 ± 0.3 a 1.1 ± 0.5 a 0.0019 
20:3n-3 0.4 ± 0.1 ab 0.4 ± 0.1 ab 0.4 ± 0.1 ab 0.6 ± 0.2 a 0.3 ± 0.1 b 0.1 ± 0.1 c < 0.001 
20:4n-3 0.5 ± 0.2 c 0.5 ± 0.1 c 0.6 ± 0.2 bc 1.0 ± 0.2 a 1.0 ± 0.3 a 0.9 ± 0.4 ab < 0.001 
20:5n-3 1.2 ± 0.5 c 2.2 ± 0.4 c 2.8 ± 0.5 bc 4.9 ± 1.1 b 7.1 ± 2.0 a 7.5 ± 2.7 a < 0.001 
22:5n-3 0.7 ± 0.3 b 1.3 ± 0.4 b 1.7 ± 0.4 b 3.5 ± 1.0 a 4.5 ± 1.4 a 4.7 ± 2.0 a < 0.001 
22:6n-3 1.6 ± 0.5 c 2.7 ± 0.6 c 3.2 ± 0.6 c 6.1 ± 1.3 b 8.4 ± 2.3 ab 9.6 ± 3.1 a < 0.001 
1 Honest significant differences.  





















Table A3. Lipid content and fatty acids in the mid-intestine of S. aurata presented as mg g-1 fatty acid per tissue. Data are summarised as 
mean and standard deviation (N=3·3). Superscripts indicate Tukey’s HSD1 after ANOVA (P < 0.05). 
Diet D1  
  D2  
  D3  
  D4  
  D5  
  D6  
  Pr(>F) 
Total lipid                    
Lipid (%) 16.4 ± 3.6 a 13.8 ± 2.2 ab 11.1 ± 3.5 bc 10.5 ± 1.9 bc 11.1 ± 2.4 bc 9.5 ± 1.5 c < 0.001 
Fatty acid                    
14:0 0.9 ± 0.2 b 1.3 ± 0.3 b 1.2 ± 0.5 b 1.5 ± 0.3 b 2.6 ± 0.8 a 3.3 ± 0.8 a < 0.001 
16:0 19.4 ± 3.9 a 17.8 ± 3.4 ab 15.7 ± 4.5 ab 14.1 ± 2 b 15.5 ± 3.6 ab 13.6 ± 2.5 b 0.01 
18:0 5.7 ± 1.2 a 5.4 ± 0.8 ab 4.3 ± 1.1 bc 4.1 ± 0.6 c 4.1 ± 0.8 bc 3.9 ± 0.5 c < 0.001 
20:0 0.4 ± 0.1 a 0.4 ± 0.1 ab 0.3 ± 0.1 abc 0.3 ± 0 cd 0.3 ± 0.1 bcd 0.2 ± 0.0 d < 0.001 
22:0 0.2 ± 0.1 a 0.2 ± 0.1 ab 0.2 ± 0.1 abc 0.1 ± 0 bc 0.1 ± 0.0 bc 0.1 ± 0.0 c < 0.001 
16:1n-9 0.5 ± 0.1 a 0.4 ± 0.1 ab 0.3 ± 0.1 bc 0.3 ± 0.1 bc 0.3 ± 0.1 bc 0.2 ± 0.1 c < 0.001 
16:1n-7 1.2 ± 0.3 b 1.6 ± 0.4 b 1.5 ± 0.6 b 1.9 ± 0.3 b 3.1 ± 1.0 a 3.5 ± 0.9 a < 0.001 
18:1n-9 63.4 ± 17.3 a 45.3 ± 10.8 b 32.3 ± 14.7 bc 28.3 ± 7.2 c 23.5 ± 6.5 c 9.1 ± 2.0 d < 0.001 
18:1n-7 4.3 ± 1.1 a 3.6 ± 0.8 ab 2.7 ± 1.1 bc 2.5 ± 0.5 bc 2.8 ± 0.7 bc 2.1 ± 0.4 c < 0.001 
20:1n2 1.3 ± 0.4 a 1.1 ± 0.2 ab 0.9 ± 0.4 ab 0.8 ± 0.1 b 1.0 ± 0.3 ab 0.9 ± 0.2 b 0.007 
22:1n2 0.4 ± 0.1 ab 0.4 ± 0.2 ab 0.3 ± 0.2 b 0.3 ± 0.1 b 0.5 ± 0.2 ab 0.6 ± 0.1 a 0.004 
24:1n-9 0.6 ± 0.2 a 0.5 ± 0.1 ab 0.4 ± 0.2 ab 0.4 ± 0.1 b 0.5 ± 0.2 ab 0.5 ± 0.1 ab 0.022 
18:2n-6 24.3 ± 6.4 a 18.5 ± 3.8 ab 14.3 ± 5.6 bc 12.7 ± 2.7 bc 11.9 ± 3.2 cd 6.4 ± 1.2 d < 0.001 
20:2n-6 0.4 ± 0.1 a 0.3 ± 0.1 ab 0.3 ± 0.1 bc 0.2 ± 0.0 c 0.2 ± 0.1 cd 0.1 ± 0.0 d < 0.001 
20:4n-6 0.1 ± 0.1 d 0.2 ± 0.0 c 0.2 ± 0.0 bc 0.3 ± 0.0 b 0.5 ± 0.1 a 0.5 ± 0.1 a < 0.001 
18:3n-3 5.4 ± 1.7 a 3.9 ± 0.9 b 2.9 ± 1.4 bc 2.6 ± 0.7 bc 2.3 ± 0.7 cd 0.8 ± 0.2 d < 0.001 
18:4n-3 0.0 ± 0.0 c 0.1 ± 0.1 bc 0.2 ± 0.1 bc 0.2 ± 0.1 b 0.5 ± 0.2 a 0.6 ± 0.2 a < 0.001 
20:4n-3 0.0 ± 0.0 c 0.0 ± 0.1 c 0.1 ± 0.1 bc 0.2 ± 0.0 b 0.3 ± 0.1 a 0.3 ± 0.1 a < 0.001 
20:5n-3 0.6 ± 0.1 d 1.2 ± 0.1 cd 1.4 ± 0.4 cd 1.9 ± 0.2 c 3.5 ± 0.8 b 4.6 ± 1.0 a < 0.001 
22:5n-3 0.3 ± 0.1 c 0.5 ± 0.1 bc 0.5 ± 0.1 bc 0.7 ± 0.1 b 1.0 ± 0.3 a 1.3 ± 0.3 a < 0.001 
22:6n-3 1.1 ± 0.2 e 2.0 ± 0.2 d 2.4 ± 0.5 cd 3.1 ± 0.2 c 4.7 ± 0.7 b 6.7 ± 1.1 a < 0.001 
1 Honest significant differences 














Table A4. Results of proximate analysis of European seabass (Dicentrarchus labrax) body compartments (N=3) after 18 weeks feeding on 
experimental diets D1 - D6. Values are reported as g kg-1 (± SD). The results of statistical treatment by ANOVA (different lower-case letters 
denote Tukey's HSD1 tests). 
Diet  D1    D2    D3    D4    D5    D6    Pr(>F) 
Liver Moisture 371.7 ± 2.1 a 426.0 ± 61.0 abc 398.0 ± 26.6 ab 439.7 ± 18.6 abc 469.3 ± 4.5 bc 491.3 ± 17.6 c 0.003 
 Ash 5.2 ± 0.2 
a 6.1 ± 1.2 ab 5.4 ± 0.5 ab 6.6 ± 0.5 ab 6.8 ± 0.7 ab 7.3 ± 0.8 b 0.022 
 Protein 60.4 ± 0.6 
a 72.6 ± 9.0 abc 66.2 ± 6.2 ab 79.3 ± 3.2 bc 79.0 ± 2.2 bc 84.0 ± 5.3 c <0.001 
  Lipid 485.2 ± 7.6 d 416.7 ± 75.3 bcd 427.0 ± 35.4 cd 362.5 ± 11.1 abc 322.3 ± 15.1 ab 302.4 ± 20.5 a <0.001 
Carcass Moisture 634.7 ± 12.2  608.3 ± 11.0  605.7 ± 16.8  599.7 ± 6.1  610.3 ± 17.0  600.3 ± 18.2 
  n.sig 
 Ash 35.9 ± 2.8  37.0 ± 3.1  34.8 ± 1.6  38.1 ± 2.7  31.0 ± 3.0  37.7 ± 7.2  n.sig 
 Protein 168.4 ± 1.4  170.9 ± 0.2  171.9 ± 9.2  170.3 ± 0.2  169.4 ± 3.6  168.3 ± 3.2  n.sig 
  Lipid 143.7 ± 17.7   170.0 ± 17.8   181.4 ± 11.9   174.8 ± 7.8   173.0 ± 11.7   165.6 ± 13.9  n.sig 
Viscera Moisture 203.7 ± 15.3  187.0 ± 35.1  211.7 ± 7.6  181.0 ± 12.5  199.3 ± 29.3  207.7 ± 10.3 
  n.sig 
 Ash 3.1 ± 0.1  3.2 ± 0.5  3.4 ± 0.2  2.9 ± 0.5  3.0 ± 0.3  3.4 ± 0.2  n.sig 
 Protein 31.5 ± 8.3  32.9 ± 7.9  31.2 ± 3.3  32.1 ± 5.6  36.6 ± 6.6  38.3 ± 5.2  n.sig 
  Lipid 708.0 ± 14.0   724.6 ± 36.3   705.0 ± 44.3   718.8 ± 19.7   691.1 ± 53.4   729.6 ± 33.0  n.sig 
Whole  Moisture 565.7 ± 10.2  566.3 ± 10.1  565.3 ± 5  566.8 ± 19.0  566.0 ± 10.8  570.0 ± 6.2 
  n.sig 
body Ash 33.7 ± 2.5  35.4 ± 7.3  34.8 ± 2.7  34.9 ± 2.2  32.6 ± 4.8  36.0 ± 3.2  n.sig 
 Protein 154.2 ± 6.8  154.1 ± 6.9  155.8 ± 5.8  157.1 ± 3.8  153.6 ± 0.9  158.1 ± 2.7  n.sig 
  Lipid 205.5 ± 24.9   219.7 ± 0.7   201.9 ± 14.0   223.6 ± 14.6   209.6 ± 15.6   201.0 ± 22.9  n.sig 















Table A5. Tissue total lipid (%) and mean levels (N = 3 · 3) of fatty acids (mg g-1 ± SD) in the liver of European seabass (D. labrax) after 
18 weeks feeding on the experimental diets, D1 - D6. Results of statistical treatment by ANOVA (lower case letters indicate Tukey's HSD1).  
 Diet: D1    D2    D3    D4    D5    D6    Pr(>F) 
Total Lipid 50.21 ± 5.32 c 38.95 ± 6.88 abc 43.68 ± 10.14 bc 39.20 ± 7.55 ab 29.39 ± 4.75 a 31.35 ± 8.99 a <0.001 
Fatty acid                    
14:0 6.11 ± 1.19 b 4.66 ± 1.07 ab 4.61 ± 1.02 a 4.39 ± 0.73 a 3.48 ± 0.62 a 4.05 ± 1.33 a <0.001 
16:0 85.12 ± 13.33 b 70.42 ± 14.01 ab 73.07 ± 15.78 ab 68.98 ± 12.48 ab 55.29 ± 7.72 a 55.77 ± 15.74 a <0.001 
18:0 32.05 ± 6.61 c 24.98 ± 7.24 bc 25.66 ± 6.72 bc 21.78 ± 5.51 ab 16.71 ± 3.61 a 16.70 ± 4.46 a <0.001 
20:0 1.01 ± 0.16 d 0.73 ± 0.18 c 0.79 ± 0.21 c 0.64 ± 0.13 bc 0.45 ± 0.07 ab 0.43 ± 0.11 a <0.001 
22:0 0.25 ± 0.06 b 0.20 ± 0.06 ab 0.20 ± 0.06 ab 0.24 ± 0.10 b 0.10 ± 0.02 a 0.13 ± 0.17 a <0.001 
16:1n-9 4.29 ± 0.58 c 2.93 ± 0.72 b 3.03 ± 0.60 b 2.65 ± 0.43 ab 2.01 ± 0.27 a 1.95 ± 0.46 a <0.001 
16:1n-7 11.87 ± 3.07  9.41 ± 2.44  9.76 ± 2.28  9.84 ± 1.71  8.89 ± 1.35  10.48 ± 3.39  n.sig 
18:1n-9 217.45 ± 28.67 d 158.40 ± 37.21 c 180.97 ± 48.19 cd 152.49 ± 34.13 bc 107.67 ± 21.48 ab 102.71 ± 26.81 a <0.001 
18:1n-7 8.00 ± 1.22  6.36 ± 1.25  7.73 ± 2.12  7.41 ± 1.64  5.71 ± 1.15  7.29 ± 2.69  n.sig 
20:1n2 4.65 ± 0.84 c 3.25 ± 0.79 ab 4.20 ± 1.29 bc 3.52 ± 0.74 abc 2.38 ± 0.67 a 2.53 ± 0.90 a <0.001 
22:1n2 0.51 ± 0.15  0.44 ± 0.19  0.60 ± 0.21  0.50 ± 0.11  0.43 ± 0.09  0.55 ± 0.24  n.sig 
24:1n-9 0.73 ± 0.31  0.65 ± 0.21  0.71 ± 0.27  0.54 ± 0.14  0.53 ± 0.14  0.60 ± 0.23  0.033 
Iso 18:2n 7.37 ± 1.02 d 4.68 ± 1.36 c 4.97 ± 1.10 c 3.85 ± 0.68 bc 2.84 ± 0.47 ab 2.50 ± 0.51 a <0.001 
18:2n-6 28.31 ± 6.18 c 19.41 ± 8.37 ab 22.95 ± 7.68 bc 19.07 ± 4.33 b 10.80 ± 3.44 a 9.45 ± 4.42 a <0.001 
18:3n-6 2.38 ± 0.44 c 1.27 ± 0.37 b 1.54 ± 0.43 b 1.10 ± 0.22 b 0.65 ± 0.13 a 0.55 ± 0.2 a <0.001 
20:2n-6 0.86 ± 0.21 ab 0.67 ± 0.24 ab 0.91 ± 0.36 b 0.77 ± 0.17 ab 0.53 ± 0.16 a 0.58 ± 0.27 ab 0.0083 
20:3n-6 0.09 ± 0.07  0.08 ± 0.05  0.10 ± 0.07  0.12 ± 0.12  0.06 ± 0.05  0.08 ± 0.07  n.sig 
20:4n-6 0.16 ± 0.03 a 0.20 ± 0.09 ab 0.26 ± 0.07 cb 0.36 ± 0.05 dc 0.47 ± 0.09 de 0.67 ± 0.18 e <0.001 
18:3n-3 5.38 ± 1.35 d 3.99 ± 2.29 bc 4.61 ± 1.67 cd 3.72 ± 0.92 c 1.90 ± 0.63 ab 1.18 ± 0.58 a <0.001 
18:4n-3 0.92 ± 0.17 ab 0.69 ± 0.22 a 1.11 ± 0.54 ab 0.98 ± 0.25 ab 0.91 ± 0.24 ab 1.41 ± 0.70 b 0.022 
20:4n-3 nd   nd   0.12 ± 0.07 
a 0.12 ± 0.08 a 0.19 ± 0.09 a 0.38 ± 0.22 b 0.0013 
20:5n-3 0.76 ± 0.12 a 2.01 ± 0.88 b 3.10 ± 0.92 bc 4.12 ± 1.04 cd 5.09 ± 1.41 d 8.49 ± 3.95 e <0.001 
22:5n-3 nd   0.26 ± 0.30 
a 0.37 ± 0.15 b 0.49 ± 0.26 b 0.57 ± 0.28 bc 1.15 ± 0.76 c <0.001 
22:6n-3 0.68 ± 0.14 a 1.72 ± 1.18 b 2.01 ± 0.82 bc 3.19 ± 1.12 cd 4.11 ± 1.43 de 7.38 ± 4.16 e <0.001 
16:n 0.50 ± 0.08 a 0.60 ± 0.07 ab 0.79 ± 0.23 bc 1.07 ± 0.44 cd 0.96 ± 0.28 cd 1.64 ± 0.71 d <0.001 
1 Honest significant differences. 














Table A6. Total lipid (%) and mean levels (N = 3 · 3) of fatty acids (mg g-1 ± SD) in the mid-intestine of European seabass (D. labrax) after 
18 weeks feeding on the experimental diets, D1 - D6. Results of statistical treatment by ANOVA (lower case letters indicate Tukey's HSD1). 
 Diet D1    D2    D3    D4    D5    D6    Pr(>F) 
Total Lipid* 6.83 ± 1.53  7.12 ± 1.46  6.51 ± 1.15  6.53 ± 1.56  6.88 ± 1.56  6.43 ± 1.67  n.sig 
Fatty acid                    
14:0 0.38 ± 0.14 d 0.53 ± 0.20 cd 0.57 ± 0.13 c 0.69 ± 0.23 bc 1.12 ± 0.42 ab 1.46 ± 0.52 a <0.001 
16:0 7.67 ± 2.91  8.32 ± 2.35  8.23 ± 1.60  8.05 ± 2.00  8.99 ± 2.81  8.56 ± 2.62  n.sig 
18:0 2.80 ± 0.68  2.85 ± 0.42  2.95 ± 0.43  2.88 ± 0.49  3.04 ± 0.59  3.02 ± 0.58  n.sig 
20:0 0.16 ± 0.07 a 0.15 ± 0.05 a 0.14 ± 0.03 a 0.13 ± 0.03 ab 0.13 ± 0.04 ab 0.10 ± 0.03 b 0.0064 
22:0 0.08 ± 0.04  0.07 ± 0.02  0.07 ± 0.01  0.07 ± 0.01  0.06 ± 0.02  0.06 ± 0.02  n.sig 
16:1n-9 0.19 ± 0.06  0.18 ± 0.05  0.17 ± 0.03  0.16 ± 0.03  0.18 ± 0.06  0.16 ± 0.04  n.sig 
16:1n-7 0.52 ± 0.18 d 0.74 ± 0.30 cd 0.72 ± 0.19 cd 0.88 ± 0.31 bc 1.42 ± 0.58 ab 1.78 ± 0.64 a <0.001 
18:1n-9 16.64 ± 8.35 b 16.40 ± 6.11 b 14.18 ± 3.11 b 12.97 ± 4.24 b 11.94 ± 4.63 ab 7.65 ± 2.64 a <0.001 
18:1n-7 0.87 ± 0.42  1.12 ± 0.35  1.07 ± 0.2  1.06 ± 0.28  1.19 ± 0.40  1.14 ± 0.35  n.sig 
20:1n2 0.68 ± 0.31  0.65 ± 0.23  0.60 ± 0.12  0.57 ± 0.17  0.61 ± 0.22  0.52 ± 0.16  n.sig 
22:1n2 0.15 ± 0.08  0.15 ± 0.07  0.15 ± 0.05  0.16 ± 0.05  0.21 ± 0.07  0.22 ± 0.08  n.sig 
24:1n-9 0.11 ± 0.03  0.11 ± 0.02  0.12 ± 0.02  0.11 ± 0.03  0.14 ± 0.02  0.14 ± 0.03  n.sig 
Iso 18:2n* 0.23 ± 0.08 a 0.19 ± 0.05 ab 0.18 ± 0.03 abc 0.16 ± 0.05 abc 0.15 ± 0.06 bc 0.13 ± 0.04 c 0.0014 
18:2n-6 9.13 ± 3.48 b 8.70 ± 2.49 b 8.20 ± 1.38 b 7.48 ± 1.81 ab 6.89 ± 1.98 ab 5.04 ± 1.62 a <0.001 
18:3n-6 0.20 ± 0.08 c 0.17 ± 0.04 bc 0.17 ± 0.03 bc 0.15 ± 0.03 abc 0.12 ± 0.03 ab 0.10 ± 0.03 a <0.001 
20:2n-6 0.29 ± 0.07  0.27 ± 0.07  0.27 ± 0.04  0.28 ± 0.07  0.27 ± 0.07  0.24 ± 0.05    
20:3n-6 0.10 ± 0.03 b 0.08 ± 0.02 ab 0.08 ± 0.02 ab 0.07 ± 0.01 ab 0.07 ± 0.01 a 0.07 ± 0.02 a 0.018 
20:4n-6 0.17 ± 0.02 a 0.27 ± 0.02 b 0.30 ± 0.05 bc 0.35 ± 0.05 c 0.46 ± 0.08 d 0.55 ± 0.08 e <0.001 
22:5n-6 0.04 ± 0.01 a 0.06 ± 0.01 ab 0.07 ± 0.01 b 0.08 ± 0.01 b 0.10 ± 0.02 c 0.12 ± 0.03 c <0.001 
18:3n-3 1.62 ± 0.83 b 1.64 ± 0.65 b 1.42 ± 0.27 b 1.28 ± 0.41 b 1.10 ± 0.39 b 0.59 ± 0.20 a <0.001 
18:4n-3 0.11 ± 0.04 c 0.13 ± 0.05 bc 0.13 ± 0.03 bc 0.17 ± 0.07 b 0.29 ± 0.13 a 0.41 ± 0.17 a <0.001 
20:4n-3 0.03 ± 0.01 c 0.04 ± 0.01 b 0.04 ± 0.01 b 0.06 ± 0.02 b 0.10 ± 0.04 a 0.14 ± 0.05 a <0.001 
20:5n-3 0.85 ± 0.15 d 1.34 ± 0.25 c 1.51 ± 0.22 bc 1.86 ± 0.44 b 2.81 ± 0.83 a 3.66 ± 1.08 a <0.001 
22:5n-3 0.23 ± 0.04 d 0.28 ± 0.04 cd 0.32 ± 0.04 c 0.34 ± 0.07 bc 0.45 ± 0.13 ab 0.54 ± 0.16 a <0.001 
22:6n-3 1.65 ± 0.21 d 2.17 ± 0.21 c 2.53 ± 0.37 bc 2.80 ± 0.48 b 3.67 ± 0.78 a 4.43 ± 0.94 a <0.001 
16:n 0.16 ± 0.02 b 0.16 ± 0.02 b 0.16 ± 0.02 b 0.17 ± 0.02 b 0.29 ± 0.15 a 0.41 ± 0.22 a <0.001 
1 Honest significant differences. 
2 Sum of 20C or 22C monounsaturates (n-7 + n-9 +n-11). 
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